Avon Products (AVP) 10-Q 31 Oct 19 2019 Q3 Quarterly report Financial data

Cover Page

Cover Page	9 Months Ended
	Sep. 30, 2019shares
Cover page.
Document Type	10-Q
Document Quarterly Report	true
Document Period End Date	Sep. 30, 2019
Document Transition Report	false
Entity File Number	1-4881
Entity Incorporation, State or Country Code	NY
Entity Tax Identification Number	13-0544597
Entity Address, Address Line One	Building 6, Chiswick Park
Entity Address, City or Town	London
Entity Address, Postal Zip Code	W4 5HR
Entity Address, Country	GB
Country Region	44
City Area Code	1904
Local Phone Number	232425
Title of 12(b) Security	Common stock, par value $0.25 per share
Trading Symbol	AVP
Security Exchange Name	NYSE
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Large Accelerated Filer
Entity Small Business	false
Entity Emerging Growth Company	false
Entity Shell Company	false
Entity Common Stock, Shares Outstanding	443,525,346
Entity Registrant Name	AVON PRODUCTS INC
Entity Central Index Key	0000008868
Current Fiscal Year End Date	--12-31
Document Fiscal Year Focus	2019
Document Fiscal Period Focus	Q3
Amendment Flag	false

Consolidated Statements of Oper

Consolidated Statements of Operations - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Sep. 30, 2019	Sep. 30, 2018	Sep. 30, 2019	Sep. 30, 2018
Revenue	$ 1,188	$ 1,424.2	$ 3,549.7	$ 4,169.6
Costs, expenses and other:
Cost of sales	(468.2)	(538.4)	(1,482.7)	(1,657.8)
Selling, general and administrative expenses	(622.1)	(698.9)	(1,942.7)	(2,227)
Operating profit	97.7	186.9	124.3	284.8
Interest expense	(32)	(31.3)	(95.9)	(102)
Loss on extinguishment of debt and credit facilities	(8.1)	0	(10.1)	(2.9)
Interest income	2.1	4.3	5.3	12
Other income (expense), net	57.9	22.2	87.3	0.3
Gain on sale of business/assets	26.8	0	50.3	0
Total other income (expenses)	46.7	(4.8)	36.9	(92.6)
Income from continuing operations, before income taxes	144.4	182.1	161.2	192.2
Income taxes	(31.5)	(68.3)	(78.2)	(136.5)
Income from continuing operations, net of tax	112.9	113.8	83	55.7
Loss from discontinued operations, net of tax	(6.3)	0	(29)	0
Net income	106.6	113.8	54	55.7
Net loss attributable to noncontrolling interests	0.3	0.7	0.7	2.4
Net income attributable to Avon	$ 106.9	$ 114.5	$ 54.7	$ 58.1
Basic
Basic from continuing operations (in dollars per share)	$ 0.21	$ 0.21	$ 0.14	$ 0.09
Basic from discontinued operations (in dollars per share)	(0.01)	0	(0.06)	0
Basic attributable to Avon (in dollars per share)	0.20	0.21	0.08	0.09
Diluted
Diluted from continuing operations (in dollars per share)	0.21	0.21	0.14	0.09
Diluted from discontinued operations (in dollars per share)	(0.01)	0	(0.06)	0
Diluted attributable to Avon (in dollars per share)	$ 0.20	$ 0.21	$ 0.08	$ 0.09
Product sales
Revenue	$ 1,117.2	$ 1,346.3	$ 3,342.2	$ 3,924.7
Other revenue
Revenue	$ 70.8	$ 77.9	$ 207.5	$ 244.9

Consolidated Statements of Comp

Consolidated Statements of Comprehensive Income (Loss) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Sep. 30, 2019	Sep. 30, 2018	Sep. 30, 2019	Sep. 30, 2018
Statement of Comprehensive Income [Abstract]
Net income	$ 106.6	$ 113.8	$ 54	$ 55.7
Other comprehensive loss:
Foreign currency translation adjustments	0	0.8	1.3	(49.1)
Unrealized losses on revaluation of long-term intercompany balances, net of taxes	(19.1)	(4.6)	(19.4)	(48.7)
Change in unrealized gains/losses on cash flow hedges, net of taxes	0.1	0	(2.5)	0
Adjustments of and amortization of net actuarial loss and prior service cost, net of taxes	1.6	2.1	4.7	7.8
Sale of business	(3.4)	0	(3.4)	0
Total other comprehensive loss, net of income taxes	(20.8)	(1.7)	(19.3)	(90)
Comprehensive income	85.8	112.1	34.7	(34.3)
Less: comprehensive loss attributable to noncontrolling interests	(0.3)	(0.9)	(0.8)	(2.8)
Comprehensive income attributable to Avon	$ 86.1	$ 113	$ 35.5	$ (31.5)

Consolidated Statements of Co_2

Consolidated Statements of Comprehensive Income (Loss) (Parenthetical) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Sep. 30, 2019	Sep. 30, 2018	Sep. 30, 2019	Sep. 30, 2018
Statement of Comprehensive Income [Abstract]
Unrealized losses on revaluation of long-term intercompany balances, tax	$ 0	$ 0	$ 0	$ 0
Change in unrealized gain/losses on cash flow hedges, tax	0	0	0	0
Adjustments of and amortization of net actuarial loss and prior service cost, tax	$ 0.2	$ 0.1	$ 0.5	$ 0.4

Consolidated Balance Sheets

Consolidated Balance Sheets - USD ($) $ in Millions	Sep. 30, 2019	Dec. 31, 2018
Current Assets
Cash and cash equivalents	$ 564.2	$ 532.7
Accounts receivable, net	303	349.7
Inventories	499.4	542
Prepaid expenses and other	265.4	272
Assets held for sale	18.3	65.6
Total current assets	1,650.3	1,762
Property, plant and equipment, at cost	1,101.4	1,207.8
Less accumulated depreciation	(624.4)	(650.2)
Property, plant and equipment, net	477	557.6
Right-of-use assets	172.3
Goodwill	82.5	87.4
Deferred tax asset	174.2	212.6
Other assets	513.9	390.4
Total assets	3,070.2	3,010
Current Liabilities
Debt maturing within one year	116.2	12
Accounts payable	642	816.5
Accrued compensation	104.4	85.5
Other accrued liabilities	387.9	451.3
Sales taxes and taxes other than income	98.2	103.9
Income taxes	10.4	15.9
Total current liabilities	1,373.3	1,496.5
Long-term debt	1,589.1	1,581.6
Long-term operating lease liability	141.7
Employee benefit plans	128.2	128.3
Long-term income taxes	127.4	136.2
Other liabilities	74.6	72.1
Total liabilities	3,434.3	3,414.7
Series C convertible preferred stock	511.1	492.1
Shareholders’ Deficit
Common stock	190.4	190.3
Additional paid-in capital	2,310.5	2,303.6
Retained earnings	2,270	2,234.3
Accumulated other comprehensive loss	(1,049.7)	(1,030.4)
Treasury stock, at cost	(4,603.3)	(4,602.3)
Total Avon shareholders’ deficit	(882.1)	(904.5)
Noncontrolling interests	6.9	7.7
Total shareholders’ deficit	(875.2)	(896.8)
Total liabilities, series C convertible preferred stock and shareholders’ deficit	3,070.2	3,010
Held for sale liabilities
Current Liabilities
Held for sale liabilities	0	11.4
Discontinued operations
Current Liabilities
Held for sale liabilities	$ 14.2	$ 0

Consolidated Statements of Cash

Consolidated Statements of Cash Flows - USD ($) $ in Millions		3 Months Ended		9 Months Ended
		Sep. 30, 2019	Sep. 30, 2018	Sep. 30, 2019	Sep. 30, 2018
Cash Flows from Operating Activities
Net income		$ 106.6	$ 113.8	$ 54	$ 55.7
Loss from discontinued operations, net of tax		(6.3)	0	(29)	0
Income from continuing operations, net of tax		112.9	113.8	83	55.7
Adjustments to reconcile net income from continuing operations to net cash provided (used) by operating activities:
Depreciation		18.1	19.5	54.6	61.1
Amortization		5.9	6.5	18.7	20.3
Provision for doubtful accounts		28.2	40.7	86.9	126.9
Provision for obsolescence		6	9.2	22.2	22.5
Share-based compensation		3.7	2	8.9	9.5
Foreign exchange losses (gains)		0.6	(9.5)	(6.7)	4
Deferred income taxes		14.4	(28.3)	21.7	(28.5)
Impairment loss on assets		2.1	0	15.4	0
Gain on sale of business / assets		(26.8)	0	(50.3)	0
Certain Brazil indirect taxes		(118.3)	(194.7)	(118.3)	(194.7)
Other		11.5	11	16.7	14.2
Changes in assets and liabilities:
Accounts receivable		(15.2)	(43.4)	(56.1)	(93.4)
Inventories		(7.9)	(32.1)	10.1	(131.8)
Prepaid expenses and other		18.9	(39.9)	34.1	(38.2)
Accounts payable and accrued liabilities		(21.5)	45.9	(232.8)	(30.7)
Income and other taxes		(1.7)	74.4	5.5	74.1
Noncurrent assets and liabilities		(0.6)	63.3	(18.9)	60.7
Net cash provided (used) by operating activities of continuing operations		30.3	38.4	(105.3)	(68.3)
Cash Flows from Investing Activities
Capital expenditures		(10.3)	(23)	(42.8)	(71)
Disposal of assets		1	0.9	1.8	2.3
Net proceeds from sale of business / assets		23.4	0	99.9	0
Other investing activities		1	0	1	(3.3)
Net cash provided (used) by investing activities of continuing operations		15.1	(22.1)	59.9	(72)
Cash Flows from Financing Activities
Debt, net (maturities of three months or less)		(7.4)	3.6	(6.9)	(6.8)
Proceeds from debt		400	0	400	0
Repayment of debt		(275.5)	(0.3)	(275.8)	(238.9)
Repurchase of common stock		0.1	0.1	(1)	(3.1)
Costs associated with debt issue / repayment		(16.4)	0	(25.4)	0
Proceeds from monetization of COFINS tax credits		19.4	0	19.4	0
Other financing activities		0.7	(6.2)	0.5	(6.3)
Net cash provided (used) by financing activities of continuing operations		120.9	(2.8)	110.8	(255.1)
Net cash used by operating activities of discontinued operations		(10.2)	0	(14.8)	0
Net cash used by discontinued operations		(10.2)	0	(14.8)	0
Effect of exchange rate changes on cash and cash equivalents, and restricted cash		(12.9)	(4.8)	(15.2)	(33.5)
Net increase in cash and cash equivalents, and restricted cash		143.2	8.7	35.4	(428.9)
Cash and cash equivalents, and restricted cash at beginning of year	[1]	428.6	443.9	536.4	881.5
Cash and cash equivalents, and restricted cash at end of period		$ 571.8	$ 452.6	$ 571.8	$ 452.6
[1]	The balance at the beginning of the nine month period ended September 30, 2019 includes cash and cash equivalents of $3.7 classified as Held for sale assets in our Consolidated Balance Sheets.

Consolidated Statements of Ca_2

Consolidated Statements of Cash Flows - Parenthetical - USD ($) $ in Millions	Sep. 30, 2019	Dec. 31, 2018
Statement of Cash Flows [Abstract]
Held for sale cash and cash equivalents	$ 0	$ 3.7
Long-term restricted cash	$ 7.6	$ 0

Consolidated Statements of Chan

Consolidated Statements of Changes in Shareholders' Equity (Deficit) Statement - USD ($) shares in Millions, $ in Millions	Total	Common Stock	Additional Paid-in Capital	Retained Earnings	Accumulated Other Comprehensive Loss	Treasury Stock	Noncontrolling Interest
Beginning balance (in shares) at Dec. 31, 2017		758.7				318.4
Beginning balance at Dec. 31, 2017	$ (714.7)	$ 189.7	$ 2,291.2	$ 2,320.3	$ (926.2)	$ (4,600)	$ 10.3
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net (loss) income	(21.1)			(20.3)			(0.8)
Other comprehensive (loss) income	35.6				35.2		0.4
Dividends accrued - Series C convertible preferred stock	(6)			(6)
Exercise/ vesting/ expense of share-based compensation (in shares)		2.2				(0.1)
Exercise/ vesting/ expense of share-based compensation	3.6	$ 0.6	2.5	(0.4)		$ 0.9
Repurchase of common stock (in shares)						0.9
Repurchase of common stock	(2.7)					$ (2.7)
Purchases and sales of noncontrolling interests, net of dividends paid	(0.2)						(0.2)
Ending balance (in shares) at Mar. 31, 2018		760.9				319.2
Ending balance at Mar. 31, 2018	(746.6)	$ 190.3	2,293.7	2,252.5	(891)	$ (4,601.8)	9.7
Beginning balance (in shares) at Dec. 31, 2017		758.7				318.4
Beginning balance at Dec. 31, 2017	(714.7)	$ 189.7	2,291.2	2,320.3	(926.2)	$ (4,600)	10.3
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net (loss) income	55.7
Other comprehensive (loss) income	(90)
Ending balance (in shares) at Sep. 30, 2018		761.7				319.4
Ending balance at Sep. 30, 2018	(803)	$ 190.3	2,299.1	2,318.3	(1,015.9)	$ (4,602.3)	7.5
Beginning balance (in shares) at Mar. 31, 2018		760.9				319.2
Beginning balance at Mar. 31, 2018	(746.6)	$ 190.3	2,293.7	2,252.5	(891)	$ (4,601.8)	9.7
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net (loss) income	(37)			(36.1)			(0.9)
Other comprehensive (loss) income	(123.8)				(123.4)		(0.4)
Dividends accrued - Series C convertible preferred stock	(6)			(6)
Exercise/ vesting/ expense of share-based compensation (in shares)		0.8
Exercise/ vesting/ expense of share-based compensation	3.4		3.8	(0.4)
Repurchase of common stock (in shares)						0.2
Repurchase of common stock	(0.5)					$ (0.5)
Ending balance (in shares) at Jun. 30, 2018		761.7				319.4
Ending balance at Jun. 30, 2018	(910.5)	$ 190.3	2,297.5	2,210	(1,014.4)	$ (4,602.3)	8.4
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net (loss) income	113.8			114.5			(0.7)
Other comprehensive (loss) income	(1.7)				(1.5)		(0.2)
Dividends accrued - Series C convertible preferred stock	(6.2)			(6.2)
Exercise/ vesting/ expense of share-based compensation	1.6		1.6
Ending balance (in shares) at Sep. 30, 2018		761.7				319.4
Ending balance at Sep. 30, 2018	(803)	$ 190.3	2,299.1	2,318.3	(1,015.9)	$ (4,602.3)	7.5
Beginning balance (in shares) at Dec. 31, 2018		761.8				319.4
Beginning balance at Dec. 31, 2018	(896.8)	$ 190.3	2,303.6	2,234.3	(1,030.4)	$ (4,602.3)	7.7
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net (loss) income	(33.5)			(32.7)			(0.8)
Other comprehensive (loss) income	(3.9)				(4)		0.1
Dividends accrued - Series C convertible preferred stock	(6.2)			(6.2)
Exercise/ vesting/ expense of share-based compensation (in shares)		1.3
Exercise/ vesting/ expense of share-based compensation	(1.2)	$ 0.3	(1.5)
Purchases and sales of noncontrolling interests, net of dividends paid	0.1						0.1
Ending balance (in shares) at Mar. 31, 2019		763.1				319.4
Ending balance at Mar. 31, 2019	(941.5)	$ 190.6	2,302.1	2,195.4	(1,034.4)	$ (4,602.3)	7.1
Beginning balance (in shares) at Dec. 31, 2018		761.8				319.4
Beginning balance at Dec. 31, 2018	(896.8)	$ 190.3	2,303.6	2,234.3	(1,030.4)	$ (4,602.3)	7.7
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net (loss) income	54
Other comprehensive (loss) income	(19.3)
Ending balance (in shares) at Sep. 30, 2019		763.4				319.9
Ending balance at Sep. 30, 2019	(875.2)	$ 190.4	2,310.5	2,270	(1,049.7)	$ (4,603.3)	6.9
Beginning balance (in shares) at Mar. 31, 2019		763.1				319.4
Beginning balance at Mar. 31, 2019	(941.5)	$ 190.6	2,302.1	2,195.4	(1,034.4)	$ (4,602.3)	7.1
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net (loss) income	(19.1)			(19.5)			0.4
Other comprehensive (loss) income	5.5				5.5		0
Dividends accrued - Series C convertible preferred stock	(6.4)			(6.4)
Exercise/ vesting/ expense of share-based compensation	5.4		5.4
Repurchase of common stock (in shares)		0.1				0.5
Repurchase of common stock	(1)	$ 0.1				$ (1)
Purchases and sales of noncontrolling interests, net of dividends paid	(0.3)						(0.3)
Ending balance (in shares) at Jun. 30, 2019		763.2				319.9
Ending balance at Jun. 30, 2019	(957.3)	$ 190.7	2,307.5	2,169.5	(1,028.9)	$ (4,603.3)	7.2
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net (loss) income	106.6			106.9			(0.3)
Other comprehensive (loss) income	(20.8)				(20.8)
Dividends accrued - Series C convertible preferred stock	(6.4)			(6.4)
Exercise/ vesting/ expense of share-based compensation (in shares)		0.3
Exercise/ vesting/ expense of share-based compensation	3.3	$ 0.3	3
Repurchase of common stock	(0.6)	$ (0.6)
Ending balance (in shares) at Sep. 30, 2019		763.4				319.9
Ending balance at Sep. 30, 2019	$ (875.2)	$ 190.4	$ 2,310.5	$ 2,270	$ (1,049.7)	$ (4,603.3)	$ 6.9

Consolidated Statements of Ch_2

Consolidated Statements of Changes in Shareholders' Equity (Deficit) - Parenthetical - USD ($) $ in Millions	3 Months Ended
	Jun. 30, 2019	Mar. 31, 2019	Mar. 31, 2018
Statement of Stockholders' Equity [Abstract]
Dividends	$ 0.1	$ 0	$ 0

ACCOUNTING POLICIES

ACCOUNTING POLICIES	9 Months Ended
	Sep. 30, 2019
Accounting Policies [Abstract]
ACCOUNTING POLICIES	ACCOUNTING POLICIES Basis of Presentation We prepare our unaudited interim Consolidated Financial Statements in conformity with accounting principles generally accepted in the United States ("GAAP"). We consistently applied the accounting policies described in our 2018 Annual Report on Form 10-K ("2018 Form 10-K") in preparing these unaudited interim Consolidated Financial Statements, other than those impacted by new accounting standards as described below. In our opinion, the unaudited interim Consolidated Financial Statements reflect all adjustments of a normal recurring nature that are necessary for a fair statement of the results for the interim periods presented. Results for interim periods are not necessarily indicative of results for a full year. You should read these unaudited interim Consolidated Financial Statements in conjunction with our Consolidated Financial Statements contained in our 2018 Form 10-K. When used in this report, the terms "Avon," "Company," "we" or "us" mean Avon Products, Inc. For interim Consolidated Financial Statements purposes, we generally provide for accruals under our various employee benefit plans for each quarter based on one quarter of the estimated annual expense, and adjust these accruals as estimates are refined. In addition, our income tax provision is determined using an estimate of our consolidated annual effective tax rate, adjusted in the current period for discrete income tax items including: • the effects of significant, unusual or extraordinary pretax and income tax items, if any; • withholding taxes recognized associated with cash repatriations; and • the impact of loss-making subsidiaries for which we cannot recognize an income tax benefit and subsidiaries for which an effective tax rate cannot be reliably estimated. Accounting Standards Implemented Leases In February 2016, the FASB issued ASU 2016-02, Leases , which requires all assets and liabilities arising from leases to be recognized in our Consolidated Balance Sheets. We adopted this new accounting guidance effective January 1, 2019. In July 2018, the FASB added an optional transition method which we elected upon adoption of the new standard. This allowed us to recognize and measure leases existing at January 1, 2019 without restating comparative information. In addition, we elected to apply the package of practical expedients permitted under the transition guidance within the new standard, which among other things, allows us to carry forward the historical lease classification. We determine if an arrangement is a lease at the lease commencement date. In addition to our lease agreements, we review all material new vendor arrangements for potential embedded lease obligations. The asset balance related to operating and finance leases is presented within right-of-use (ROU) asset and property, plant and equipment, respectively, on our Consolidated Balance Sheet. The short-term liability balance related to operating and finance leases is presented within other accrued liabilities on our Consolidated Balance Sheets. The long-term liability balance is presented within long-term operating lease liability and long-term debt on our Consolidated Balance Sheets for operating and finance leases, respectively. The lease liability is recognized based on the present value of the remaining fixed or in-substance fixed lease payments discounted using our incremental borrowing rates. We use a specific incremental borrowing rate for our material leases, which is determined based on the geography, nature of the asset and term of the lease. These rates are determined based on inputs provided by external banks and updated periodically. The lease liability includes the exercise of a purchase option only if we are reasonably certain to exercise as of the commencement date of the lease. The residual value guarantee amount is only included in the lease liability calculation to the extent payment is probable to the lessor as of the commencement of the lease. The ROU asset is calculated based on the lease liability adjusted for any lease payments paid to the lessor at or before the commencement date (i.e. prepaid rent) and initial direct costs incurred by Avon and excluding any lease incentives received from the Lessor. Variable lease payments are payments to the lessor not included in the lease liability calculation. We define variable lease payments as payments made by Avon to the lessor for the right to use a leased asset that vary because of changes in facts or circumstances (such as changes in an index rate, volume, usage, etc.) occurring after the lease commencement date, other than predetermined contractual changes due to the passage of time (for example, predetermined rent increase amounts that are set out in the contract). Variable lease payments or charges are accounted for as incurred. The lease term for purposes of lease accounting may include options to extend or terminate the lease when it is reasonably certain that we will exercise that option as of the commencement date of the lease. For operating leases, the lease expense is recognized on a straight-line basis over the lease term. For finance leases, the Company amortizes the ROU asset on a straight-line basis and records interest expense on the lease liability created at lease commencement over the lease term. We account for our lease and non-lease components as a single component for most of our asset classes, and therefore both are included in the calculation of lease liability recognized on the Consolidated Balance Sheets. However, for certain lease asset classes related to identified embedded leases we account for the lease and non-lease components separately, and therefore, the non-lease component is not included in the lease liability. Leases with an initial term of twelve months or less are not recorded on the Consolidated Balance Sheet; we recognize lease expense for these leases over their lease term. See Note 9, Leases, to the Consolidated Financial Statements contained herein for further details. ASU 2018-02, Income Statement - Reporting Comprehensive Income In February 2018, the FASB issued ASU 2018-02, Income Statement - Reporting Comprehensive Income , which permits entities to reclassify the disproportionate income tax effects of the 2017 enactment of U.S. tax reform legislation (the "Act") on items within accumulated other comprehensive income (loss) to retained earnings. We adopted this new accounting guidance effective January 1, 2019 and elected not to reclassify the disproportionate income tax effects of the Act from accumulated other comprehensive income (loss) to retained earnings. Accounting Standards to be Implemented ASU 2016-13, Financial Instruments - Credit Losses In January 2016, the FASB issued ASU 2016-13, Financial Instruments - Credit Losses, which requires measurement and recognition of expected credit losses for financial assets held. We intend to adopt this new accounting guidance effective January 1, 2020. We are currently assessing the impact of adopting this standard but do not expect the adoption of this guidance to have a material impact on our Consolidated Financial Statements.

EARNINGS PER SHARE AND SHARE RE

EARNINGS PER SHARE AND SHARE REPURCHASES	9 Months Ended
	Sep. 30, 2019
Earnings Per Share [Abstract]
EARNINGS PER SHARE AND SHARE REPURCHASES	EARNINGS PER SHARE AND SHARE REPURCHASES We compute earnings per share ("EPS") using the two-class method, which is a earnings allocation formula that determines loss per share for common stock and loss allocated to convertible preferred stock and participating securities, as appropriate. The earnings allocated to convertible preferred stock are the larger of 1) the preferred dividends accrued in the period or 2) the percentage of earnings from continuing operations allocable to the preferred stock as if they had been converted to common stock. Our participating securities are our grants of restricted stock and restricted stock units, which contain non-forfeitable rights to dividend equivalents to the extent any dividends are declared and paid on our common stock. We compute basic EPS by dividing net income (loss) allocated to common shareholders by the weighted-average number of shares outstanding during the period. Diluted EPS is calculated to give effect to all potentially dilutive common shares that were outstanding during the period. Three Months Ended September 30, Nine Months Ended September 30, (Shares in millions) 2019 2018 2019 2018 Numerator from continuing operations: Income from continuing operations, less amounts attributable to noncontrolling interests $ 113.2 $ 114.5 $ 83.7 $ 58.1 Less: Earnings allocated to participating securities 1.6 1.4 1.2 .7 Less: Earnings allocated to convertible preferred stock 18.6 18.8 19.0 18.1 Income from continuing operations allocated to common shareholders 93.0 94.3 63.5 39.3 Numerator from discontinued operations: Loss from discontinued operations $ (6.3) $ — $ (29.0) $ — Loss allocated to common shareholders (6.3) — (29.0) — Numerator attributable to Avon: Net income attributable to Avon $ 106.9 $ 114.5 $ 54.7 $ 58.1 Less: Earnings allocated to participating securities 1.6 1.4 1.2 .7 Less: Earnings allocated to convertible preferred stock 18.6 18.8 19.0 18.1 Income allocated to common shareholders 86.7 94.3 34.5 39.3 Denominator: Basic EPS weighted-average shares outstanding 442.4 442.3 442.7 441.8 Diluted effect of assumed conversion of stock-based compensation .2 — .2 — Diluted effect of assumed conversion of preferred stock — — — — Diluted EPS adjusted weighted-average shares outstanding 442.6 442.3 442.9 441.8 Earnings per Common Share from continuing operations: Basic $ 0.21 $ 0.21 $ 0.14 $ 0.09 Diluted $ 0.21 $ 0.21 $ 0.14 $ 0.09 Loss per Common Share from discontinued operations: Basic $ (0.01) $ — $ (0.06) $ — Diluted $ (0.01) $ — $ (0.06) $ — Earnings per Common Share attributable to Avon: Basic $ 0.20 $ 0.21 $ 0.08 $ 0.09 Diluted $ 0.20 $ 0.21 $ 0.08 $ 0.09 Amounts in the table above may not necessarily sum due to rounding. During the three and nine months ended September 30, 2019, we did not include stock options to purchase 8.6 million and 16.6 million shares, respectively, of Avon common stock in the calculation of diluted EPS as the exercise prices of those options were greater than the average market price. Since the inclusion of such shares would be anti-dilutive, these are excluded from the calculation. During the three and nine months ended September 30, 2018, we did not include stock options to purchase 18.1 million shares and 17.6 million shares, respectively, of Avon common stock in the calculation of diluted EPS for the same reason. For the three and nine months ended September 30, 2019 and 2018, respectively, it is more dilutive to assume the series C convertible preferred stock is not converted into common stock; therefore, the weighted-average shares outstanding were not adjusted by the as-if converted series C convertible preferred stock because the effect would be anti-dilutive. The inclusion of the series C convertible preferred stock would increase the earnings per share for the three and nine months ended September 30, 2019 and 2018. If the as-if converted series C convertible preferred stock had been dilutive, approximately 87.1 million additional shares would have been included in the diluted weighted average number of shares outstanding for the three and nine months ended September 30, 2019 and 2018. See Note 6, Related Party Transactions, to the Consolidated Financial Statements contained herein. We purchased approximately 0.5 million shares of Avon common stock for $1.5 during the first nine months of 2019, as compared to approximately 1.1 million shares of Avon common stock for $3.2 during the first nine months of 2018, through acquisition of stock from employees in connection with tax payments upon the vesting of restricted stock units and performance restricted stock units.

DISCONTINUED OPERATIONS, ASSETS

DISCONTINUED OPERATIONS, ASSETS AND LIABILITIES HELD FOR SALE AND DIVESTITURES	9 Months Ended
	Sep. 30, 2019
Discontinued Operations and Disposal Groups [Abstract]
DISCONTINUED OPERATIONS, ASSETS AND LIABILITIES HELD FOR SALE AND DIVESTITURES	DISCONTINUED OPERATIONS, ASSETS AND LIABILITIES HELD FOR SALE AND DIVESTITURES Discontinued Operations On December 17, 2015, the Company entered into definitive agreements with affiliates controlled by Cerberus Capital Management, L.P. ("Cerberus"). The agreements resulted in the separation of the Company's North America business, which represented the Company's operations in the United States, Canada and Puerto Rico, from the Company into New Avon Company, formerly New Avon LLC ("New Avon"), a privately-held company majority-owned and managed by Cerberus NA Investor LLC (an affiliate of Cerberus). The Company retained an investment of 19.9% ownership interest in New Avon. These transactions closed on March 1, 2016, from that date, resolution of contingent liabilities relating to Avon's ownership and operation of the North America business prior to its separation from the Company into New Avon have been treated as discontinued operations. Refer to Divestitures section below for information relating to the sale of New Avon. The Company incurred costs during the three and nine months ended September 30, 2019 following the resolution of certain contingent liabilities related to its ownership and operation of the North America business prior to its separation into New Avon. The major classes of financial statement components comprising the loss on discontinued operations, net of tax for New Avon are shown below: Three Months Ended September 30, 2019 Nine Months Ended September 30, 2019 Selling, general and administrative expenses $ 6.3 $ 29.0 Operating loss $ (6.3) $ (29.0) Loss from discontinued operations, net of tax $ (6.3) $ (29.0) There were no amounts recorded in discontinued operations for the three and nine months ended September 30, 2018. Assets and Liabilities Held for Sale The major classes of assets and liabilities comprising Held for sale assets and Held for sale liabilities on the Consolidated Balance Sheets as of September 30, 2019 and December 31, 2018 are shown in the following table. September 30, 2019 Current Held for sale assets Property, Plant & Equipment (net) $ 18.3 $ 18.3 December 31, 2018 Avon Manufacturing (Guangzhou) Rye Office Malaysia Maximin Total Current Held for sale assets Inventories $ 8.7 $ — $ — $ 8.7 Property, Plant & Equipment (net) 36.7 12.3 3.0 52.0 Cash and cash equivalents 3.7 — — 3.7 Other assets 1.1 — .1 1.2 $ 50.2 $ 12.3 $ 3.1 $ 65.6 Current held for sale liabilities Accounts payable $ 8.6 $ — $ — $ 8.6 Other liabilities 2.6 — .2 2.8 $ 11.2 $ — $ .2 $ 11.4 The Company, in line with the Open Up Avon strategy, identified two additional properties to be sold which met the held for sale criteria under Accounting Standard Codification ("ASC") 360, Property, Plant and Equipment as of September 30, 2019. The Company expects to close these transactions within a year. Refer to Divestitures section below for information on the sale of Avon Manufacturing (Guangzhou), Rye Office, Malaysia Maximin and New Avon. Divestitures Rye Office On June 26, 2019, we completed the sale of the Rye office for a selling price of $23.2, less expenses of approximately $0.8, resulting in proceeds of $22.4. These proceeds are presented as investing activities in the Consolidated Statement of Cash Flows. In the second quarter of 2019, we recorded a gain on sale of $9.9 before and after tax, which is reported separately in the Consolidated Statements of Operations. The gain recorded represents the difference between the proceeds and the carrying value of the Rye office on the date of sale. During the first quarter of 2019, we refined the calculation for the Held for sale assets which gave rise to an additional $.2 in assets. Malaysia Maximin On May 9, 2019, we completed the sale of all of the equity interests in Maximin Corporation Sdn Bhd ("Malaysia Maximin") for a total selling price of $7.8. The cash proceeds of $7.6, net of expenses, are presented within investing activities in the Consolidated Statement of Cash Flows. In the second quarter of 2019, we recorded a gain on sale of $3.3 before tax, which is reported separately in the Consolidated Statements of Operations, and $3.0 after tax. The gain recorded represents the difference between the proceeds and the carrying value of Malaysia Maximin on the date of sale. During the second quarter of 2019, we refined the calculation for the Held for sale assets which gave rise to an additional $1.4 in assets. China manufacturing On February 15, 2019, we completed the sale to TheFaceShop Co., Ltd., an affiliate of LG Household & Health Care Ltd., of all of the equity interests in Avon Manufacturing (Guangzhou), Ltd. for a total selling price of $71.0, less expenses of approximately $1.1. The selling price included $23.5 relating to outstanding intercompany loans payable to Avon Manufacturing (Guangzhou), Ltd. from other Avon subsidiaries that was presented as financing activities in the Consolidated Statement of Cash Flows when settled in April 2019. The cash proceeds of $46.4, net of loan amounts, are presented as investing activities in the Consolidated Statement of Cash Flows, which includes $7.6 of restricted cash as of September 30, 2019, refer to Note 4, Restricted Cash to the Consolidated Financial Statements contained herein. In the first quarter of 2019, we recorded a gain on sale of $10.3 before tax, which is reported separately in the Consolidated Statements of Operations, and $8.2 after tax, representing the difference between the proceeds, including the settlement of the intercompany loans, and the carrying value of Avon Manufacturing (Guangzhou), Ltd. on the date of sale. New Avon In April 2019, we signed an agreement with LG Household & Health Care Ltd. to sell our 19.9% ownership interest in New Avon. During August, 2019, we completed the sale of New Avon for a selling price of $24.5. Expenses were approximately $1.1, resulting in cash proceeds of $23.4. These proceeds are presented as investing activities in the Consolidated Statement of Cash Flows. In the third quarter of 2019, we recorded a gain on sale of $26.8 before and after tax, which is reported in the Consolidated Statements of Operations as Gain on sale of business/asset. The gain recorded represents the total proceeds and the release of accumulated other comprehensive income of $3.4.

RESTRICTED CASH

RESTRICTED CASH	9 Months Ended
	Sep. 30, 2019
Restricted Cash and Cash Equivalents [Abstract]
Restricted Cash	RESTRICTED CASH Restricted cash is related to the sale of Avon Manufacturing (Guangzhou), Ltd. as described in Note 3, Discontinued Operations, Assets and Liabilities Held for Sale and Divestitures to the Consolidated Financial Statements contained herein. Restricted cash is subject to legal restrictions imposed by the Equity Purchase Agreement between TheFaceShop Co., Ltd., an affiliate of LG Household & Health Care Ltd., Avon Asia Holdings Company and Avon Products (China) Co., Ltd. related to the sale of Avon Manufacturing (Guangzhou), Ltd. These deposits are not available for general use by the Company. The following table provides a reconciliation of cash, cash equivalents, and restricted cash reported within the Consolidated Balance Sheet that sum to the total of the same such amounts shown in the Consolidated Statement of Cash Flows for the nine month period ended September 30, 2019. September 30, 2019 December 31, 2018 Cash and cash equivalents $ 564.2 $ 532.7 Long-term restricted cash (1) 7.6 — Held for sale cash and cash equivalents — 3.7 Cash and cash equivalents, and restricted cash at end of period per the statement of cash flows $ 571.8 $ 536.4 (1) Long-term restricted cash is presented in other assets in our Consolidated Balance Sheets.

INVESTMENT IN NEW AVON

INVESTMENT IN NEW AVON	9 Months Ended
	Sep. 30, 2019
Equity Method Investments and Joint Ventures [Abstract]
INVESTMENT IN NEW AVON	INVESTMENT IN NEW AVONIn connection with the separation of the Company's North America business, which closed on March 1, 2016, the Company retained a 19.9% ownership interest in New Avon, a privately-held company that is majority-owned and managed by an affiliate of Cerberus. In April 2019, Avon and Cerberus signed an agreement with LG Household & Health Care Ltd. for the sale of New Avon, including our 19.9% ownership interest. This transaction closed on August 14, 2019. See Note 3, Discontinued Operations, Assets and Liabilities Held for Sale and Divestitures, for additional information.

RELATED PARTY TRANSACTIONS

RELATED PARTY TRANSACTIONS	9 Months Ended
	Sep. 30, 2019
Related Party Transactions [Abstract]
RELATED PARTY TRANSACTIONS	RELATED PARTY TRANSACTIONS The following tables present the related party transactions with New Avon, affiliates of Cerberus and the Instituto Avon in Brazil. There are no other related party transactions. On August 14, 2019, we sold our investment in New Avon to LG Household & Health Care Ltd. Upon completion of the sale, New Avon is no longer a related party. See Note 3, Discontinued Operation, Assets and Liabilities Held for Sale and Divestitures, to the Consolidated Financial Statements contained herein, for further details. Three Months Ended September 30, Nine Months Ended September 30, 2019 2018 2019 2018 Statement of Operations Data Revenue from sale of product to New Avon (1) $ 3.5 $ 7.3 $ 12.0 $ 20.3 Gross profit from sale of product to New Avon (1) $ .1 $ .6 $ .2 $ 1.3 Cost of sales for purchases from New Avon (2) $ .7 $ .9 $ 2.1 $ 2.1 Selling, general and administrative expenses related to New Avon: Transition services, intellectual property, technical support and innovation and subleases (3) $ — $ (.6) $ (.2) $ (4.3) Project management team (4) .6 $ .2 $ 4.0 $ 1.0 Net reduction of selling, general and administrative expenses $ .6 $ (.4) $ 3.8 $ (3.3) Interest income from Instituto Avon (5) $ — $ .1 $ .1 $ .1 September 30, 2019 December 31, 2018 Balance Sheet Data Inventories (6) N/A $ .3 Receivables due from New Avon (6) N/A $ 7.0 Receivables due from Instituto Avon (5) $ 2.0 $ 3.2 Payables due to New Avon (6) N/A $ .2 Payables due to an affiliate of Cerberus (7) $ 2.1 $ .6 (1) The Company supplies product to New Avon as part of a manufacturing and supply agreement. On August 14, 2019, the Company sold it's investment in New Avon to LG Household & Health Care Ltd, from this point New Avon is no longer a related party. Transactions entered into with New Avon for the three month and nine month periods ended September 30, 2019 have been disclosed above. (2) New Avon supplies product to the Company as part of the same manufacturing and supply agreement discussed in footnote (1) above. The Company purchased $.5 and $.7 from New Avon associated with this agreement during the three months ended September 30, 2019 and 2018, respectively, and recorded $.7 and $.9 associated with these purchases within cost of sales in our Consolidated Statement of Operations during the three months ended September 30, 2019 and 2018, respectively. The Company purchased $1.6 and $1.9 from New Avon associated with this agreement during the nine months ended September 30, 2019 and 2018, respectively, and recorded $2.1 and $2.1 associated with these purchases within cost of sales in our Consolidated Statement of Operations during the nine months ended September 30, 2019 and 2018, respectively. On August 14, 2019, the Company sold its investment in New Avon to LG Household & Health Care Ltd; from this point New Avon is no longer a related party. Transactions entered into with New Avon for the three month and nine month periods ended September 30, 2019 have been disclosed above. (3) The Company also entered into a transition services agreement to provide certain services to New Avon, which expired on October 31, 2018, as well as an intellectual property license agreement, an agreement for technical support and innovation and sublease for office space. The net amounts recorded within selling, general and administrative expenses generally represent a recovery of the related costs. (4) The Company also entered into agreements with an affiliate of Cerberus, which provide for the secondment of Cerberus affiliate personnel to the Company's project management team responsible for assisting with the execution of the implementation of the Company’s strategic initiatives. The Company recorded net cost of $.6 and $.2 in selling, general and administrative expenses associated with these agreements during the three months ended September 30, 2019 and 2018, respectively, and recorded $4.0 and $1.0 in selling, general and administrative expenses associated with these agreements during the nine months ended September 30, 2019 and 2018, respectively. See Note 15, Restructuring Initiatives to the Consolidated Financial Statements contained herein, for additional information related to the Company's strategic initiatives. (5) During the second quarter of 2018, the Company entered into an agreement to loan the Instituto Avon, an independent non-government charitable organization in Brazil, R$12 million (Brazilian real) for an unsecured 5-year term at a fixed interest rate of 7% per annum, to be paid back in five equal annual installments. The Instituto Avon was created by an Avon subsidiary in Brazil, with the board and executive team comprised of Avon Brazil management. The purpose of the loan was to provide the Instituto Avon with the means to donate funds to Fundação Pio XII (a leading cancer prevention and treatment organization in Brazil and owner of the Hospital do Câncer de Barretos), in order to invest in equipment with the objective of expanding breast cancer prevention and treatment. During the third quarter of 2019 Institutio Avon repaid $1 million of the loan. (6) On August 14, 2019, the Company sold its investment in New Avon to LG Household & Health Care Ltd, from this point New Avon is no longer a related party. Therefore at September 30, 2019, we do not have any related party balances with New Avon. (7) The payables due to an affiliate of Cerberus relate to the agreement for the project management team, and were classified within other accrued liabilities in our Consolidated Balance Sheets. In addition, the Company also issued standby letters of credit to the lessors of certain equipment, a lease for which was transferred to New Avon in connection with the separation of the Company's North America business. As of September 30, 2019, the Company has a liability of $.8 for the estimated value of such standby letters of credit. Series C Preferred Stock

REVENUE

REVENUE	9 Months Ended
	Sep. 30, 2019
Revenue from Contract with Customer [Abstract]
Revenue	REVENUE Disaggregation of revenue In the following table, revenue is disaggregated by product or service type. All revenue is recognized at a point in time when control of a product is transferred to a customer: Three Months Ended September 30, 2019 Reportable segments Europe, Middle East & Africa South Latin America North Latin America Asia Pacific Total reportable segments Other operating segments and business activities Total Beauty: Skincare $ 125.2 $ 129.3 $ 44.0 $ 27.7 $ 326.2 $ — $ 326.2 Fragrance 129.2 100.2 47.1 19.1 295.6 — 295.6 Color 70.7 69.3 20.3 11.3 171.6 — 171.6 Total Beauty 325.1 298.8 111.4 58.1 793.4 — 793.4 Fashion & Home: Fashion 46.4 37.6 19.4 40.5 143.9 — 143.9 Home 6.4 56.1 43.7 6.0 112.2 — 112.2 Total Fashion & Home 52.8 93.7 63.1 46.5 256.1 — 256.1 Certain Brazil indirect taxes* — 67.7 — — 67.7 — 67.7 Product sales 377.9 460.2 174.5 104.6 1,117.2 — 1,117.2 Representative fees 20.0 28.7 10.2 1.7 60.6 60.6 Other .4 5.1 — — 5.5 4.7 10.2 Other revenue 20.4 33.8 10.2 1.7 66.1 4.7 70.8 Total revenue $ 398.3 $ 494.0 $ 184.7 $ 106.3 $ 1,183.3 $ 4.7 $ 1,188.0 Three Months Ended September 30, 2018 Reportable segments Europe, Middle East & Africa South Latin America North Latin America Asia Pacific Total reportable segments Other operating segments and business activities Total Beauty: Skincare $ 133.7 $ 137.8 $ 38.2 $ 29.3 $ 339.0 $ — $ 339.0 Fragrance 139.5 113.8 54.9 23.7 331.9 — 331.9 Color 80.1 76.5 21.2 14.2 192.0 — 192.0 Total Beauty 353.3 328.1 114.3 67.2 862.9 — 862.9 Fashion & Home: Fashion 58.9 46.0 25.1 44.7 174.7 — 174.7 Home 8.7 68.6 56.0 6.8 140.1 .2 140.3 Total Fashion & Home 67.6 114.6 81.1 51.5 314.8 .2 315.0 Brazil IPI tax release** — 168.4 — — 168.4 — 168.4 Product sales 420.9 611.1 195.4 118.7 1,346.1 .2 1,346.3 Representative fees 21.8 33.7 11.6 1.8 68.9 .1 69.0 Other .2 .6 — — .8 8.1 8.9 Other revenue 22.0 34.3 11.6 1.8 69.7 8.2 77.9 Total revenue $ 442.9 $ 645.4 $ 207.0 $ 120.5 $ 1,415.8 $ 8.4 $ 1,424.2 Nine Months Ended September 30, 2019 Reportable segments Europe, Middle East & Africa South Latin America North Latin America Asia Pacific Total reportable segments Other operating segments and business activities Total Beauty: Skincare $ 400.9 $ 386.1 $ 144.2 $ 90.2 $ 1,021.4 $ 1,021.4 Fragrance 386.9 313.0 140.7 56.1 896.7 896.7 Color 246.6 196.2 63.4 35.4 541.6 541.6 Total Beauty 1,034.4 895.3 348.3 181.7 2,459.7 — 2,459.7 Fashion & Home: Fashion 162.1 117.7 61.4 123.2 464.4 464.4 Home 21.3 178.3 131.0 19.8 350.4 350.4 Total Fashion & Home 183.4 296.0 192.4 143.0 814.8 — 814.8 Certain Brazil indirect taxes* — 67.7 — — 67.7 — 67.7 Product sales 1,217.8 1,259.0 540.7 324.7 3,342.2 — 3,342.2 Representative fees 63.5 87.0 30.5 5.2 186.2 186.2 Other .8 5.7 — .1 6.6 14.7 21.3 Other revenue 64.3 92.7 30.5 5.3 192.8 14.7 207.5 Total revenue $ 1,282.1 $ 1,351.7 $ 571.2 $ 330.0 $ 3,535.0 $ 14.7 $ 3,549.7 Nine Months Ended September 30, 2018 Reportable segments Europe, Middle East & Africa South Latin America North Latin America Asia Pacific Total reportable segments Other operating segments and business activities Total Beauty: Skincare $ 457.4 $ 423.4 $ 128.8 $ 90.9 $ 1,100.5 $ 6.4 $ 1,106.9 Fragrance 446.5 363.9 160.9 62.4 1,033.7 2.9 1,036.6 Color 299.0 237.9 62.8 40.3 640.0 4.8 644.8 Total Beauty 1,202.9 1,025.2 352.5 193.6 2,774.2 14.1 2,788.3 Fashion & Home: Fashion 211.5 142.4 70.1 125.2 549.2 3.0 552.2 Home 25.6 213.1 153.9 21.2 413.8 2.0 415.8 Total Fashion & Home 237.1 355.5 224.0 146.4 963.0 5.0 968.0 Brazil IPI tax release** — 168.4 — — 168.4 — 168.4 Product sales 1,440.0 1,549.1 576.5 340.0 3,905.6 19.1 3,924.7 Representative fees 71.5 105.1 33.4 4.9 214.9 2.0 216.9 Other .5 4.4 — .1 5.0 23.0 28.0 Other revenue 72.0 109.5 33.4 5.0 219.9 25.0 244.9 Total revenue $ 1,512.0 $ 1,658.6 $ 609.9 $ 345.0 $ 4,125.5 $ 44.1 $ 4,169.6 * 2019 includes the impact of certain Brazil indirect taxes which was recorded in product sales of approximately $68, in our Consolidated Income Statements. See Note 14 Supplemental Balance Sheet Information, to the Consolidated Financial Statements contained herein for further information. **2018 includes the impact of the Brazil IPI, which was recorded in product sales of approximately $168, in our Consolidated Income Statements. See Note 11, Contingencies, to the Consolidated Financial Statements contained herein for further information. Contract balances The timing of revenue recognition generally is different from the timing of a promise made to a Representative. As a result, we have contract liabilities, which primarily relate to the advance consideration received from Representatives prior to transfer of the related good or service for material rights, such as loyalty points and status programs, and are primarily classified within other accrued liabilities (with the long-term portion in other liabilities) in our Consolidated Balance Sheets. Generally, we record accounts receivable when we invoice a Representative. In addition, we record an estimate of an allowance for doubtful accounts on receivable balances based on an analysis of historical data and current circumstances, including seasonality and changing trends. The allowance for doubtful accounts is reviewed for adequacy, at a minimum, on a quarterly basis. We generally have no detailed information concerning, or any communication with, any ultimate consumer of our products beyond the Representative. We have no legal recourse against the ultimate consumer for the collection of any accounts receivable balances due from the Representative to us. If the financial condition of the Representatives were to deteriorate, resulting in their inability to make payments, additional allowances may be required. The following table provides information about receivables and contract liabilities from contracts with customers at September 30, 2019 and December 31, 2018: September 30, 2019 December 31, 2018 Accounts receivable, net of allowances of $65 and $93 $ 303.0 $ 349.7 Contract liabilities $ 49.1 $ 84.4 The contract liability balances relate to certain material rights (loyalty points, status program and prospective discounts). During the nine months ended September 30, 2019, we recognized $67.2 of revenue related to the contract liability balance at the beginning of the nine month period ended September 30, 2019, as the result of performance obligations satisfied. In addition, we deferred an additional $32.9 related to certain material rights granted during the period, for which the performance obligations are not yet satisfied. Of the amount deferred during the period, substantially all will be recognized within a year, with the significant majority to be captured within a quarter. The remaining movement in the contract liability balance is attributable to foreign exchange differences arising on the translation of the balance as at September 30, 2019 as compared with December 31, 2018. Contract costs Incremental costs to obtain contracts, such as bonuses or commissions, are recognized as an asset if the entity expects to recover them. However, ASC 340-40, Other Assets and Deferred Costs , offers a practical expedient to recognize the incremental costs of obtaining a contract as an expense when incurred if the amortization period of the asset that the entity otherwise would have recognized is one year or less. We elected the practical expedient and expense costs to obtain contracts when incurred because our amortization period is one year or less. Costs to fulfill contracts with Representatives are comprised of shipping and handling (including order processing) and payment processing services, which are expensed as incurred. The fees for these services are included in the transaction price.

INVENTORIES

INVENTORIES	9 Months Ended
	Sep. 30, 2019
Inventory Disclosure [Abstract]
INVENTORIES	INVENTORIES Components of Inventories September 30, 2019 December 31, 2018 Raw materials $ 131.2 $ 157.8 Finished goods 368.2 384.2 Total $ 499.4 $ 542.0

LEASES

LEASES	9 Months Ended
	Sep. 30, 2019
Leases [Abstract]
Leases	LEASES We have operating and finance leases for corporate and market offices, warehouses, automotive and other equipment. Some of our leases may include options to extend or terminate the lease. Certain leases also include options to purchase the leased property. The depreciable life of assets and leasehold improvements are limited by the expected lease term, unless there is a transfer of title or purchase option reasonably certain of exercise. Classification September 30, 2019 January 1, 2019 Assets Operating right-of-use assets Right-of-use asset $ 172.3 $ 187.5 Finance right-of-use assets Property, Plant and Equipment 2.5 3.2 Total right-of-use assets 174.8 190.7 Liabilities Current Operating lease liabilities Other accrued liabilities $ 43.9 $ 45.4 Finance lease liabilities Other accrued liabilities 1.0 1.1 Total current lease liabilities 44.9 46.5 Noncurrent Operating lease liabilities Long-term operating lease liability $ 141.7 $ 155.9 Finance lease liabilities Long-term debt 1.5 1.9 Total noncurrent lease liabilities $ 143.2 $ 157.8 Total lease liability $ 188.1 $ 204.3 The table below shows the lease income and expenses recorded in the Consolidated Statement of Operations incurred during the three and nine months ended September 30, 2019. Three months ended September 30, Nine months ended September 30, Lease Costs Classification 2019 2019 Operating lease cost (1) Selling, general and administrative expenses $ 16.9 $ 49.9 Finance lease cost Amortization of right-of-use assets Selling, general and administrative expenses .4 1.2 Interest on lease liabilities Interest Expense .1 .2 Short-term leases costs Selling, general and administrative expenses .9 2.9 Sublease income (2) Selling, general and administrative expenses (2.5) (8.3) Net lease cost $ 15.8 $ 45.9 (1) Includes variable lease costs which are immaterial. These are presented in selling, general and administrative expenses in our Consolidated Statements of Operations. (2) Sublease portfolio consists of the sublease of our previous principal executive office located at 777 Third Avenue, New York, NY. The maturity analysis of the finance and operating lease liabilities is reflected below. This table also reflects the reconciliation of the undiscounted cash flows to the discounted finance and operating lease liabilities as recognized in the September 30, 2019 Consolidated Balance Sheet: Maturity of Lease Liabilities Operating Leases Finance Leases Total 2019 $ 15.4 $ .3 $ 15.7 2020 55.3 1.1 56.4 2021 46.1 .8 46.9 2022 38.3 .5 38.8 2023 25.7 .1 25.8 2024 18.4 — 18.4 Thereafter 29.1 — 29.1 Total lease payments $ 228.3 $ 2.8 $ 231.1 Less: Interest 42.7 .3 43.0 Present value of lease liabilities $ 185.6 $ 2.5 $ 188.1 At December 31, 2018 our operating and finance lease obligations by due dates were as follows: Maturity of Lease Liabilities Operating Leases Finance Leases Total 2019 $ 56.4 $ 1.1 $ 57.5 2020 42.0 .6 42.6 2021 35.3 .4 35.7 2022 31.1 .2 31.3 2023 22.4 .1 22.5 Thereafter 46.9 .1 47.0 Total lease payments (1) $ 234.1 $ 2.5 $ 236.6 (1) Total lease payments of $236.6 represent undiscounted cash flows and therefore do not reconcile to the total discounted lease liability of $204.3 at January 1, 2019 shown above. The Company has calculated the weighted-average remaining lease term, presented in years below, and the weighted-average discount rate for our operating and finance lease population. As noted in our lease accounting policy (See Note 1, Accounting Policies to the Consolidated Financial Statements contained herein), the Company uses the incremental borrowing rate as the lease discount rate. Lease Term and Discount Rate September 30, 2019 Weighted-average remaining lease term (years) Operating leases 5.0 Finance leases 2.7 Weighted-average discount rate Operating leases 8.5 % Finance leases 10.7 % The table below sets out the classification of lease payments in the Consolidated Statement of Cash Flows. The right-of-use assets obtained in exchange for new finance and operating lease liabilities represent the new operating and finance leases entered into during the three and nine months ended September 30, 2019. Other Information Three months ended September 30, 2019 Nine months ended September 30, 2019 Operating Cash Flows From Operating Leases $ 16.2 $ 47.9 Financing Cash Flows From Finance Leases .3 1.0 Cash Paid For Amounts Included In Measurement of Liabilities $ 16.5 $ 48.9 Right-of-use Assets Obtained In Exchange For New Finance Liabilities $ — $ .9 Right-of-use Assets Obtained In Exchange For New Operating Liabilities $ 8.5 $ 33.9
Leases	LEASES We have operating and finance leases for corporate and market offices, warehouses, automotive and other equipment. Some of our leases may include options to extend or terminate the lease. Certain leases also include options to purchase the leased property. The depreciable life of assets and leasehold improvements are limited by the expected lease term, unless there is a transfer of title or purchase option reasonably certain of exercise. Classification September 30, 2019 January 1, 2019 Assets Operating right-of-use assets Right-of-use asset $ 172.3 $ 187.5 Finance right-of-use assets Property, Plant and Equipment 2.5 3.2 Total right-of-use assets 174.8 190.7 Liabilities Current Operating lease liabilities Other accrued liabilities $ 43.9 $ 45.4 Finance lease liabilities Other accrued liabilities 1.0 1.1 Total current lease liabilities 44.9 46.5 Noncurrent Operating lease liabilities Long-term operating lease liability $ 141.7 $ 155.9 Finance lease liabilities Long-term debt 1.5 1.9 Total noncurrent lease liabilities $ 143.2 $ 157.8 Total lease liability $ 188.1 $ 204.3 The table below shows the lease income and expenses recorded in the Consolidated Statement of Operations incurred during the three and nine months ended September 30, 2019. Three months ended September 30, Nine months ended September 30, Lease Costs Classification 2019 2019 Operating lease cost (1) Selling, general and administrative expenses $ 16.9 $ 49.9 Finance lease cost Amortization of right-of-use assets Selling, general and administrative expenses .4 1.2 Interest on lease liabilities Interest Expense .1 .2 Short-term leases costs Selling, general and administrative expenses .9 2.9 Sublease income (2) Selling, general and administrative expenses (2.5) (8.3) Net lease cost $ 15.8 $ 45.9 (1) Includes variable lease costs which are immaterial. These are presented in selling, general and administrative expenses in our Consolidated Statements of Operations. (2) Sublease portfolio consists of the sublease of our previous principal executive office located at 777 Third Avenue, New York, NY. The maturity analysis of the finance and operating lease liabilities is reflected below. This table also reflects the reconciliation of the undiscounted cash flows to the discounted finance and operating lease liabilities as recognized in the September 30, 2019 Consolidated Balance Sheet: Maturity of Lease Liabilities Operating Leases Finance Leases Total 2019 $ 15.4 $ .3 $ 15.7 2020 55.3 1.1 56.4 2021 46.1 .8 46.9 2022 38.3 .5 38.8 2023 25.7 .1 25.8 2024 18.4 — 18.4 Thereafter 29.1 — 29.1 Total lease payments $ 228.3 $ 2.8 $ 231.1 Less: Interest 42.7 .3 43.0 Present value of lease liabilities $ 185.6 $ 2.5 $ 188.1 At December 31, 2018 our operating and finance lease obligations by due dates were as follows: Maturity of Lease Liabilities Operating Leases Finance Leases Total 2019 $ 56.4 $ 1.1 $ 57.5 2020 42.0 .6 42.6 2021 35.3 .4 35.7 2022 31.1 .2 31.3 2023 22.4 .1 22.5 Thereafter 46.9 .1 47.0 Total lease payments (1) $ 234.1 $ 2.5 $ 236.6 (1) Total lease payments of $236.6 represent undiscounted cash flows and therefore do not reconcile to the total discounted lease liability of $204.3 at January 1, 2019 shown above. The Company has calculated the weighted-average remaining lease term, presented in years below, and the weighted-average discount rate for our operating and finance lease population. As noted in our lease accounting policy (See Note 1, Accounting Policies to the Consolidated Financial Statements contained herein), the Company uses the incremental borrowing rate as the lease discount rate. Lease Term and Discount Rate September 30, 2019 Weighted-average remaining lease term (years) Operating leases 5.0 Finance leases 2.7 Weighted-average discount rate Operating leases 8.5 % Finance leases 10.7 % The table below sets out the classification of lease payments in the Consolidated Statement of Cash Flows. The right-of-use assets obtained in exchange for new finance and operating lease liabilities represent the new operating and finance leases entered into during the three and nine months ended September 30, 2019. Other Information Three months ended September 30, 2019 Nine months ended September 30, 2019 Operating Cash Flows From Operating Leases $ 16.2 $ 47.9 Financing Cash Flows From Finance Leases .3 1.0 Cash Paid For Amounts Included In Measurement of Liabilities $ 16.5 $ 48.9 Right-of-use Assets Obtained In Exchange For New Finance Liabilities $ — $ .9 Right-of-use Assets Obtained In Exchange For New Operating Liabilities $ 8.5 $ 33.9

EMPLOYEE BENEFIT PLANS

EMPLOYEE BENEFIT PLANS	9 Months Ended
	Sep. 30, 2019
Retirement Benefits, Description [Abstract]
EMPLOYEE BENEFIT PLANS	EMPLOYEE BENEFIT PLANS Three Months Ended September 30, Pension Benefits Net Periodic Benefit Costs U.S. Plans Non-U.S. Plans Postretirement Benefits 2019 2018 2019 2018 2019 2018 Service cost (1) $ .3 $ .6 $ .9 $ 1.1 $ — $ — Interest cost .6 .6 3.5 3.4 .3 .2 Expected return on plan assets (.8) (1.0) (7.2) (7.3) — — Amortization of prior service credit — — — (.1) — (.1) Amortization of net actuarial losses .6 .7 1.1 1.5 — .1 Net periodic benefit costs (1) $ .7 $ .9 $ (1.7) $ (1.4) $ .3 $ .2 Nine Months Ended September 30, Pension Benefits Net Periodic Benefit Costs U.S. Plans Non-U.S. Plans Postretirement Benefits 2019 2018 2019 2018 2019 2018 Service cost (1) $ 1.3 $ 2.4 $ 2.9 $ 3.5 $ — $ .1 Interest cost 1.8 1.8 11.2 11.6 .9 .8 Expected return on plan assets (2.4) (2.6) (22.8) (23.9) — — Amortization of prior service credit — — — (.1) — (.3) Amortization of net actuarial losses 2.0 3.3 3.7 5.1 — .1 Settlements/curtailments — — 0.1 — — — Net periodic benefit costs (1) $ 2.7 $ 4.9 $ (4.9) $ (3.8) $ .9 $ .7 (1) Service cost is presented in selling, general and administrative expenses in our Consolidated Statements of Operations. The components of net periodic benefit costs other than service cost are presented in other income (expense), net in our Consolidated Statements of Operations. During the nine months ended September 30, 2019, we made $1 of contributions to the U.S. and contributions of $3 to the non-U.S. defined benefit pension and postretirement benefit plans, respectively. During the remainder of 2019, we anticipate contributing approximately $0 to $5 and approximately $0 to $5 to fund our U.S. and non-U.S. defined benefit pension and postretirement benefit plans, respectively.

CONTINGENCIES

CONTINGENCIES	9 Months Ended
	Sep. 30, 2019
Commitments and Contingencies Disclosure [Abstract]
CONTINGENCIES	CONTINGENCIES Brazilian Tax Assessments In December 2012, our Brazilian subsidiary, Avon Industrial LTDA (Avon Brazil Manufacturing) received an excise tax (IPI) assessment for the year 2008. The assessment totals approximately $293, including penalties and accrued interest. As in prior IPI cases that have been resolved in Avon’s favor, this assessment asserts that the establishment in 1995 of separate manufacturing and distribution companies in Brazil was done without a valid business purpose and that Avon Brazil Manufacturing did not observe minimum pricing rules to define the taxable basis of excise tax. The structure adopted in 1995 is comparable to that used by many other companies in Brazil. We believe that our Brazilian corporate structure is appropriate, both operationally and legally, and that the 2012 IPI assessment is unfounded. These matters are being vigorously contested. In July 2013, the 2012 IPI assessment was upheld at the first administrative level and we appealed this decision to the second administrative level. On April 18, 2018, Avon received official notification that the second administrative level has issued a partially favorable and partially unfavorable decision. In this decision, the original assessment was reduced by approximately $62 (including associated penalty and interest), subject to Federal Revenue appeal. The remaining $231 of the assessment was upheld at the second administrative level. On April 20, 2018, we appealed this decision in the third administrative level where the matter remains pending resolution. We expect to have a decision by the end of 2019. On October 3, 2017, Avon Brazil Manufacturing received a new tax assessment notice regarding IPI for 2014 on grounds similar to the 2012 assessment. The 2017 IPI assessment totals approximately $228, including penalties and accrued interest. On April 2, 2018, Avon was notified of an unfavorable decision at the first administrative level. On February 25, 2019, this IPI assessment was upheld at the second administrative level and on April 11, 2019 we appealed this decision to the third administrative level. The structure adopted in 1995 is comparable to that used by many other companies in Brazil. We believe that our Brazilian corporate structure is appropriate, both operationally and legally, and that the 2017 IPI assessment is unfounded. In the event that the 2012 and the 2017 IPI assessments are upheld in the third and final administrative level, it may be necessary for us to provide monetary security in the full amount of the debt to pursue further appeals in the judicial levels, which, depending on the circumstances, may result in a charge to earnings and an adverse effect on the Company's Consolidated Statements of Cash Flows. It is not possible to reasonably estimate the likelihood or potential amount of assessments that may be issued for subsequent periods (tax years up through 2010 are closed by statute). We believe that the 2012 and the 2017 IPI assessments are unfounded, however, based on the likelihood that these will be upheld, we assess the risks as disclosed above as reasonably possible. At September 30, 2019, we have not recognized a liability for the 2012 or 2017 IPI assessments. Brazil IPI Tax on Cosmetics Separate from the tax assessments received by Avon Brazil Manufacturing, Avon Cosmeticos LTDA (Avon Brazil) is involved in litigation related to an executive decree issued in May 2015. This decree increased the amount of IPI taxes that are to be remitted by Avon Brazil to the taxing authority on the sales of cosmetic products. Avon Brazil filed an objection to this IPI tax increase on the basis that it is not constitutional. In December 2016, Avon Brazil received a favorable decision from the Federal District Court regarding this objection. This decision has been appealed by the tax authorities. From May 2015 through April 2016, Avon Brazil remitted the taxes associated with this IPI tax increase into a judicial deposit which would be remitted to the taxing authorities in the event that we are not successful in our objection to the tax increase. In May 2016, Avon Brazil received a favorable preliminary decision on its objection to the tax and was granted a preliminary injunction. As a result, beginning in May 2016, Avon Brazil was no longer required to remit the taxes associated with IPI into a judicial deposit. On June 12, 2018, we received a decision authorizing Avon to withdraw the amount held as a judicial deposit, substituting it by letter of guarantee, which was presented. On June 29, 2018, the tax authorities presented an appeal against that decision. On July 30, 2018, the funds were received in our bank account. As of September 30, 2018, due in part to recent judicial decisions across the industry and other developments, we concluded, supported by the opinion of legal counsel, that the Executive Decree is unconstitutional. We therefore assessed the IPI tax under ASC 450, Contingencies and determined that the risk of loss is reasonably possible but not probable. Accordingly, we released the associated liability as of September 30, 2018 of approximately $195 and ceased accruing the IPI taxes from October 1, 2018. The liability had been classified within long-term sales taxes and taxes other than income in our Consolidated Balance Sheet, and the release was recorded in product sales and other income (expense), net in the amounts of approximately $168 and approximately $27, respectively, in our Consolidated Income Statements for the quarter ended September 30, 2018. An unfavorable ruling to our objection of this IPI tax increase would have an adverse effect on the Company's Consolidated Income Statements and Consolidated Statements of Cash Flows as Avon Brazil would have to remit the reasonably possible amount of $249 to the taxing authorities (including the judicial deposit that was returned to us on July 30, 2018). We are not able to reliably predict the timing of the outcome of our objection to this tax increase. A favorable judicial ruling to our objection of this IPI tax would also have an adverse effect on the Company's Consolidated Statements of Cash Flows as Avon Brazil would have to remit all or a portion of the associated income tax liability to the taxing authorities. The Company is accruing a tax reserve, which amounts to approximately $77 at September 30, 2019. This reserve would be settled on final adjudication of the law through a combination of cash and use of deferred tax assets. Talc-Related Litigation The Company has been named a defendant in numerous personal injury lawsuits filed in U.S. courts, alleging that certain talc products the Company sold in the past were contaminated with asbestos. Many of these actions involve a number of co-defendants from a variety of different industries, including manufacturers of cosmetics and manufacturers of other products that, unlike the Company’s products, were designed to contain asbestos. As of September 30, 2019, there were 106 individual cases pending against the Company. During the three months ended September 30, 2019, 16 new cases were filed and 28 cases were dismissed, settled, or otherwise resolved. The value of our settlements in this area thus far has not been material, either individually or in the aggregate. Additional similar cases arising out of the use of the Company's talc products are reasonably anticipated. We believe that the claims asserted against us in these cases are without merit. We are defending vigorously against these claims and will continue to do so. To date, the Company has not proceeded to trial in any case filed against it and there have been no findings of liability enforceable against the Company. However, nationwide trial results in similar cases filed against other manufacturers of cosmetic talc products have ranged from outright dismissals to very large jury awards of both compensatory and punitive damages. Given the inherent uncertainties of litigation, we cannot predict the outcome of all individual cases pending against the Company, and we are only able to make a reasonable estimate for a small number of individual cases that have advanced to the later stages of legal proceedings. For the remaining cases, we provide an estimate of exposure on an aggregated and ongoing basis, which takes into account the historical outcomes of all cases we have resolved to date. Any accruals currently recorded on the Company’s balance sheet with respect to these cases are not material. Other than these accruals, we are at this time unable to estimate our reasonably possible or probable losses. However, any adverse outcomes, either in an individual case or in the aggregate, could be material. Future costs to litigate these cases, which we expense as incurred, are not known but may be significant, though some costs will be covered by insurance. Brazilian Labor-Related Litigation On an ongoing basis, the Company is subject to numerous and diverse labor-related lawsuits filed by employees in Brazil. These cases are assessed on an aggregated and ongoing basis based on historical outcomes of similar cases. The claims made are often for significantly larger sums than have historically been paid out by the Company. Our practice continues to be to recognize a liability based on our assessment of historical payments in similar cases. Our best estimate of the probable loss for such current cases at September 30, 2019 is approximately $12 and, accordingly, we have recognized a liability for this amount. Shareholder Litigation On February 14, 2019, a purported shareholder’s class action complaint (Bevinal v. Avon Products, Inc., et al., No. 19-cv-1420) was filed in the United States District Court for the Southern District of New York against the Company and certain former officers of the Company. On June 3, 2019, the court appointed a lead plaintiff and class counsel. The complaint was subsequently amended on June 28, 2019 and recaptioned “In re Avon Products, Inc. Securities Litigation” on July 8, 2019. The amended complaint is brought on behalf of a purported class consisting of all purchasers or acquirers of Avon common stock between January 21, 2016 and November 1, 2017, inclusive. The complaint asserts violations of Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 (the "Exchange Act") based on allegedly false or misleading statements and alleged market manipulation with respect to, among other things, changes made to Avon’s credit terms for Representatives in Brazil. On July 26, 2019 we filed a motion to dismiss. In light of the early stage of the litigation, we are unable to predict the outcome of this matter and are unable to assess the likelihood of loss or to make a reasonable estimate of the amount or range of loss that could result from an unfavorable outcome. Other Matters Various other lawsuits and claims, arising in the ordinary course of business or related to businesses previously sold, are pending or threatened against Avon. In management's opinion, based on its review of the information available at this time, the total cost of resolving such other contingencies at September 30, 2019, is not expected to have a material adverse effect on our consolidated financial position, results of operations or cash flows.

ACCUMULATED OTHER COMPREHENSIVE

ACCUMULATED OTHER COMPREHENSIVE INCOME (LOSS)	9 Months Ended
	Sep. 30, 2019
Equity [Abstract]
ACCUMULATED OTHER COMPREHENSIVE INCOME (LOSS)	ACCUMULATED OTHER COMPREHENSIVE INCOME (LOSS) The tables below present the changes in AOCI by component and the reclassifications out of AOCI for the three months ended September 30, 2019 and 2018: Three Months Ended September 30, 2019 Foreign Currency Translation Adjustments Cash Flow Hedges Net Investment Hedges Pension and Postretirement Benefits Investment in New Avon Total Balance at June 30, 2019 $ (935.2) $ (2.1) $ (4.3) $ (90.7) $ 3.4 $ (1,028.9) Other comprehensive loss other than reclassifications (19.1) (.1) — — — (19.2) Reclassifications into earnings: Derivative losses on cash flow hedges, net of tax of $0.0 — .2 — — — .2 Amortization of net actuarial loss and prior service cost, net of tax of $0.2 (1) — — — 1.6 — 1.6 Sale of New Avon — — — — (3.4) (3.4) Total reclassifications into earnings — .2 — 1.6 (3.4) (1.6) Balance at September 30, 2019 $ (954.3) $ (2.0) $ (4.3) $ (89.1) $ — $ (1,049.7) Three Months Ended September 30, 2018 Foreign Currency Translation Adjustments Net Investment Hedges Pension and Postretirement Benefits Investment in New Avon Total Balance at June 30, 2018 $ (923.5) $ (4.3) $ (90.0) $ 3.4 $ (1,014.4) Other comprehensive loss other than reclassifications (3.6) — — — (3.6) Reclassifications into earnings: Amortization of net actuarial loss and prior service cost, net of tax of $0.1 (1) — — 2.1 — 2.1 Total reclassifications into earnings — — 2.1 — 2.1 Balance at September 30, 2018 $ (927.1) $ (4.3) $ (87.9) $ 3.4 $ (1,015.9) Nine Months Ended September 30, 2019 Foreign Currency Translation Adjustments Cash Flow Hedges Net Investment Hedges Pension and Postretirement Benefits Investment in New Avon Total Balance at December 31, 2018 $ (936.2) $ .5 $ (4.3) $ (93.8) $ 3.4 $ (1,030.4) Other comprehensive loss other than reclassifications (18.1) (3.6) — — — (21.7) Reclassifications into earnings: Derivative losses on cash flow hedges, net of tax of $0.0 — 1.1 — — — 1.1 Amortization of net actuarial loss and prior service cost, net of tax of $0.5 (1) — — — 4.7 — 4.7 Sale of New Avon — — — — (3.4) (3.4) Total reclassifications into earnings — 1.1 — 4.7 (3.4) 2.4 Balance at September 30, 2019 $ (954.3) $ (2.0) $ (4.3) $ (89.1) $ — $ (1,049.7) Nine Months Ended September 30, 2018: Foreign Currency Translation Adjustments Net Investment Hedges Pension and Postretirement Benefits Investment in New Avon Total Balance at December 31, 2017 $ (829.6) $ (4.3) $ (95.7) $ 3.4 $ (926.2) Other comprehensive loss other than reclassifications (97.5) — — — (97.5) Reclassifications into earnings: Amortization of net actuarial loss and prior service cost, net of tax of $0.4(1) — — 7.8 — 7.8 Total reclassifications into earnings — — 7.8 — 7.8 Balance at September 30, 2018 $ (927.1) $ (4.3) $ (87.9) $ 3.4 $ (1,015.9) (1) Gross amount reclassified to other income (expense), net in our Consolidated Statements of Operations, and related taxes reclassified to income taxes in our Consolidated Statements of Operations. Foreign exchange net loss of $5.1 and net gain of $1.2 for the three months ended September 30, 2019 and 2018, respectively, and foreign exchange net losses of $5.8 and $2.5 for the nine months ended September 30, 2019 and 2018, respectively, resulting from the translation of actuarial losses and prior service cost recorded in AOCI, are included in foreign currency translation adjustments in our Consolidated Statements of Comprehensive Income (Loss).

SEGMENT INFORMATION

SEGMENT INFORMATION	9 Months Ended
	Sep. 30, 2019
Segment Reporting [Abstract]
SEGMENT INFORMATION	SEGMENT INFORMATIONWe determine segment profit by deducting the related costs and expenses from segment revenue. Segment profit includes an allocation of global marketing and digital expenses based on actual revenues. Segment profit excludes global expenses other than the allocation of marketing and digital, costs to implement ("CTI") restructuring initiatives (see Note 15, Restructuring Initiatives to the Consolidated Financial Statements contained herein), certain significant asset impairment charges, and other expenses, which are not allocated to a particular segment, if applicable. This is consistent with the manner in which we assess our performance and allocate resources. Summarized financial information concerning our reportable segments was as follows: Three Months Ended September 30, Nine Months Ended September 30, Total Revenue 2019 2018 2019 2018 Europe, Middle East & Africa $ 398.3 $ 442.9 $ 1,282.1 $ 1,512.0 South Latin America* 494.0 645.4 1,351.7 1,658.6 North Latin America 184.7 207.0 571.2 609.9 Asia Pacific 106.3 120.5 330.0 345.0 Total revenue from reportable segments* 1,183.3 1,415.8 3,535.0 4,125.5 Other operating segments and business activities (1) 4.7 8.4 14.7 44.1 Total revenue* $ 1,188.0 $ 1,424.2 $ 3,549.7 $ 4,169.6 Three Months Ended September 30, Nine Months Ended September 30, Operating Profit 2019 2018 2019 2018 Segment Profit Europe, Middle East & Africa $ 47.6 $ 46.1 $ 165.8 $ 194.9 South Latin America* 118.4 194.1 207.4 276.5 North Latin America 17.0 14.3 52.6 54.1 Asia Pacific 9.4 9.6 36.9 27.3 Total profit from reportable segments* $ 192.4 $ 264.1 $ 462.7 $ 552.8 Other operating segments and business activities (1) .9 1.1 2.0 2.7 Unallocated global expenses (58.9) (58.5) (187.3) (216.3) CTI restructuring initiatives (17.5) (19.8) (116.7) (54.4) Other expenses (2) (19.2) — (36.4) — Operating profit* $ 97.7 $ 186.9 $ 124.3 $ 284.8 * 2019 includes the impact of certain Brazil indirect taxes which was recorded in product sales of approximately $68, in our Consolidated Income Statements. See Note 14 Supplemental Balance Sheet Information, to the Consolidated Financial Statements contained herein for further information. 2018 includes the impact of the Brazil IPI, which was recorded in product sales of approximately $168, in our Consolidated Income Statements. See Note 11, Contingencies, to the Consolidated Financial Statements contained herein for further information. (1) Other operating segments and business activities include markets that have been exited. Effective in the first quarter of 2018, given that we exited Australia and New Zealand during 2018, the results of Australia and New Zealand are now reported in Other operating segments and business activities for all periods presented, while previously the results had been reported in the Asia Pacific segment. Other operating segments and business activities also include revenue from the sale of products to New Avon since the separation of the Company's North America business into New Avon on March 1, 2016 and ongoing royalties from the licensing of our name and products.

SUPPLEMENTAL BALANCE SHEET INFO

SUPPLEMENTAL BALANCE SHEET INFORMATION	9 Months Ended
	Sep. 30, 2019
Organization, Consolidation and Presentation of Financial Statements [Abstract]
SUPPLEMENTAL BALANCE SHEET INFORMATION	SUPPLEMENTAL BALANCE SHEET INFORMATION At September 30, 2019 and December 31, 2018, prepaid expenses and other included the following: Components of Prepaid Expenses and Other September 30, 2019 December 31, 2018 Prepaid taxes and tax refunds receivable $ 155.1 $ 145.0 Receivables other than trade 47.7 69.2 Prepaid brochure costs, paper and other literature 12.0 14.9 Other 50.6 42.9 Prepaid expenses and other $ 265.4 $ 272.0 At September 30, 2019 and December 31, 2018, other assets included the following: Components of Other Assets (1) September 30, 2019 December 31, 2018 Net overfunded pension plans $ 95.2 $ 88.1 Capitalized software 81.0 89.3 Judicial deposits 67.9 74.1 Long-term receivables 186.4 73.2 Trust assets associated with supplemental benefit plans 39.4 37.0 Tooling (plates and molds associated with our beauty products) 12.6 12.6 Other 31.4 16.1 Other assets $ 513.9 $ 390.4 (1) Deferred tax asset balance as of September 30, 2019 and December 31, 2018 is presented separately in the Consolidated Balance Sheet Long-term receivables includes approximately $118 of certain Brazil indirect taxes (COFINS), recognized in the three months ended September 30, 2019. Approximately $68 and $50 was recorded in product sales and other income (expense), net, in our Consolidated Income Statements following favorable judicial decisions in the three months ending September 30, 2019. The corresponding tax charge on this transaction is approximately $23 and is included in the deferred tax asset balance as of September 30, 2019 which is presented separately in the Consolidated Balance Sheet.

RESTRUCTURING INITIATIVES

RESTRUCTURING INITIATIVES	9 Months Ended
	Sep. 30, 2019
Restructuring and Related Activities [Abstract]
RESTRUCTURING INITIATIVES	RESTRUCTURING INITIATIVES Transformation Plan and Open Up Avon Open Up Avon In September 2018, we initiated a new strategy in order to return Avon to growth ("Open Up Avon"). The Open Up Avon strategy is integral to our ability to return Avon to growth, built around the necessity of incorporating new approaches to various elements of our business, including increased utilization of third-party providers in manufacturing and technology, a more fit for purpose asset base, and a focus on enabling our Representatives to more easily interact with the company and achieve relevant earnings. The commercial elements of the strategy were developed to help increase Representative earnings and thereby retention. Elements of the Representative strategy include improvements in service functions, increased training on utilization of digital tools to expand her consumer reach, product bundling and regimens designed to help improve her earnings opportunity and sharper more targeted product innovation to drive brand relevancy. Cost savings under this plan are targeted as annualized cost savings of approximately $400 by 2021, and expected to be generated from efficiencies in manufacturing and sourcing, distribution, general and administrative activities, and back office functions, as well as through revenue management, interest and tax. These savings are expected to be achieved through restructuring actions (that may result in charges related to severance, contract terminations and inventory and other asset write-offs), as well as other cost-savings strategies that would not result in restructuring charges. In January 2019, we announced significant advancements in this strategy, including a structural reset of inventory processes and a reduction in global workforce. The structural reset of inventory will result in lower operational and ongoing obsolescence costs. Over the longer term, it will result in a more concentrated focus on high-turn, higher margin products, driving greater earnings for Representatives due to lessened discount pressure and enhanced service levels. The structural reset resulted in an incremental one-off inventory obsolescence expense of $88 recognized at December 31, 2018. At September 30, 2019, we are trending ahead of the expected 10% global workforce reduction as announced in January 2019, to align with ongoing operating model changes and to create a leaner organization that is better aligned with Avon’s current and future business focus. This reduction is incremental to an 8% reduction of the global workforce that was completed in 2018. The restructuring charge relating to the global workforce reduction, which was approved by the Board of Directors in January 2019, forms an integral part of the Open Up Avon initiative, the impacts of this are disclosed below. We initiated the Open Up Avon strategy to enable us to achieve our goals of low-single-digit Constant $ revenue growth and low double-digit operating margin by 2021. We plan to reinvest a portion of these cost savings in commercial initiatives, including training for Representatives, and digital and information technology infrastructure initiatives. As a result of Open Up Avon restructuring actions approved to-date, we have recorded total costs to implement these restructuring initiatives of $227.4 before taxes, of which $10.8 and $84.1 was recorded during the three and nine months ended September 30, 2019, respectively, in our Consolidated Statements of Operations. Transformation Plan In January 2016, we initiated a transformation plan (the "Transformation Plan"), in order to enable us to achieve our long-term goals of mid-single-digit constant-dollar ("Constant $") revenue growth and low double-digit operating margin. Under this plan, we had targeted pre-tax annualized cost savings of approximately $350 after three years, which we exceeded through restructuring actions, as well as other cost-savings strategies that did not result in restructuring charges. As a result of these restructuring actions approved to-date, we have recorded total costs to implement these restructuring initiatives of $214.4 before taxes, of which $6.7 and $9.0 was recorded during the three and nine months ended September 30, 2019, respectively, in our Consolidated Statements of Operations. There are no further restructuring actions to be taken associated with our Transformation Plan, as beginning in the third quarter of 2018, all new restructuring actions approved operate under our new Open Up Avon plan described above. Costs to Implement Restructuring Initiatives - Three and Nine Months Ended September 30, 2019 and 2018 During the three months ended September 30, 2019, we recorded net costs to implement of $17.5, of which $10.8 related to Open Up Avon and $6.7 related to the Transformation Plan in our Consolidated Statements of Operations. During the three months ended September 30, 2018, we recorded costs to implement of $19.8, of which $19.1 related to Open Up Avon and .7 related to the Transformation Plan in our Consolidated Statements of Operations. During the nine months ended September 30, 2019, we recorded net costs to implement of $93.2, of which $84.1 related to Open Up Avon, $9.0 related to the Transformation Plan, and $.1 related to other restructuring initiatives, in our Consolidated Statements of Operations. During the nine months ended September 30, 2018, we recorded costs to implement of $54.4 of which $19.1 related to Open Up Avon, $36.0 related to the Transformation Plan and $.7 benefit related to other restructuring initiatives in our Consolidated Statements of Operations. The costs during the three and nine months ended September 30, 2019 and 2018 consisted of the following: Three Months Ended September 30, Nine Months Ended September 30, 2019 2018 2019 2018 CTI recorded in operating profit - COGS Manufacturing asset write-offs $ 1.1 $ — $ 10.9 $ — Inventory write-off (2.1) (.1) 1.0 1.0 (1.0) (.1) 11.9 1.0 CTI recorded in operating profit - SG&A Net charges for employee-related costs, including severance benefits 3.2 6.4 51.9 31.9 Implementation costs, primarily related to professional service fees 7.8 11.8 33.7 17.5 Dual running costs 3.7 — 8.2 — Contract termination and other net benefits (.1) (1.7) 4.5 (1.0) Impairment of other assets .1 2.5 2.4 2.5 Accelerated depreciation 2.3 .9 2.6 2.5 Variable lease charges 1.5 — 1.5 — 18.5 19.9 104.8 53.4 CTI recorded in operating profit 17.5 19.8 116.7 54.4 CTI recorded in other (income) expense Gain on sale of Rye Office — — (9.9) — Gain on sale of Malaysia Maximin — — (3.3) — Gain on sale of China business (relating mainly to foreign currency translation adjustment gain) — — (10.3) — Total CTI $ 17.5 $ 19.8 $ 93.2 $ 54.4 Open Up Avon $ 10.8 $ 19.1 $ 84.1 $ 19.1 Transformation Plan $ 6.7 $ 0.7 $ 9.0 $ 36.0 Other $ — $ — $ .1 $ (.7) The tables below include restructuring costs such as employee-related costs, inventory and asset write-offs, foreign currency translation write-offs and contract terminations, and do not include other costs to implement restructuring initiatives such as professional services fees, dual running costs, accelerated depreciation and gain on sale of business. The liability balance included in other accrued liabilities in our Consolidated Statements of Operations for the restructuring actions associated with Open Up Avon at September 30, 2019 is as follows: Employee-Related Costs Inventory/Assets Write-offs Foreign Currency Translation Adjustment Write-offs Contract Terminations/Other Total Balance at December 31, 2018 $ 19.6 $ — $ — $ 1.1 $ 20.7 2019 charges $ 56.1 $ 14.3 $ (10.9) $ 4.4 63.9 Adjustments (3.6) — — (.1) (3.7) Cash payments (46.2) — — (2.5) (48.7) Non-cash write-offs — (14.3) 10.9 — (3.4) Foreign exchange (3.0) — — — (3.0) Balance at September 30, 2019 $ 22.9 $ — $ — $ 2.9 $ 25.8 The liability balance included in other accrued liabilities in our Consolidated Balance Sheet for the restructuring actions associated with our Transformation Plan as of September 30, 2019 is as follows: Employee-Related Costs Contract Terminations/Other Total Balance at December 31, 2018 $ 34.4 $ 3.6 $ 38.0 2019 charges (0.7) .2 (.5) Cash payments (26.3) (2.3) (28.6) Foreign exchange .1 — .1 Balance at September 30, 2019 $ 7.5 $ 1.5 $ 9.0 The majority of cash payments, if applicable, associated with the year-end liability are expected to be made during 2019. The following table presents the restructuring charges incurred to date, under Open Up Avon and the Transformation Plan, along with the estimated charges expected to be incurred on approved initiatives under the plans: Employee- Related Costs Inventory/ Asset Write-offs Contract Foreign Currency Translation Adjustment Write-offs Total Open Up Avon Charges incurred to-date $ 78.9 $ 104.1 $ 5.1 $ (10.9) $ 177.2 Estimated charges to be incurred on approved initiatives — — 1.7 — 1.7 Total expected charges on approved initiatives $ 78.9 $ 104.1 $ 6.8 $ (10.9) $ 178.9 Transformation Plan Charges incurred to-date $ 127.3 $ 2.4 $ 40.9 $ 3.4 $ 174.0 Estimated charges to be incurred on approved initiatives — — — — — Total expected charges on approved initiatives $ 127.3 $ 2.4 $ 40.9 $ 3.4 $ 174.0 The charges, net of adjustments, of initiatives under the Open Up Avon and the Transformation Plan, along with the estimated charges expected to be incurred on approved initiatives under the plans, by reportable segment are as follows: Europe, Middle East & Africa South Latin America North Latin America Asia Global & Other Operating Segments Total Open Up Avon 2018 $ 32.2 $ 36.4 $ 27.9 $ 14.4 $ 6.2 $ 117.1 First quarter 2019 13.5 12.7 2.9 (3.2) 7.3 33.2 Second quarter 2019 4.5 13.7 4.3 (1.2) 3.9 25.2 Third quarter 2019 (.8) 1.6 .4 .4 .1 1.7 Charges incurred to-date 49.4 64.4 35.5 10.4 17.5 177.2 Estimated charges to be incurred on approved initiatives 1.7 1.7 Total expected charges on approved initiatives $ 51.1 $ 64.4 $ 35.5 $ 10.4 $ 17.5 $ 178.9 Transformation Plan 2015 $ — $ — $ — $ — $ 21.4 $ 21.4 2016 30.9 13.2 4.4 9.1 16.8 74.4 2017 .9 5.6 (.6) (.5) 49.4 54.8 2018 5.0 4.1 .6 .6 13.4 23.7 First quarter 2019 (1.1) — — — .3 (.8) Second quarter 2019 — — — — — — Third quarter 2019 (.1) .5 — — .1 .5 Charges incurred to-date 35.6 23.4 4.4 9.2 101.4 174.0 Estimated charges to be incurred on approved initiatives — — — — — — Total expected charges on approved initiatives $ 35.6 $ 23.4 $ 4.4 $ 9.2 $ 101.4 $ 174.0

AGREEMENT AND PLAN OF MERGERS W

AGREEMENT AND PLAN OF MERGERS WITH NATURA COSMETICOS S.A.	9 Months Ended
	Sep. 30, 2019
Business Combinations [Abstract]
AGREEMENT AND PLAN OF MERGERS WITH NATURA COSMETICOS S.A.	AGREEMENT AND PLAN OF MERGERS WITH NATURA COSMÉTICOS S.A. On May 22, 2019, the Company entered into an Agreement and Plan of Mergers (as amended, the "Merger Agreement") with Natura Cosméticos S.A., a Brazilian corporation (s ociedade anônima ) ("Natura Cosméticos"), Natura &Co Holding S.A., a Brazilian corporation ( sociedade anônima ) ("Natura &Co Holding"), Nectarine Merger Sub I, Inc., a Delaware corporation and a direct wholly owned subsidiary of Natura &Co Holding ("Merger Sub I"), and Nectarine Merger Sub II, Inc., a Delaware corporation and a direct wholly owned subsidiary of Merger Sub I ("Merger Sub II"), pursuant to which (i) Natura &Co Holding will, after the completion of certain restructuring steps, hold all issued and outstanding shares of Natura Cosméticos, (ii) Merger Sub II will merge with and into Avon, with Avon surviving the merger and (iii) Merger Sub I will merge with and into Natura &Co Holding, with Natura &Co Holding surviving the merger and as a result of which Avon will become a wholly owned direct subsidiary of Natura &Co Holding (collectively, the "Transaction"). If the Transaction is completed, Avon and Natura Cosméticos will each become wholly owned subsidiaries of Natura &Co Holding. If the Transaction is completed, each share of Avon common stock issued and outstanding immediately prior to the consummation of the Transaction will be converted into the right to receive, at the election of the holder thereof, (i) 0.300 validly issued and allotted, fully paid-up American Depositary Shares of Natura &Co Holding, each representing one Natura &Co Holding Share ("Natura &Co Holding ADSs") against the deposit of two shares of common stock of Natura &Co Holding ("Natura &Co Holding Shares"), subject to adjustment in accordance with the terms of the Merger Agreement, and any cash in lieu of fractional Natura &Co Holding ADSs or (ii) 0.600 validly issued and allotted, fully paid-up Natura &Co Holding Shares, subject to adjustment in accordance with the terms of the Merger Agreement, and any cash in lieu of fractional Natura &Co Holding Shares, and each share of Avon series C preferred stock held by Cleveland Apple Investor L.P. issued and outstanding immediately prior to the consummation of the Transaction will be automatically converted into the right to receive an amount in cash without interest equal to the Stated Value (as defined in Avon's certificate of incorporation) of such shares of series C preferred stock. Upon the consummation of the Transaction, Natura &Co Holding Shares are expected to be listed on the B3 S.A. - Brasil, Bolsa, Balcão stock exchange (the "B3") and Natura &Co Holding ADSs are expected to be listed on the New York Stock Exchange (the "NYSE"). Additionally, upon the consummation of the Transaction, Avon common stock will cease to be traded on the NYSE. The Merger Agreement contains customary representations and warranties of Avon, Natura Cosméticos and Natura &Co Holding relating to their respective businesses and public filings, in each case generally subject to a materiality qualifier. Additionally, the Merger Agreement provides for customary pre-closing covenants of Avon, including (i) covenants relating to conducting its business in the ordinary course consistent with past practice and to refrain from taking certain actions without Natura Cosméticos's consent, (ii) covenants not to solicit proposals relating to alternative transactions or, subject to certain exceptions, enter into discussions concerning, or provide information in connection with, alternative transactions and (iii) covenants to recommend, subject to certain exceptions, that Avon's shareholders adopt the Merger Agreement. The timing and completion of the Transaction is subject to a number of closing conditions, including (i) Avon and Natura Cosméticos shareholder approvals having been obtained in accordance with applicable law, (ii) clearance from competition authorities in certain jurisdictions where Avon and Natura Cosméticos operate, (iii) the absence of any judgment, injunction or other order issued by a court of competent jurisdiction prohibiting the Transaction, (iv) effectiveness of registration statements for Natura &Co Holding's ADSs, (v) listing approval for Natura &Co Holding's ADSs on the NYSE, (vi) listing approval for Natura &Co Holding's shares on the B3 stock exchange under the Novo Mercado listing segment and (vii) subject to certain materiality exceptions, the accuracy of Avon's, Natura Cosméticos's and Natura &Co Holding's representations and warranties in the Merger Agreement and performance by each party of their obligations under the Merger Agreement. The Company has incurred costs to date of $27 in relation to the Transaction, primarily professional fees. It is expected that additional costs will be incurred prior to or at the closing of the Transaction, including approximately $31 with respect to professional fees that are contingent on the successful closing of the Transaction.

GOODWILL

GOODWILL	9 Months Ended
	Sep. 30, 2019
Goodwill and Intangible Assets Disclosure [Abstract]
GOODWILL	GOODWILL Europe, Middle East & Africa South Latin Asia Total Net balance at December 31, 2018 $ 18.0 $ 66.8 $ 2.6 $ 87.4 Changes during the period ended September 30, 2019: Foreign exchange (1.0) (3.9) — (4.9) Net balance at September 30, 2019 $ 17.0 $ 62.9 $ 2.6 $ 82.5

FAIR VALUE

FAIR VALUE	9 Months Ended
	Sep. 30, 2019
Fair Value Disclosures [Abstract]
FAIR VALUE	FAIR VALUE Assets and Liabilities Recorded at Fair Value on a Recurring Basis The following table presents the fair value hierarchy for those assets and liabilities measured at fair value on a recurring basis as of September 30, 2019: Level 1 Level 2 Total Assets: Available-for-sale securities $ 4.0 $ — $ 4.0 Foreign exchange forward contracts $ — $ 17.0 $ 17.0 Total $ 4.0 $ 17.0 $ 21.0 Liabilities: Foreign exchange forward contracts $ — $ 2.0 $ 2.0 Total $ — $ 2.0 $ 2.0 The assets and liabilities measured at fair value on a recurring basis were immaterial at December 31, 2018. Fair Value of Financial Instruments Our financial instruments include cash and cash equivalents, available-for-sale securities, short-term investments, accounts receivable, debt maturing within one year, accounts payable, long-term debt and foreign exchange forward contracts. The carrying value for cash and cash equivalents, accounts receivable, accounts payable and short-term investments approximate fair value because of the short-term nature of these instruments. The net asset (liability) amounts recorded in the balance sheet (carrying amount) and the estimated fair values of our remaining financial instruments at September 30, 2019 and December 31, 2018, respectively, consisted of the following: September 30, 2019 December 31, 2018 Carrying Fair Carrying Fair Available-for-sale securities $ 4.0 $ 4.0 $ 3.8 $ 3.8 Debt maturing within one year (1) (116.2) (117.4) (12.0) (12.0) Long-term debt (1) (1,589.1) (1,696.7) (1,581.6) (1,460.2) Foreign exchange forward contracts 15.0 15.0 (5.1) (5.1) (1) The carrying value of debt maturing within one year and long-term debt is presented net of debt issuance costs and includes any related discount or premium and unamortized deferred gains on terminated interest-rate swap agreements, as applicable. The methods and assumptions used to estimate fair value are as follows: • Available-for-sale securities - The fair values of these investments were the quoted market prices for issues listed on securities exchanges. • Debt maturing within one year and long-term debt - The fair values of our debt and other financing were determined using Level 2 inputs based on indicative market prices. • Foreign exchange forward contracts - The fair values of forward contracts were estimated based on quoted forward foreign exchange prices at the reporting date.

DERIVATIVE INSTRUMENTS AND HEDG

DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES	9 Months Ended
	Sep. 30, 2019
Derivative Instruments and Hedging Activities Disclosure [Abstract]
DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES	DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES We operate globally, with manufacturing and distribution facilities in various countries around the world. We may reduce our exposure to fluctuations in the fair value and cash flows associated with changes in interest rates and foreign exchange rates by creating offsetting positions, including through the use of derivative financial instruments. If we use foreign currency-rate sensitive and interest-rate sensitive instruments to hedge a certain portion of our existing and forecasted transactions, we would expect that any gain or loss in value of the hedge instruments generally would be offset by decreases or increases in the value of the underlying forecasted transactions. We do not enter into derivative financial instruments for trading or speculative purposes, nor are we a party to leveraged derivatives. The master agreements governing our derivative contracts generally contain standard provisions that could trigger early termination of the contracts in certain circumstances, including if we were to merge with another entity and the creditworthiness of the surviving entity were to be "materially weaker" than that of Avon prior to the merger. Derivatives are recognized in the Consolidated Balance Sheets at their fair values. The following table presents the fair value of derivative instruments at September 30, 2019: Asset Liability Balance Sheet Fair Balance Sheet Fair Derivatives designated as hedges: Foreign exchange forward contracts Prepaid expenses and other $ — Accounts payable $ 1.9 Derivatives not designated as hedges: Foreign exchange forward contracts Prepaid expenses and other $ 17.0 Accounts payable $ .1 Total derivatives $ 17.0 $ 2.0 The fair value of derivative instruments outstanding was immaterial at December 31, 2018. Interest Rate Risk A portion of our borrowings is subject to interest rate risk. In the past we have used interest-rate swap agreements, which effectively converted the fixed rate on long-term debt to a floating interest rate, to manage our interest rate exposure. The agreements were designated as fair value hedges. As of September 30, 2019, we do not have any interest-rate swap agreements. Approximately 7% and 1% of our debt portfolio, at September 30, 2019 and December 31, 2018, respectively, was exposed to floating interest rates. For the purpose of this calculation, we consider all short-term debt to be exposed to floating interest rates. In March 2012, we terminated two of our interest-rate swap agreements previously designated as fair value hedges, with notional amounts totaling $350. As of the interest-rate swap agreements’ termination date, the aggregate favorable adjustment to the carrying value (deferred gain) of our debt was $46.1, which was amortized as a reduction of interest expense until repayment of the underlying debt obligations in June 2018, at which point the remaining unamortized balance was fully released to the Consolidated Statement of Operations. The net impact of the gain amortization was zero for both the three and nine months ended September 30, 2019, and zero and $6.0 for the three and nine months ended September 30, 2018, respectively. At September 30, 2019, there was no unamortized deferred gain associated with the March 2012 interest-rate swap termination as the underlying debt obligations have been paid. Foreign Currency Risk We may use foreign exchange forward contracts to manage a portion of our foreign currency exchange rate exposures. At September 30, 2019, we had outstanding foreign exchange forward contracts with notional amounts totaling approximately $893.3 for various currencies, of which $13.1 were designated as cash flow hedges. We may use foreign exchange forward contracts to manage foreign currency exposure of certain intercompany loans. The change in fair value of these contracts is immediately recognized in earnings and substantially offsets the foreign currency translation impact recognized in earnings relating to the associated intercompany loans. During the three and nine months ended September 30, 2019, we recorded gains of $35.1 and $57.0, respectively, in other income (expense), net in our Consolidated Statements of Operations related to these undesignated foreign exchange forward contracts. During the three and nine months ended September 30, 2018, we recorded a gain of $2.0 and a loss of $1.1, respectively, in other income (expense), net in our Consolidated Statements of Operations related to other undesignated foreign exchange forward contracts.

DEBT

DEBT	9 Months Ended
	Sep. 30, 2019
Debt Disclosure [Abstract]
DEBT	DEBT Revolving Credit Facility In June 2015, Avon International Operations, Inc. ("AIO"), a wholly-owned domestic subsidiary of the Company, entered into a five-year $400.0 senior secured revolving credit facility (the "2015 facility"). In February 2019, Avon International Capital, p.l.c. ("AIC"), a wholly-owned foreign subsidiary of the Company, entered into a three-year €200.0 million senior secured revolving credit facility (the "2019 facility"). As of September 30, 2019 this amounted to $218. The 2019 facility replaced the 2015 facility and the 2015 facility was terminated at such time. There were no amounts drawn under the 2015 revolving credit facility on the date of termination and no early termination penalties were incurred. In the first quarter of 2019, $2.0 was recorded for the write-off of unamortized issuance costs related to the 2015 revolving credit facility. As of September 30, 2019, there were no amounts outstanding under the 2019 facility. The 2019 facility will terminate in February 2022; provided, however, that it shall terminate on the 91 st day prior to the maturity of the 4.60% Notes (as defined below), if on such 91 st day, the applicable notes are not redeemed, repaid, discharged, defeased or otherwise refinanced in full. In the first quarter of 2019, the Company capitalized $11.0 of issue costs relating to the new revolving credit facility; this resulted in a cash outflow presented in other financing activities within the Consolidated Statement of Cash Flows. As of September 30, 2019, we were in compliance with our interest coverage and net leverage ratios under the 2019 facility. The amount of the facility available to be drawn down on is reduced by any standby letters of credit granted by an obligor, which, as of September 30, 2019, was approximately $23. As of September 30, 2019, based on then applicable exchange rates, the entire amount of the remaining 2019 facility, which is approximately €179 million, could have been drawn down without violating any covenant. Public Notes In March 2013, we issued, in a public offering, $500.0 principal amount of 4.60% Notes due March 15, 2020 (the "4.60% Notes"), $500.0 principal amount of 5.00% Notes due March 15, 2023 (the "5.00% Notes") and $250.0 principal amount of 6.95% Notes due March 15, 2043 (the "6.95% Notes") (collectively, the "2013 Notes"). Interest on the 2013 Notes is payable semi-annually on March 15 and September 15 of each year. The indenture governing the 2013 Notes contains interest rate adjustment provisions depending on the long-term credit ratings assigned to the 2013 Notes by S&P and Moody's. As described in the indenture, the interest rates on the 2013 Notes increase by .25% for each one-notch downgrade below investment grade on each of our long-term credit ratings assigned to the 2013 Notes by S&P or Moody's. These adjustments are limited to a total increase of 2.00% above the respective interest rates in effect on the date of issuance of the 2013 Notes. As a result of the long-term credit rating downgrades by S&P and Moody's since issuance of the 2013 Notes, the interest rates on these notes have increased by the maximum allowable increase. As of September 30, the remaining aggregate principal amount of the 4.60% Notes was $112.3 which will mature on March 15, 2020. In July 2019, AIC issued $400.0 Senior Secured Notes (the 2019 Notes), the proceeds of which were partially used to purchase an aggregate principal amount of $274.8 of the 4.60% Notes. In the third quarter of 2019, AIC capitalized $9 of issue costs relating to the 2019 Notes, this resulted in a cash outflow presented in other financing activities within the Consolidated Statement of Cash Flows. Senior Secured Notes In August 2016, AIO issued, in a private placement exempt from registration under the Securities Act of 1933, as amended, $500.0 in aggregate principal amount of 7.875% Senior Secured Notes, which will mature on August 15, 2022 (the "2016 Notes"). Interest on the 2016 Notes is payable semi-annually on February 15 and August 15 of each year.

INCOME TAXES

INCOME TAXES	9 Months Ended
	Sep. 30, 2019
Income Tax Disclosure [Abstract]
INCOME TAXES	INCOME TAXES Our quarterly income tax provision is calculated using an estimated annual effective income tax approach. The quarterly effective tax rate can differ from our estimated annual effective tax rate as the Company cannot apply an effective tax rate approach for all of its operations. For those entities that can apply an effective tax rate approach, as of September 30, 2019, our annual effective tax rate, excluding discrete items, is 25.2% for 2019, as compared to 23.6% as of September 30, 2018. The remaining entities, which are operations that generate pre-tax losses which cannot be tax benefited and/or have an effective tax rate which cannot be reliably estimated, have to account for their income taxes on a discrete year-to-date basis as of the end of each quarter and are excluded from the effective tax rate approach. The estimated annual effective tax rate for 2019 also excludes the unfavorable impact of withholding taxes associated with certain intercompany payments, including royalties, service charges, interest and dividends, which in the aggregate are relatively consistent each year due to the need to repatriate funds to cover U.S. and U.K. based costs, such as interest on debt and corporate overhead. Withholding taxes associated with the relatively consistent intercompany payments are accounted for discretely and accrued in the provision for income taxes as they become due. The provision for income taxes for the three months ended September 30, 2019 and 2018 was $31.5 and $68.3, respectively. Our effective tax rates for the three months ended September 30, 2019 and 2018 were 21.8% and 37.5%, respectively. The effective tax rates for the three months ended September 30, 2019 and 2018 were impacted by CTI restructuring charges which could not all be benefitted, country mix of earnings and withholding taxes. The effective tax rate for the three months ended September 30, 2019 was also favorably impacted by the accrual of miscellaneous income tax benefits of approximately $2.3. The effective tax rate for the three months ended September 30, 2018 was also favorably impacted by the accrual of tax benefits of approximately $14.0 associated with the initial recognition of tax benefits associated with Avon’s interpretation of case law, net releases of tax reserves of approximately $3.1 associated with our uncertain tax positions and other net benefits of approximately $1.9. The provision for income taxes for the nine months ended September 30, 2019 and 2018 was $78.2 and $136.5, respectively. Our effective tax rates for the nine months ended September 30, 2019 and 2018 were 48.5% and 71.0%. The effective tax rates for the nine months ended September 30, 2019 and 2018 were impacted by CTI restructuring charges which could not all be benefitted, country mix of earnings and withholding taxes. The effective tax rate for the nine months ended September 30, 2019 was also favorably impacted by the accrual of net income tax benefits of approximately $5.2 associated with the release of income tax reserves of approximately $3.0 associated with our uncertain tax positions and other net, miscellaneous income tax benefits of approximately $2.2. The effective tax rate for the nine months ended September 30, 2018 was also favorably impacted by the accrual of tax benefits of approximately $14.0 associated with the initial recognition of tax benefits associated with Avon’s interpretation of recent case law, the recognition of approximately $4.1 of deferred tax assets that had previously been subject to a full valuation allowance and other net benefits of approximately $1.0 offset with a net increase of approximately $10.9 associated with our uncertain tax positions. In its final analysis of the impacts of the Tax Cuts and Job Act (the "TCJA") during the fourth quarter of 2018, the Company elected to treat income taxes associated with Global Intangible Low-Taxed Income ("GILTI"), as a period cost. As a result, the 2019 provision for income taxes reflects this treatment. The 2018 provision for income taxes was also calculated treating GILTI as a period cost. For both periods, GILTI did not have a material effect. The TCJA has significant complexity. The Company has considered the published guidance provided by the various Federal and state regulatory authorities into the calculation of its income tax provisions available as of September 30, 2019 and September 30, 2018 for the respective periods ended September 30, 2019 and September 30, 2018. In prior years, we had previously recorded valuation allowances against certain deferred tax assets associated with the U.S. and various foreign jurisdictions. We intend to continue maintaining these valuation allowances on our deferred tax assets until there is sufficient evidence to support the reversal of all or some portion of these allowances. Release of the valuation allowance would result in the recognition of certain deferred tax assets and a decrease to income tax expense for the period the release is recorded. However, the exact timing and amount of the valuation allowance release are subject to change on the basis of the level of profitability that we are able to actually achieve.

ACCOUNTING POLICIES (Policy)

ACCOUNTING POLICIES (Policy)	9 Months Ended
	Sep. 30, 2019
Accounting Policies [Abstract]
Basis of Presentation	Basis of Presentation We prepare our unaudited interim Consolidated Financial Statements in conformity with accounting principles generally accepted in the United States ("GAAP"). We consistently applied the accounting policies described in our 2018 Annual Report on Form 10-K ("2018 Form 10-K") in preparing these unaudited interim Consolidated Financial Statements, other than those impacted by new accounting standards as described below. In our opinion, the unaudited interim Consolidated Financial Statements reflect all adjustments of a normal recurring nature that are necessary for a fair statement of the results for the interim periods presented. Results for interim periods are not necessarily indicative of results for a full year. You should read these unaudited interim Consolidated Financial Statements in conjunction with our Consolidated Financial Statements contained in our 2018 Form 10-K. When used in this report, the terms "Avon," "Company," "we" or "us" mean Avon Products, Inc. For interim Consolidated Financial Statements purposes, we generally provide for accruals under our various employee benefit plans for each quarter based on one quarter of the estimated annual expense, and adjust these accruals as estimates are refined. In addition, our income tax provision is determined using an estimate of our consolidated annual effective tax rate, adjusted in the current period for discrete income tax items including: • the effects of significant, unusual or extraordinary pretax and income tax items, if any; • withholding taxes recognized associated with cash repatriations; and
Leases	Leases In February 2016, the FASB issued ASU 2016-02, Leases , which requires all assets and liabilities arising from leases to be recognized in our Consolidated Balance Sheets. We adopted this new accounting guidance effective January 1, 2019. In July 2018, the FASB added an optional transition method which we elected upon adoption of the new standard. This allowed us to recognize and measure leases existing at January 1, 2019 without restating comparative information. In addition, we elected to apply the package of practical expedients permitted under the transition guidance within the new standard, which among other things, allows us to carry forward the historical lease classification. We determine if an arrangement is a lease at the lease commencement date. In addition to our lease agreements, we review all material new vendor arrangements for potential embedded lease obligations. The asset balance related to operating and finance leases is presented within right-of-use (ROU) asset and property, plant and equipment, respectively, on our Consolidated Balance Sheet. The short-term liability balance related to operating and finance leases is presented within other accrued liabilities on our Consolidated Balance Sheets. The long-term liability balance is presented within long-term operating lease liability and long-term debt on our Consolidated Balance Sheets for operating and finance leases, respectively. The lease liability is recognized based on the present value of the remaining fixed or in-substance fixed lease payments discounted using our incremental borrowing rates. We use a specific incremental borrowing rate for our material leases, which is determined based on the geography, nature of the asset and term of the lease. These rates are determined based on inputs provided by external banks and updated periodically. The lease liability includes the exercise of a purchase option only if we are reasonably certain to exercise as of the commencement date of the lease. The residual value guarantee amount is only included in the lease liability calculation to the extent payment is probable to the lessor as of the commencement of the lease. The ROU asset is calculated based on the lease liability adjusted for any lease payments paid to the lessor at or before the commencement date (i.e. prepaid rent) and initial direct costs incurred by Avon and excluding any lease incentives received from the Lessor. Variable lease payments are payments to the lessor not included in the lease liability calculation. We define variable lease payments as payments made by Avon to the lessor for the right to use a leased asset that vary because of changes in facts or circumstances (such as changes in an index rate, volume, usage, etc.) occurring after the lease commencement date, other than predetermined contractual changes due to the passage of time (for example, predetermined rent increase amounts that are set out in the contract). Variable lease payments or charges are accounted for as incurred. The lease term for purposes of lease accounting may include options to extend or terminate the lease when it is reasonably certain that we will exercise that option as of the commencement date of the lease. For operating leases, the lease expense is recognized on a straight-line basis over the lease term. For finance leases, the Company amortizes the ROU asset on a straight-line basis and records interest expense on the lease liability created at lease commencement over the lease term. We account for our lease and non-lease components as a single component for most of our asset classes, and therefore both are included in the calculation of lease liability recognized on the Consolidated Balance Sheets. However, for certain lease asset classes related to identified embedded leases we account for the lease and non-lease components separately, and therefore, the non-lease component is not included in the lease liability.
Other Accounting Standards	ASU 2018-02, Income Statement - Reporting Comprehensive Income In February 2018, the FASB issued ASU 2018-02, Income Statement - Reporting Comprehensive Income , which permits entities to reclassify the disproportionate income tax effects of the 2017 enactment of U.S. tax reform legislation (the "Act") on items within accumulated other comprehensive income (loss) to retained earnings. We adopted this new accounting guidance effective January 1, 2019 and elected not to reclassify the disproportionate income tax effects of the Act from accumulated other comprehensive income (loss) to retained earnings. Accounting Standards to be Implemented ASU 2016-13, Financial Instruments - Credit Losses In January 2016, the FASB issued ASU 2016-13, Financial Instruments - Credit Losses, which requires measurement and recognition of expected credit losses for financial assets held. We intend to adopt this new accounting guidance effective January 1, 2020. We are currently assessing the impact of adopting this standard but do not expect the adoption of this guidance to have a material impact on our Consolidated Financial Statements.

EARNINGS PER SHARE AND SHARE _2

EARNINGS PER SHARE AND SHARE REPURCHASES (Tables)	9 Months Ended
	Sep. 30, 2019
Earnings Per Share [Abstract]
Components of Basic and Diluted Earnings per Share	Three Months Ended September 30, Nine Months Ended September 30, (Shares in millions) 2019 2018 2019 2018 Numerator from continuing operations: Income from continuing operations, less amounts attributable to noncontrolling interests $ 113.2 $ 114.5 $ 83.7 $ 58.1 Less: Earnings allocated to participating securities 1.6 1.4 1.2 .7 Less: Earnings allocated to convertible preferred stock 18.6 18.8 19.0 18.1 Income from continuing operations allocated to common shareholders 93.0 94.3 63.5 39.3 Numerator from discontinued operations: Loss from discontinued operations $ (6.3) $ — $ (29.0) $ — Loss allocated to common shareholders (6.3) — (29.0) — Numerator attributable to Avon: Net income attributable to Avon $ 106.9 $ 114.5 $ 54.7 $ 58.1 Less: Earnings allocated to participating securities 1.6 1.4 1.2 .7 Less: Earnings allocated to convertible preferred stock 18.6 18.8 19.0 18.1 Income allocated to common shareholders 86.7 94.3 34.5 39.3 Denominator: Basic EPS weighted-average shares outstanding 442.4 442.3 442.7 441.8 Diluted effect of assumed conversion of stock-based compensation .2 — .2 — Diluted effect of assumed conversion of preferred stock — — — — Diluted EPS adjusted weighted-average shares outstanding 442.6 442.3 442.9 441.8 Earnings per Common Share from continuing operations: Basic $ 0.21 $ 0.21 $ 0.14 $ 0.09 Diluted $ 0.21 $ 0.21 $ 0.14 $ 0.09 Loss per Common Share from discontinued operations: Basic $ (0.01) $ — $ (0.06) $ — Diluted $ (0.01) $ — $ (0.06) $ — Earnings per Common Share attributable to Avon: Basic $ 0.20 $ 0.21 $ 0.08 $ 0.09 Diluted $ 0.20 $ 0.21 $ 0.08 $ 0.09 Amounts in the table above may not necessarily sum due to rounding.

DISCONTINUED OPERATIONS, ASSE_2

DISCONTINUED OPERATIONS, ASSETS AND LIABILITIES HELD FOR SALE AND DIVESTITURES (Tables)	9 Months Ended
	Sep. 30, 2019
Discontinued Operations and Disposal Groups [Abstract]
Major Classes of Financial Statement Components Comprising the Loss on Discontinued Operations	The major classes of financial statement components comprising the loss on discontinued operations, net of tax for New Avon are shown below: Three Months Ended September 30, 2019 Nine Months Ended September 30, 2019 Selling, general and administrative expenses $ 6.3 $ 29.0 Operating loss $ (6.3) $ (29.0) Loss from discontinued operations, net of tax $ (6.3) $ (29.0)
Major Classes of Financial Statement Components Comprising the Loss on Discontinued Operations	December 31, 2018 Avon Manufacturing (Guangzhou) Rye Office Malaysia Maximin Total Current Held for sale assets Inventories $ 8.7 $ — $ — $ 8.7 Property, Plant & Equipment (net) 36.7 12.3 3.0 52.0 Cash and cash equivalents 3.7 — — 3.7 Other assets 1.1 — .1 1.2 $ 50.2 $ 12.3 $ 3.1 $ 65.6 Current held for sale liabilities Accounts payable $ 8.6 $ — $ — $ 8.6 Other liabilities 2.6 — .2 2.8 $ 11.2 $ — $ .2 $ 11.4
Major Classes of Financial Statement Components Comprising the Loss on Discontinued Operations	The major classes of assets and liabilities comprising Held for sale assets and Held for sale liabilities on the Consolidated Balance Sheets as of September 30, 2019 and December 31, 2018 are shown in the following table. September 30, 2019 Current Held for sale assets Property, Plant & Equipment (net) $ 18.3 $ 18.3

RESTRICTED CASH (Tables)

RESTRICTED CASH (Tables)	9 Months Ended
	Sep. 30, 2019
Restricted Cash and Cash Equivalents [Abstract]
Schedule of Cash and Cash Equivalents	The following table provides a reconciliation of cash, cash equivalents, and restricted cash reported within the Consolidated Balance Sheet that sum to the total of the same such amounts shown in the Consolidated Statement of Cash Flows for the nine month period ended September 30, 2019. September 30, 2019 December 31, 2018 Cash and cash equivalents $ 564.2 $ 532.7 Long-term restricted cash (1) 7.6 — Held for sale cash and cash equivalents — 3.7 Cash and cash equivalents, and restricted cash at end of period per the statement of cash flows $ 571.8 $ 536.4 (1) Long-term restricted cash is presented in other assets in our Consolidated Balance Sheets.

RELATED PARTY TRANSACTIONS (Tab

RELATED PARTY TRANSACTIONS (Tables)	9 Months Ended
	Sep. 30, 2019
Related Party Transactions [Abstract]
Schedule of Related Party Transactions	The following tables present the related party transactions with New Avon, affiliates of Cerberus and the Instituto Avon in Brazil. There are no other related party transactions. On August 14, 2019, we sold our investment in New Avon to LG Household & Health Care Ltd. Upon completion of the sale, New Avon is no longer a related party. See Note 3, Discontinued Operation, Assets and Liabilities Held for Sale and Divestitures, to the Consolidated Financial Statements contained herein, for further details. Three Months Ended September 30, Nine Months Ended September 30, 2019 2018 2019 2018 Statement of Operations Data Revenue from sale of product to New Avon (1) $ 3.5 $ 7.3 $ 12.0 $ 20.3 Gross profit from sale of product to New Avon (1) $ .1 $ .6 $ .2 $ 1.3 Cost of sales for purchases from New Avon (2) $ .7 $ .9 $ 2.1 $ 2.1 Selling, general and administrative expenses related to New Avon: Transition services, intellectual property, technical support and innovation and subleases (3) $ — $ (.6) $ (.2) $ (4.3) Project management team (4) .6 $ .2 $ 4.0 $ 1.0 Net reduction of selling, general and administrative expenses $ .6 $ (.4) $ 3.8 $ (3.3) Interest income from Instituto Avon (5) $ — $ .1 $ .1 $ .1 September 30, 2019 December 31, 2018 Balance Sheet Data Inventories (6) N/A $ .3 Receivables due from New Avon (6) N/A $ 7.0 Receivables due from Instituto Avon (5) $ 2.0 $ 3.2 Payables due to New Avon (6) N/A $ .2 Payables due to an affiliate of Cerberus (7) $ 2.1 $ .6 (1) The Company supplies product to New Avon as part of a manufacturing and supply agreement. On August 14, 2019, the Company sold it's investment in New Avon to LG Household & Health Care Ltd, from this point New Avon is no longer a related party. Transactions entered into with New Avon for the three month and nine month periods ended September 30, 2019 have been disclosed above. (2) New Avon supplies product to the Company as part of the same manufacturing and supply agreement discussed in footnote (1) above. The Company purchased $.5 and $.7 from New Avon associated with this agreement during the three months ended September 30, 2019 and 2018, respectively, and recorded $.7 and $.9 associated with these purchases within cost of sales in our Consolidated Statement of Operations during the three months ended September 30, 2019 and 2018, respectively. The Company purchased $1.6 and $1.9 from New Avon associated with this agreement during the nine months ended September 30, 2019 and 2018, respectively, and recorded $2.1 and $2.1 associated with these purchases within cost of sales in our Consolidated Statement of Operations during the nine months ended September 30, 2019 and 2018, respectively. On August 14, 2019, the Company sold its investment in New Avon to LG Household & Health Care Ltd; from this point New Avon is no longer a related party. Transactions entered into with New Avon for the three month and nine month periods ended September 30, 2019 have been disclosed above. (3) The Company also entered into a transition services agreement to provide certain services to New Avon, which expired on October 31, 2018, as well as an intellectual property license agreement, an agreement for technical support and innovation and sublease for office space. The net amounts recorded within selling, general and administrative expenses generally represent a recovery of the related costs. (4) The Company also entered into agreements with an affiliate of Cerberus, which provide for the secondment of Cerberus affiliate personnel to the Company's project management team responsible for assisting with the execution of the implementation of the Company’s strategic initiatives. The Company recorded net cost of $.6 and $.2 in selling, general and administrative expenses associated with these agreements during the three months ended September 30, 2019 and 2018, respectively, and recorded $4.0 and $1.0 in selling, general and administrative expenses associated with these agreements during the nine months ended September 30, 2019 and 2018, respectively. See Note 15, Restructuring Initiatives to the Consolidated Financial Statements contained herein, for additional information related to the Company's strategic initiatives. (5) During the second quarter of 2018, the Company entered into an agreement to loan the Instituto Avon, an independent non-government charitable organization in Brazil, R$12 million (Brazilian real) for an unsecured 5-year term at a fixed interest rate of 7% per annum, to be paid back in five equal annual installments. The Instituto Avon was created by an Avon subsidiary in Brazil, with the board and executive team comprised of Avon Brazil management. The purpose of the loan was to provide the Instituto Avon with the means to donate funds to Fundação Pio XII (a leading cancer prevention and treatment organization in Brazil and owner of the Hospital do Câncer de Barretos), in order to invest in equipment with the objective of expanding breast cancer prevention and treatment. During the third quarter of 2019 Institutio Avon repaid $1 million of the loan. (6) On August 14, 2019, the Company sold its investment in New Avon to LG Household & Health Care Ltd, from this point New Avon is no longer a related party. Therefore at September 30, 2019, we do not have any related party balances with New Avon. (7) The payables due to an affiliate of Cerberus relate to the agreement for the project management team, and were classified within other accrued liabilities in our Consolidated Balance Sheets.

REVENUE (Tables)

REVENUE (Tables)	9 Months Ended
	Sep. 30, 2019
Revenue from Contract with Customer [Abstract]
Disaggregation of Revenue	In the following table, revenue is disaggregated by product or service type. All revenue is recognized at a point in time when control of a product is transferred to a customer: Three Months Ended September 30, 2019 Reportable segments Europe, Middle East & Africa South Latin America North Latin America Asia Pacific Total reportable segments Other operating segments and business activities Total Beauty: Skincare $ 125.2 $ 129.3 $ 44.0 $ 27.7 $ 326.2 $ — $ 326.2 Fragrance 129.2 100.2 47.1 19.1 295.6 — 295.6 Color 70.7 69.3 20.3 11.3 171.6 — 171.6 Total Beauty 325.1 298.8 111.4 58.1 793.4 — 793.4 Fashion & Home: Fashion 46.4 37.6 19.4 40.5 143.9 — 143.9 Home 6.4 56.1 43.7 6.0 112.2 — 112.2 Total Fashion & Home 52.8 93.7 63.1 46.5 256.1 — 256.1 Certain Brazil indirect taxes* — 67.7 — — 67.7 — 67.7 Product sales 377.9 460.2 174.5 104.6 1,117.2 — 1,117.2 Representative fees 20.0 28.7 10.2 1.7 60.6 60.6 Other .4 5.1 — — 5.5 4.7 10.2 Other revenue 20.4 33.8 10.2 1.7 66.1 4.7 70.8 Total revenue $ 398.3 $ 494.0 $ 184.7 $ 106.3 $ 1,183.3 $ 4.7 $ 1,188.0 Three Months Ended September 30, 2018 Reportable segments Europe, Middle East & Africa South Latin America North Latin America Asia Pacific Total reportable segments Other operating segments and business activities Total Beauty: Skincare $ 133.7 $ 137.8 $ 38.2 $ 29.3 $ 339.0 $ — $ 339.0 Fragrance 139.5 113.8 54.9 23.7 331.9 — 331.9 Color 80.1 76.5 21.2 14.2 192.0 — 192.0 Total Beauty 353.3 328.1 114.3 67.2 862.9 — 862.9 Fashion & Home: Fashion 58.9 46.0 25.1 44.7 174.7 — 174.7 Home 8.7 68.6 56.0 6.8 140.1 .2 140.3 Total Fashion & Home 67.6 114.6 81.1 51.5 314.8 .2 315.0 Brazil IPI tax release** — 168.4 — — 168.4 — 168.4 Product sales 420.9 611.1 195.4 118.7 1,346.1 .2 1,346.3 Representative fees 21.8 33.7 11.6 1.8 68.9 .1 69.0 Other .2 .6 — — .8 8.1 8.9 Other revenue 22.0 34.3 11.6 1.8 69.7 8.2 77.9 Total revenue $ 442.9 $ 645.4 $ 207.0 $ 120.5 $ 1,415.8 $ 8.4 $ 1,424.2 Nine Months Ended September 30, 2019 Reportable segments Europe, Middle East & Africa South Latin America North Latin America Asia Pacific Total reportable segments Other operating segments and business activities Total Beauty: Skincare $ 400.9 $ 386.1 $ 144.2 $ 90.2 $ 1,021.4 $ 1,021.4 Fragrance 386.9 313.0 140.7 56.1 896.7 896.7 Color 246.6 196.2 63.4 35.4 541.6 541.6 Total Beauty 1,034.4 895.3 348.3 181.7 2,459.7 — 2,459.7 Fashion & Home: Fashion 162.1 117.7 61.4 123.2 464.4 464.4 Home 21.3 178.3 131.0 19.8 350.4 350.4 Total Fashion & Home 183.4 296.0 192.4 143.0 814.8 — 814.8 Certain Brazil indirect taxes* — 67.7 — — 67.7 — 67.7 Product sales 1,217.8 1,259.0 540.7 324.7 3,342.2 — 3,342.2 Representative fees 63.5 87.0 30.5 5.2 186.2 186.2 Other .8 5.7 — .1 6.6 14.7 21.3 Other revenue 64.3 92.7 30.5 5.3 192.8 14.7 207.5 Total revenue $ 1,282.1 $ 1,351.7 $ 571.2 $ 330.0 $ 3,535.0 $ 14.7 $ 3,549.7 Nine Months Ended September 30, 2018 Reportable segments Europe, Middle East & Africa South Latin America North Latin America Asia Pacific Total reportable segments Other operating segments and business activities Total Beauty: Skincare $ 457.4 $ 423.4 $ 128.8 $ 90.9 $ 1,100.5 $ 6.4 $ 1,106.9 Fragrance 446.5 363.9 160.9 62.4 1,033.7 2.9 1,036.6 Color 299.0 237.9 62.8 40.3 640.0 4.8 644.8 Total Beauty 1,202.9 1,025.2 352.5 193.6 2,774.2 14.1 2,788.3 Fashion & Home: Fashion 211.5 142.4 70.1 125.2 549.2 3.0 552.2 Home 25.6 213.1 153.9 21.2 413.8 2.0 415.8 Total Fashion & Home 237.1 355.5 224.0 146.4 963.0 5.0 968.0 Brazil IPI tax release** — 168.4 — — 168.4 — 168.4 Product sales 1,440.0 1,549.1 576.5 340.0 3,905.6 19.1 3,924.7 Representative fees 71.5 105.1 33.4 4.9 214.9 2.0 216.9 Other .5 4.4 — .1 5.0 23.0 28.0 Other revenue 72.0 109.5 33.4 5.0 219.9 25.0 244.9 Total revenue $ 1,512.0 $ 1,658.6 $ 609.9 $ 345.0 $ 4,125.5 $ 44.1 $ 4,169.6 * 2019 includes the impact of certain Brazil indirect taxes which was recorded in product sales of approximately $68, in our Consolidated Income Statements. See Note 14 Supplemental Balance Sheet Information, to the Consolidated Financial Statements contained herein for further information. **2018 includes the impact of the Brazil IPI, which was recorded in product sales of approximately $168, in our Consolidated Income Statements. See Note 11, Contingencies, to the Consolidated Financial Statements contained herein for further information.
Receivables and Contract Liabilities from Contracts with Customers	The following table provides information about receivables and contract liabilities from contracts with customers at September 30, 2019 and December 31, 2018: September 30, 2019 December 31, 2018 Accounts receivable, net of allowances of $65 and $93 $ 303.0 $ 349.7 Contract liabilities $ 49.1 $ 84.4

INVENTORIES (Tables)

INVENTORIES (Tables)	9 Months Ended
	Sep. 30, 2019
Inventory Disclosure [Abstract]
Schedule of Components of Inventories	Components of Inventories September 30, 2019 December 31, 2018 Raw materials $ 131.2 $ 157.8 Finished goods 368.2 384.2 Total $ 499.4 $ 542.0

LEASES (Tables)

LEASES (Tables)	9 Months Ended
	Sep. 30, 2019
Leases [Abstract]
Assets and Liabilities, Lessee	Classification September 30, 2019 January 1, 2019 Assets Operating right-of-use assets Right-of-use asset $ 172.3 $ 187.5 Finance right-of-use assets Property, Plant and Equipment 2.5 3.2 Total right-of-use assets 174.8 190.7 Liabilities Current Operating lease liabilities Other accrued liabilities $ 43.9 $ 45.4 Finance lease liabilities Other accrued liabilities 1.0 1.1 Total current lease liabilities 44.9 46.5 Noncurrent Operating lease liabilities Long-term operating lease liability $ 141.7 $ 155.9 Finance lease liabilities Long-term debt 1.5 1.9 Total noncurrent lease liabilities $ 143.2 $ 157.8 Total lease liability $ 188.1 $ 204.3
Lease Cost	The table below shows the lease income and expenses recorded in the Consolidated Statement of Operations incurred during the three and nine months ended September 30, 2019. Three months ended September 30, Nine months ended September 30, Lease Costs Classification 2019 2019 Operating lease cost (1) Selling, general and administrative expenses $ 16.9 $ 49.9 Finance lease cost Amortization of right-of-use assets Selling, general and administrative expenses .4 1.2 Interest on lease liabilities Interest Expense .1 .2 Short-term leases costs Selling, general and administrative expenses .9 2.9 Sublease income (2) Selling, general and administrative expenses (2.5) (8.3) Net lease cost $ 15.8 $ 45.9 (1) Includes variable lease costs which are immaterial. These are presented in selling, general and administrative expenses in our Consolidated Statements of Operations.
Operating Lease Maturity Analysis	The maturity analysis of the finance and operating lease liabilities is reflected below. This table also reflects the reconciliation of the undiscounted cash flows to the discounted finance and operating lease liabilities as recognized in the September 30, 2019 Consolidated Balance Sheet: Maturity of Lease Liabilities Operating Leases Finance Leases Total 2019 $ 15.4 $ .3 $ 15.7 2020 55.3 1.1 56.4 2021 46.1 .8 46.9 2022 38.3 .5 38.8 2023 25.7 .1 25.8 2024 18.4 — 18.4 Thereafter 29.1 — 29.1 Total lease payments $ 228.3 $ 2.8 $ 231.1 Less: Interest 42.7 .3 43.0 Present value of lease liabilities $ 185.6 $ 2.5 $ 188.1
Finance Lease Maturity Analysis	The maturity analysis of the finance and operating lease liabilities is reflected below. This table also reflects the reconciliation of the undiscounted cash flows to the discounted finance and operating lease liabilities as recognized in the September 30, 2019 Consolidated Balance Sheet: Maturity of Lease Liabilities Operating Leases Finance Leases Total 2019 $ 15.4 $ .3 $ 15.7 2020 55.3 1.1 56.4 2021 46.1 .8 46.9 2022 38.3 .5 38.8 2023 25.7 .1 25.8 2024 18.4 — 18.4 Thereafter 29.1 — 29.1 Total lease payments $ 228.3 $ 2.8 $ 231.1 Less: Interest 42.7 .3 43.0 Present value of lease liabilities $ 185.6 $ 2.5 $ 188.1
Operating Lease by Due Dates	At December 31, 2018 our operating and finance lease obligations by due dates were as follows: Maturity of Lease Liabilities Operating Leases Finance Leases Total 2019 $ 56.4 $ 1.1 $ 57.5 2020 42.0 .6 42.6 2021 35.3 .4 35.7 2022 31.1 .2 31.3 2023 22.4 .1 22.5 Thereafter 46.9 .1 47.0 Total lease payments (1) $ 234.1 $ 2.5 $ 236.6
Financing Lease by Due Dates	At December 31, 2018 our operating and finance lease obligations by due dates were as follows: Maturity of Lease Liabilities Operating Leases Finance Leases Total 2019 $ 56.4 $ 1.1 $ 57.5 2020 42.0 .6 42.6 2021 35.3 .4 35.7 2022 31.1 .2 31.3 2023 22.4 .1 22.5 Thereafter 46.9 .1 47.0 Total lease payments (1) $ 234.1 $ 2.5 $ 236.6
Lease Terms	The Company has calculated the weighted-average remaining lease term, presented in years below, and the weighted-average discount rate for our operating and finance lease population. As noted in our lease accounting policy (See Note 1, Accounting Policies to the Consolidated Financial Statements contained herein), the Company uses the incremental borrowing rate as the lease discount rate. Lease Term and Discount Rate September 30, 2019 Weighted-average remaining lease term (years) Operating leases 5.0 Finance leases 2.7 Weighted-average discount rate Operating leases 8.5 % Finance leases 10.7 %
Cash Flow Classification	The table below sets out the classification of lease payments in the Consolidated Statement of Cash Flows. The right-of-use assets obtained in exchange for new finance and operating lease liabilities represent the new operating and finance leases entered into during the three and nine months ended September 30, 2019. Other Information Three months ended September 30, 2019 Nine months ended September 30, 2019 Operating Cash Flows From Operating Leases $ 16.2 $ 47.9 Financing Cash Flows From Finance Leases .3 1.0 Cash Paid For Amounts Included In Measurement of Liabilities $ 16.5 $ 48.9 Right-of-use Assets Obtained In Exchange For New Finance Liabilities $ — $ .9 Right-of-use Assets Obtained In Exchange For New Operating Liabilities $ 8.5 $ 33.9

EMPLOYEE BENEFIT PLANS (Tables)

EMPLOYEE BENEFIT PLANS (Tables)	9 Months Ended
	Sep. 30, 2019
Retirement Benefits, Description [Abstract]
Schedule of Components of Net Periodic Benefit Cost	Three Months Ended September 30, Pension Benefits Net Periodic Benefit Costs U.S. Plans Non-U.S. Plans Postretirement Benefits 2019 2018 2019 2018 2019 2018 Service cost (1) $ .3 $ .6 $ .9 $ 1.1 $ — $ — Interest cost .6 .6 3.5 3.4 .3 .2 Expected return on plan assets (.8) (1.0) (7.2) (7.3) — — Amortization of prior service credit — — — (.1) — (.1) Amortization of net actuarial losses .6 .7 1.1 1.5 — .1 Net periodic benefit costs (1) $ .7 $ .9 $ (1.7) $ (1.4) $ .3 $ .2 Nine Months Ended September 30, Pension Benefits Net Periodic Benefit Costs U.S. Plans Non-U.S. Plans Postretirement Benefits 2019 2018 2019 2018 2019 2018 Service cost (1) $ 1.3 $ 2.4 $ 2.9 $ 3.5 $ — $ .1 Interest cost 1.8 1.8 11.2 11.6 .9 .8 Expected return on plan assets (2.4) (2.6) (22.8) (23.9) — — Amortization of prior service credit — — — (.1) — (.3) Amortization of net actuarial losses 2.0 3.3 3.7 5.1 — .1 Settlements/curtailments — — 0.1 — — — Net periodic benefit costs (1) $ 2.7 $ 4.9 $ (4.9) $ (3.8) $ .9 $ .7

ACCUMULATED OTHER COMPREHENSI_2

ACCUMULATED OTHER COMPREHENSIVE INCOME (LOSS) (Tables)	9 Months Ended
	Sep. 30, 2019
Equity [Abstract]
Schedule of Amounts in Accumulated Other Comprehensive Income (Loss)	The tables below present the changes in AOCI by component and the reclassifications out of AOCI for the three months ended September 30, 2019 and 2018: Three Months Ended September 30, 2019 Foreign Currency Translation Adjustments Cash Flow Hedges Net Investment Hedges Pension and Postretirement Benefits Investment in New Avon Total Balance at June 30, 2019 $ (935.2) $ (2.1) $ (4.3) $ (90.7) $ 3.4 $ (1,028.9) Other comprehensive loss other than reclassifications (19.1) (.1) — — — (19.2) Reclassifications into earnings: Derivative losses on cash flow hedges, net of tax of $0.0 — .2 — — — .2 Amortization of net actuarial loss and prior service cost, net of tax of $0.2 (1) — — — 1.6 — 1.6 Sale of New Avon — — — — (3.4) (3.4) Total reclassifications into earnings — .2 — 1.6 (3.4) (1.6) Balance at September 30, 2019 $ (954.3) $ (2.0) $ (4.3) $ (89.1) $ — $ (1,049.7) Three Months Ended September 30, 2018 Foreign Currency Translation Adjustments Net Investment Hedges Pension and Postretirement Benefits Investment in New Avon Total Balance at June 30, 2018 $ (923.5) $ (4.3) $ (90.0) $ 3.4 $ (1,014.4) Other comprehensive loss other than reclassifications (3.6) — — — (3.6) Reclassifications into earnings: Amortization of net actuarial loss and prior service cost, net of tax of $0.1 (1) — — 2.1 — 2.1 Total reclassifications into earnings — — 2.1 — 2.1 Balance at September 30, 2018 $ (927.1) $ (4.3) $ (87.9) $ 3.4 $ (1,015.9) Nine Months Ended September 30, 2019 Foreign Currency Translation Adjustments Cash Flow Hedges Net Investment Hedges Pension and Postretirement Benefits Investment in New Avon Total Balance at December 31, 2018 $ (936.2) $ .5 $ (4.3) $ (93.8) $ 3.4 $ (1,030.4) Other comprehensive loss other than reclassifications (18.1) (3.6) — — — (21.7) Reclassifications into earnings: Derivative losses on cash flow hedges, net of tax of $0.0 — 1.1 — — — 1.1 Amortization of net actuarial loss and prior service cost, net of tax of $0.5 (1) — — — 4.7 — 4.7 Sale of New Avon — — — — (3.4) (3.4) Total reclassifications into earnings — 1.1 — 4.7 (3.4) 2.4 Balance at September 30, 2019 $ (954.3) $ (2.0) $ (4.3) $ (89.1) $ — $ (1,049.7) Nine Months Ended September 30, 2018: Foreign Currency Translation Adjustments Net Investment Hedges Pension and Postretirement Benefits Investment in New Avon Total Balance at December 31, 2017 $ (829.6) $ (4.3) $ (95.7) $ 3.4 $ (926.2) Other comprehensive loss other than reclassifications (97.5) — — — (97.5) Reclassifications into earnings: Amortization of net actuarial loss and prior service cost, net of tax of $0.4(1) — — 7.8 — 7.8 Total reclassifications into earnings — — 7.8 — 7.8 Balance at September 30, 2018 $ (927.1) $ (4.3) $ (87.9) $ 3.4 $ (1,015.9) (1) Gross amount reclassified to other income (expense), net in our Consolidated Statements of Operations, and related taxes reclassified to income taxes in our Consolidated Statements of Operations.

SEGMENT INFORMATION (Tables)

SEGMENT INFORMATION (Tables)	9 Months Ended
	Sep. 30, 2019
Segment Reporting [Abstract]
Summarized Financial Information of Reportable Segments	Summarized financial information concerning our reportable segments was as follows: Three Months Ended September 30, Nine Months Ended September 30, Total Revenue 2019 2018 2019 2018 Europe, Middle East & Africa $ 398.3 $ 442.9 $ 1,282.1 $ 1,512.0 South Latin America* 494.0 645.4 1,351.7 1,658.6 North Latin America 184.7 207.0 571.2 609.9 Asia Pacific 106.3 120.5 330.0 345.0 Total revenue from reportable segments* 1,183.3 1,415.8 3,535.0 4,125.5 Other operating segments and business activities (1) 4.7 8.4 14.7 44.1 Total revenue* $ 1,188.0 $ 1,424.2 $ 3,549.7 $ 4,169.6 Three Months Ended September 30, Nine Months Ended September 30, Operating Profit 2019 2018 2019 2018 Segment Profit Europe, Middle East & Africa $ 47.6 $ 46.1 $ 165.8 $ 194.9 South Latin America* 118.4 194.1 207.4 276.5 North Latin America 17.0 14.3 52.6 54.1 Asia Pacific 9.4 9.6 36.9 27.3 Total profit from reportable segments* $ 192.4 $ 264.1 $ 462.7 $ 552.8 Other operating segments and business activities (1) .9 1.1 2.0 2.7 Unallocated global expenses (58.9) (58.5) (187.3) (216.3) CTI restructuring initiatives (17.5) (19.8) (116.7) (54.4) Other expenses (2) (19.2) — (36.4) — Operating profit* $ 97.7 $ 186.9 $ 124.3 $ 284.8 * 2019 includes the impact of certain Brazil indirect taxes which was recorded in product sales of approximately $68, in our Consolidated Income Statements. See Note 14 Supplemental Balance Sheet Information, to the Consolidated Financial Statements contained herein for further information. 2018 includes the impact of the Brazil IPI, which was recorded in product sales of approximately $168, in our Consolidated Income Statements. See Note 11, Contingencies, to the Consolidated Financial Statements contained herein for further information. (1) Other operating segments and business activities include markets that have been exited. Effective in the first quarter of 2018, given that we exited Australia and New Zealand during 2018, the results of Australia and New Zealand are now reported in Other operating segments and business activities for all periods presented, while previously the results had been reported in the Asia Pacific segment. Other operating segments and business activities also include revenue from the sale of products to New Avon since the separation of the Company's North America business into New Avon on March 1, 2016 and ongoing royalties from the licensing of our name and products.

SUPPLEMENTAL BALANCE SHEET IN_2

SUPPLEMENTAL BALANCE SHEET INFORMATION (Tables)	9 Months Ended
	Sep. 30, 2019
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Schedule of Components of Prepaid Expenses and Other	At September 30, 2019 and December 31, 2018, prepaid expenses and other included the following: Components of Prepaid Expenses and Other September 30, 2019 December 31, 2018 Prepaid taxes and tax refunds receivable $ 155.1 $ 145.0 Receivables other than trade 47.7 69.2 Prepaid brochure costs, paper and other literature 12.0 14.9 Other 50.6 42.9 Prepaid expenses and other $ 265.4 $ 272.0
Schedule of Components of Other Assets	At September 30, 2019 and December 31, 2018, other assets included the following: Components of Other Assets (1) September 30, 2019 December 31, 2018 Net overfunded pension plans $ 95.2 $ 88.1 Capitalized software 81.0 89.3 Judicial deposits 67.9 74.1 Long-term receivables 186.4 73.2 Trust assets associated with supplemental benefit plans 39.4 37.0 Tooling (plates and molds associated with our beauty products) 12.6 12.6 Other 31.4 16.1 Other assets $ 513.9 $ 390.4 (1) Deferred tax asset balance as of September 30, 2019 and December 31, 2018 is presented separately in the Consolidated Balance Sheet Long-term receivables includes approximately $118 of certain Brazil indirect taxes (COFINS), recognized in the three months ended September 30, 2019. Approximately $68 and $50 was recorded in product sales and other income (expense), net, in our Consolidated Income Statements following favorable judicial decisions in the three months ending September 30, 2019. The corresponding tax charge on this transaction is approximately $23 and is included in the deferred tax asset balance as of September 30, 2019 which is presented separately in the Consolidated Balance Sheet.

RESTRUCTURING INITIATIVES (Tabl

RESTRUCTURING INITIATIVES (Tables)	9 Months Ended
	Sep. 30, 2019
Restructuring and Related Activities [Abstract]
Summary of Restructuring and Related Costs	The costs during the three and nine months ended September 30, 2019 and 2018 consisted of the following: Three Months Ended September 30, Nine Months Ended September 30, 2019 2018 2019 2018 CTI recorded in operating profit - COGS Manufacturing asset write-offs $ 1.1 $ — $ 10.9 $ — Inventory write-off (2.1) (.1) 1.0 1.0 (1.0) (.1) 11.9 1.0 CTI recorded in operating profit - SG&A Net charges for employee-related costs, including severance benefits 3.2 6.4 51.9 31.9 Implementation costs, primarily related to professional service fees 7.8 11.8 33.7 17.5 Dual running costs 3.7 — 8.2 — Contract termination and other net benefits (.1) (1.7) 4.5 (1.0) Impairment of other assets .1 2.5 2.4 2.5 Accelerated depreciation 2.3 .9 2.6 2.5 Variable lease charges 1.5 — 1.5 — 18.5 19.9 104.8 53.4 CTI recorded in operating profit 17.5 19.8 116.7 54.4 CTI recorded in other (income) expense Gain on sale of Rye Office — — (9.9) — Gain on sale of Malaysia Maximin — — (3.3) — Gain on sale of China business (relating mainly to foreign currency translation adjustment gain) — — (10.3) — Total CTI $ 17.5 $ 19.8 $ 93.2 $ 54.4 Open Up Avon $ 10.8 $ 19.1 $ 84.1 $ 19.1 Transformation Plan $ 6.7 $ 0.7 $ 9.0 $ 36.0 Other $ — $ — $ .1 $ (.7)
Schedule of Restructuring Reserve	The liability balance included in other accrued liabilities in our Consolidated Statements of Operations for the restructuring actions associated with Open Up Avon at September 30, 2019 is as follows: Employee-Related Costs Inventory/Assets Write-offs Foreign Currency Translation Adjustment Write-offs Contract Terminations/Other Total Balance at December 31, 2018 $ 19.6 $ — $ — $ 1.1 $ 20.7 2019 charges $ 56.1 $ 14.3 $ (10.9) $ 4.4 63.9 Adjustments (3.6) — — (.1) (3.7) Cash payments (46.2) — — (2.5) (48.7) Non-cash write-offs — (14.3) 10.9 — (3.4) Foreign exchange (3.0) — — — (3.0) Balance at September 30, 2019 $ 22.9 $ — $ — $ 2.9 $ 25.8 The liability balance included in other accrued liabilities in our Consolidated Balance Sheet for the restructuring actions associated with our Transformation Plan as of September 30, 2019 is as follows: Employee-Related Costs Contract Terminations/Other Total Balance at December 31, 2018 $ 34.4 $ 3.6 $ 38.0 2019 charges (0.7) .2 (.5) Cash payments (26.3) (2.3) (28.6) Foreign exchange .1 — .1 Balance at September 30, 2019 $ 7.5 $ 1.5 $ 9.0 The majority of cash payments, if applicable, associated with the year-end liability are expected to be made during 2019. The following table presents the restructuring charges incurred to date, under Open Up Avon and the Transformation Plan, along with the estimated charges expected to be incurred on approved initiatives under the plans: Employee- Related Costs Inventory/ Asset Write-offs Contract Foreign Currency Translation Adjustment Write-offs Total Open Up Avon Charges incurred to-date $ 78.9 $ 104.1 $ 5.1 $ (10.9) $ 177.2 Estimated charges to be incurred on approved initiatives — — 1.7 — 1.7 Total expected charges on approved initiatives $ 78.9 $ 104.1 $ 6.8 $ (10.9) $ 178.9 Transformation Plan Charges incurred to-date $ 127.3 $ 2.4 $ 40.9 $ 3.4 $ 174.0 Estimated charges to be incurred on approved initiatives — — — — — Total expected charges on approved initiatives $ 127.3 $ 2.4 $ 40.9 $ 3.4 $ 174.0
Schedule of Restructuring Charges Reportable by Business Segment	The charges, net of adjustments, of initiatives under the Open Up Avon and the Transformation Plan, along with the estimated charges expected to be incurred on approved initiatives under the plans, by reportable segment are as follows: Europe, Middle East & Africa South Latin America North Latin America Asia Global & Other Operating Segments Total Open Up Avon 2018 $ 32.2 $ 36.4 $ 27.9 $ 14.4 $ 6.2 $ 117.1 First quarter 2019 13.5 12.7 2.9 (3.2) 7.3 33.2 Second quarter 2019 4.5 13.7 4.3 (1.2) 3.9 25.2 Third quarter 2019 (.8) 1.6 .4 .4 .1 1.7 Charges incurred to-date 49.4 64.4 35.5 10.4 17.5 177.2 Estimated charges to be incurred on approved initiatives 1.7 1.7 Total expected charges on approved initiatives $ 51.1 $ 64.4 $ 35.5 $ 10.4 $ 17.5 $ 178.9 Transformation Plan 2015 $ — $ — $ — $ — $ 21.4 $ 21.4 2016 30.9 13.2 4.4 9.1 16.8 74.4 2017 .9 5.6 (.6) (.5) 49.4 54.8 2018 5.0 4.1 .6 .6 13.4 23.7 First quarter 2019 (1.1) — — — .3 (.8) Second quarter 2019 — — — — — — Third quarter 2019 (.1) .5 — — .1 .5 Charges incurred to-date 35.6 23.4 4.4 9.2 101.4 174.0 Estimated charges to be incurred on approved initiatives — — — — — — Total expected charges on approved initiatives $ 35.6 $ 23.4 $ 4.4 $ 9.2 $ 101.4 $ 174.0

GOODWILL (Tables)

GOODWILL (Tables)	9 Months Ended
	Sep. 30, 2019
Goodwill and Intangible Assets Disclosure [Abstract]
Schedule of Goodwill	Europe, Middle East & Africa South Latin Asia Total Net balance at December 31, 2018 $ 18.0 $ 66.8 $ 2.6 $ 87.4 Changes during the period ended September 30, 2019: Foreign exchange (1.0) (3.9) — (4.9) Net balance at September 30, 2019 $ 17.0 $ 62.9 $ 2.6 $ 82.5

FAIR VALUE (Tables)

FAIR VALUE (Tables)	9 Months Ended
	Sep. 30, 2019
Fair Value Disclosures [Abstract]
Fair Value of Assets and Liabilities Measured on a Recurring Basis	The following table presents the fair value hierarchy for those assets and liabilities measured at fair value on a recurring basis as of September 30, 2019: Level 1 Level 2 Total Assets: Available-for-sale securities $ 4.0 $ — $ 4.0 Foreign exchange forward contracts $ — $ 17.0 $ 17.0 Total $ 4.0 $ 17.0 $ 21.0 Liabilities: Foreign exchange forward contracts $ — $ 2.0 $ 2.0 Total $ — $ 2.0 $ 2.0
Summary of Carrying Value and Fair Value of Financial Instruments	The net asset (liability) amounts recorded in the balance sheet (carrying amount) and the estimated fair values of our remaining financial instruments at September 30, 2019 and December 31, 2018, respectively, consisted of the following: September 30, 2019 December 31, 2018 Carrying Fair Carrying Fair Available-for-sale securities $ 4.0 $ 4.0 $ 3.8 $ 3.8 Debt maturing within one year (1) (116.2) (117.4) (12.0) (12.0) Long-term debt (1) (1,589.1) (1,696.7) (1,581.6) (1,460.2) Foreign exchange forward contracts 15.0 15.0 (5.1) (5.1) (1) The carrying value of debt maturing within one year and long-term debt is presented net of debt issuance costs and includes any related discount or premium and unamortized deferred gains on terminated interest-rate swap agreements, as applicable.

DERIVATIVE INSTRUMENTS AND HE_2

DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES (Tables)	9 Months Ended
	Sep. 30, 2019
Derivative Instruments and Hedging Activities Disclosure [Abstract]
Fair Value of Derivative Instruments	The following table presents the fair value of derivative instruments at September 30, 2019: Asset Liability Balance Sheet Fair Balance Sheet Fair Derivatives designated as hedges: Foreign exchange forward contracts Prepaid expenses and other $ — Accounts payable $ 1.9 Derivatives not designated as hedges: Foreign exchange forward contracts Prepaid expenses and other $ 17.0 Accounts payable $ .1 Total derivatives $ 17.0 $ 2.0

EARNINGS PER SHARE AND SHARE _3

EARNINGS PER SHARE AND SHARE REPURCHASES (Components of Basic and Diluted Earnings per Share) (Details) - USD ($) $ / shares in Units, shares in Millions, $ in Millions	3 Months Ended		9 Months Ended
	Sep. 30, 2019	Sep. 30, 2018	Sep. 30, 2019	Sep. 30, 2018
Numerator from continuing operations:
Income from continuing operations, less amounts attributable to noncontrolling interests	$ 113.2	$ 114.5	$ 83.7	$ 58.1
Less: Earnings allocated to participating securities	1.6	1.4	1.2	0.7
Less: Earnings allocated to convertible preferred stock	18.6	18.8	19	18.1
Income from continuing operations allocated to common shareholders	93	94.3	63.5	39.3
Numerator from discontinued operations:
Loss from discontinued operations	(6.3)	0	(29)	0
Loss allocated to common shareholders	(6.3)	0	(29)	0
Numerator attributable to Avon:
Net income attributable to Avon	106.9	114.5	54.7	58.1
Less: Earnings allocated to participating securities	1.6	1.4	1.2	0.7
Less: Earnings allocated to convertible preferred stock	18.6	18.8	19	18.1
Income allocated to common shareholders	$ 86.7	$ 94.3	$ 34.5	$ 39.3
Denominator:
Basic EPS weighted-average shares outstanding (in shares)	442.4	442.3	442.7	441.8
Diluted effect of assumed conversion of stock-based compensation (in shares)	0.2	0	0.2	0
Diluted effect of assumed conversion of preferred stock (in shares)	0	0	0	0
Diluted EPS adjusted weighted-average shares outstanding (in shares)	442.6	442.3	442.9	441.8
Earnings per Common Share from continuing operations:
Basic (in dollars per share)	$ 0.21	$ 0.21	$ 0.14	$ 0.09
Diluted (in dollars per share)	0.21	0.21	0.14	0.09
Loss per Common Share from discontinued operations:
Basic (in dollars per share)	(0.01)	0	(0.06)	0
Diluted (in dollars per share)	(0.01)	0	(0.06)	0
Earnings per Common Share attributable to Avon:
Basic (in dollars per share)	0.20	0.21	0.08	0.09
Diluted (in dollars per share)	$ 0.20	$ 0.21	$ 0.08	$ 0.09

EARNINGS PER SHARE AND SHARE _4

EARNINGS PER SHARE AND SHARE REPURCHASES (Narrative) (Details) - USD ($) shares in Millions, $ in Millions	3 Months Ended		9 Months Ended
	Sep. 30, 2019	Sep. 30, 2018	Sep. 30, 2019	Sep. 30, 2018
Earnings Per Share [Abstract]
Stock options excluded from computation of earnings per share (in shares)	8.6	18.1	16.6	17.6
Converted Series C Convertible Preferred Stock (in shares)	87.1	87.1	87.1	87.1
Stock repurchased during the period (in shares)			0.5	1.1
Stock repurchased during the period			$ 1.5	$ 3.2

DISCONTINUED OPERATIONS, ASSE_3

DISCONTINUED OPERATIONS, ASSETS AND LIABILITIES HELD FOR SALE AND DIVESTITURES - Additional Information (Details) - USD ($)	Jun. 26, 2019	May 09, 2019	Feb. 15, 2019	Aug. 31, 2019	Sep. 30, 2019	Jun. 30, 2019	Mar. 31, 2019	Sep. 30, 2018	Aug. 31, 2019	Sep. 30, 2019	Sep. 30, 2018	Apr. 30, 2019	Dec. 31, 2018	Mar. 01, 2016
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Net proceeds from sale of business / assets				$ 23,400,000	$ 23,400,000			$ 0		$ 99,900,000	$ 0
Gain on sale of business/assets					26,800,000			0		50,300,000	0
Release of accumulated other comprehensive income, sale of business/asset					3,400,000			$ 0		3,400,000	$ 0
Rye Office
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Sale purchase price	$ 23,200,000
Acquisition expenses	800,000
Net proceeds from sale of business / assets	$ 22,400,000
Gain on sale of business/assets						$ 9,900,000
Held for sale asset adjustment							$ 200,000
Malaysia Maximin
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Sale purchase price		$ 7,800,000
Net proceeds from sale of business / assets		$ 7,600,000
Gain on sale of business/assets						3,300,000
Held for sale asset adjustment						1,400,000
Gain on sale, net of tax						$ 3,000,000
Avon Manufacturing (Guangzhou), Ltd.
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Net proceeds from sale of business / assets			$ 46,400,000
Gain on sale of business/assets							10,300,000
Gain on sale, net of tax							$ 8,200,000
Restricted cash					7,600,000					7,600,000
Avon Manufacturing (Guangzhou), Ltd. | TheFaceShop Co., LTd.
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Sale purchase price			71,000,000
Acquisition expenses			1,100,000
Loans assumed			$ 23,500,000
New Avon
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Percentage of ownership												19.90%		19.90%
Sale purchase price				$ 24,500,000
Transaction costs									$ 1,100,000
Investment					$ 0					$ 0			$ 0

DISCONTINUED OPERATIONS, ASSE_4

DISCONTINUED OPERATIONS, ASSETS AND LIABILITIES HELD FOR SALE AND DIVESTITURES - Major Classes of Financial Statement Components Comprising the Loss on Discontinued Operations, Net of Tax in North America (Details) - USD ($) $ in Millions	3 Months Ended	9 Months Ended
	Sep. 30, 2019	Sep. 30, 2019	Dec. 31, 2018
Current Held for sale assets
Cash and cash equivalents	$ 0	$ 0	$ 3.7
Discontinued Operations
Current held for sale liabilities
Liabilities	14.2	14.2	0
Held for Sale
Current Held for sale assets
Inventories			8.7
Property, Plant & Equipment (net)			52
Cash and cash equivalents			3.7
Other assets			1.2
Assets			65.6
Current held for sale liabilities
Accounts payable			8.6
Other liabilities			2.8
Liabilities	0	0	11.4
North America Segment | Discontinued Operations
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Selling, general and administrative expenses	6.3	29
Operating loss	(6.3)	(29)
Loss from discontinued operations, net of tax	(6.3)	(29)
Avon Manufacturing Guangzhou | Held for Sale
Current Held for sale assets
Inventories			8.7
Property, Plant & Equipment (net)			36.7
Cash and cash equivalents			3.7
Other assets			1.1
Assets			50.2
Current held for sale liabilities
Accounts payable			8.6
Other liabilities			2.6
Liabilities			11.2
Rye Office | Held for Sale
Current Held for sale assets
Inventories			0
Property, Plant & Equipment (net)	18.3	18.3	12.3
Cash and cash equivalents			0
Other assets			0
Assets	$ 18.3	$ 18.3	12.3
Current held for sale liabilities
Accounts payable			0
Other liabilities			0
Liabilities			0
Malaysia Maximin | Held for Sale
Current Held for sale assets
Inventories			0
Property, Plant & Equipment (net)			3
Cash and cash equivalents			0
Other assets			0.1
Assets			3.1
Current held for sale liabilities
Accounts payable			0
Other liabilities			0.2
Liabilities			$ 0.2

RESTRICTED CASH (Details)

RESTRICTED CASH (Details) - USD ($) $ in Millions	Sep. 30, 2019	Jun. 30, 2019	[1]	Dec. 31, 2018		Sep. 30, 2018	Jun. 30, 2018	[1]	Dec. 31, 2017	[1]
Restricted Cash and Cash Equivalents [Abstract]
Cash and cash equivalents	$ 564.2			$ 532.7
Long-term restricted cash	7.6			0
Held for sale cash and cash equivalents	0			3.7
Cash and cash equivalents, and restricted cash at end of period per the statement of cash flows	$ 571.8	$ 428.6		$ 536.4	[1]	$ 452.6	$ 443.9		$ 881.5
[1]	The balance at the beginning of the nine month period ended September 30, 2019 includes cash and cash equivalents of $3.7 classified as Held for sale assets in our Consolidated Balance Sheets.

INVESTMENT IN NEW AVON (Details

INVESTMENT IN NEW AVON (Details)	Apr. 30, 2019	Mar. 01, 2016
New Avon
Schedule of Equity Method Investments [Line Items]
Percentage of ownership	19.90%	19.90%

RELATED PARTY TRANSACTIONS (Sum

RELATED PARTY TRANSACTIONS (Summary of Related Parties) (Details) R$ in Millions, $ in Millions	3 Months Ended			9 Months Ended
	Sep. 30, 2019USD ($)	Sep. 30, 2018USD ($)	Jun. 30, 2018BRL (R$)installment	Sep. 30, 2019USD ($)	Sep. 30, 2018USD ($)	Dec. 31, 2018USD ($)
Related Party Transaction [Line Items]
Inventories						$ 0.3
Equity Method Investee
Related Party Transaction [Line Items]
Net reduction of selling, general and administrative expenses	$ 0.6	$ (0.4)		$ 3.8	$ (3.3)
Equity Method Investee | Manufacturing and Supply Agreement
Related Party Transaction [Line Items]
Revenue from sale of product to New Avon	3.5	7.3		12	20.3
Gross profit from sale of product to New Avon	0.1	0.6		0.2	1.3
Cost of sales for purchases from New Avon	0.7	0.9		2.1	2.1
Purchases from related party	0.5	0.7		1.6	1.9
Equity Method Investee | Transition Services Agreement
Related Party Transaction [Line Items]
Net reduction of selling, general and administrative expenses	0	(0.6)		(0.2)	(4.3)
Equity Method Investee | Project Management Agreement
Related Party Transaction [Line Items]
Net reduction of selling, general and administrative expenses	0.6	0.2		4	1
New Avon
Related Party Transaction [Line Items]
Receivables due from related party						7
Payables to related parties						0.2
Cerberus
Related Party Transaction [Line Items]
Payables to related parties	2.1			2.1		0.6
Instituto Avon | Affiliated Entity
Related Party Transaction [Line Items]
Interest income from Instituto Avon	0	$ 0.1		0.1	$ 0.1
Receivables due from related party	2			$ 2		$ 3.2
Instituto Avon | Affiliated Entity | Loan to Related Party
Related Party Transaction [Line Items]
Loan amount | R$			R$ 12
Loan term			5 years
Loan interest rate			7.00%
Numer of loan annual installments | installment			5
Repayments of loan	$ 1

RELATED PARTY TRANSACTIONS (Det

RELATED PARTY TRANSACTIONS (Details) - USD ($)	Mar. 01, 2016	Sep. 30, 2019	Sep. 30, 2018	Dec. 31, 2018
Related Party Transaction [Line Items]
Dividend rate	1.25%
Series C convertible preferred stock		$ 511,100,000		$ 492,100,000
Dividends		0	$ 0
Equity Method Investee
Related Party Transaction [Line Items]
Standby letters of credit, recorded liability		800,000
Series C Preferred Stock
Related Party Transaction [Line Items]
Shares issued (in shares)	435,000
Shares issued	$ 435,000,000
Dividends payable		84,800,000
Private Placement
Related Party Transaction [Line Items]
Preferred stock, discount on shares		$ 8,700,000

REVENUE Disaggregation of Reven

REVENUE Disaggregation of Revenues (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Sep. 30, 2019	Sep. 30, 2018	Sep. 30, 2019	Sep. 30, 2018
Disaggregation of Revenue [Line Items]
Revenue	$ 1,188	$ 1,424.2	$ 3,549.7	$ 4,169.6
Beauty
Disaggregation of Revenue [Line Items]
Revenue	793.4	862.9	2,459.7	2,788.3
Beauty - Skincare
Disaggregation of Revenue [Line Items]
Revenue	326.2	339	1,021.4	1,106.9
Beauty - Fragrance
Disaggregation of Revenue [Line Items]
Revenue	295.6	331.9	896.7	1,036.6
Beauty - Color
Disaggregation of Revenue [Line Items]
Revenue	171.6	192	541.6	644.8
Fashion And Home
Disaggregation of Revenue [Line Items]
Revenue	256.1	315	814.8	968
Fashion & Home - Fashion
Disaggregation of Revenue [Line Items]
Revenue	143.9	174.7	464.4	552.2
Fashion & Home - Home
Disaggregation of Revenue [Line Items]
Revenue	112.2	140.3	350.4	415.8
Brazil IPI Tax Release
Disaggregation of Revenue [Line Items]
Revenue	67.7	168.4	67.7	168.4
Net Sales
Disaggregation of Revenue [Line Items]
Revenue	1,117.2	1,346.3	3,342.2	3,924.7
Other Revenue
Disaggregation of Revenue [Line Items]
Revenue	70.8	77.9	207.5	244.9
Other - Representative Fees
Disaggregation of Revenue [Line Items]
Revenue	60.6	69	186.2	216.9
Other - Other Product And Services
Disaggregation of Revenue [Line Items]
Revenue	10.2	8.9	21.3	28
Operating Segments
Disaggregation of Revenue [Line Items]
Revenue	1,183.3	1,415.8	3,535	4,125.5
Operating Segments | Beauty
Disaggregation of Revenue [Line Items]
Revenue	793.4	862.9	2,459.7	2,774.2
Operating Segments | Beauty - Skincare
Disaggregation of Revenue [Line Items]
Revenue	326.2	339	1,021.4	1,100.5
Operating Segments | Beauty - Fragrance
Disaggregation of Revenue [Line Items]
Revenue	295.6	331.9	896.7	1,033.7
Operating Segments | Beauty - Color
Disaggregation of Revenue [Line Items]
Revenue	171.6	192	541.6	640
Operating Segments | Fashion And Home
Disaggregation of Revenue [Line Items]
Revenue	256.1	314.8	814.8	963
Operating Segments | Fashion & Home - Fashion
Disaggregation of Revenue [Line Items]
Revenue	143.9	174.7	464.4	549.2
Operating Segments | Fashion & Home - Home
Disaggregation of Revenue [Line Items]
Revenue	112.2	140.1	350.4	413.8
Operating Segments | Brazil IPI Tax Release
Disaggregation of Revenue [Line Items]
Revenue	67.7	168.4	67.7	168.4
Operating Segments | Net Sales
Disaggregation of Revenue [Line Items]
Revenue	1,117.2	1,346.1	3,342.2	3,905.6
Operating Segments | Other Revenue
Disaggregation of Revenue [Line Items]
Revenue	66.1	69.7	192.8	219.9
Operating Segments | Other - Representative Fees
Disaggregation of Revenue [Line Items]
Revenue	60.6	68.9	186.2	214.9
Operating Segments | Other - Other Product And Services
Disaggregation of Revenue [Line Items]
Revenue	5.5	0.8	6.6	5
Other Operating Segments and Business Activities
Disaggregation of Revenue [Line Items]
Revenue	4.7	8.4	14.7	44.1
Other Operating Segments and Business Activities | Beauty
Disaggregation of Revenue [Line Items]
Revenue	0	0	0	14.1
Other Operating Segments and Business Activities | Beauty - Skincare
Disaggregation of Revenue [Line Items]
Revenue	0	0		6.4
Other Operating Segments and Business Activities | Beauty - Fragrance
Disaggregation of Revenue [Line Items]
Revenue	0	0		2.9
Other Operating Segments and Business Activities | Beauty - Color
Disaggregation of Revenue [Line Items]
Revenue	0	0		4.8
Other Operating Segments and Business Activities | Fashion And Home
Disaggregation of Revenue [Line Items]
Revenue	0	0.2	0	5
Other Operating Segments and Business Activities | Fashion & Home - Fashion
Disaggregation of Revenue [Line Items]
Revenue	0	0		3
Other Operating Segments and Business Activities | Fashion & Home - Home
Disaggregation of Revenue [Line Items]
Revenue	0	0.2		2
Other Operating Segments and Business Activities | Brazil IPI Tax Release
Disaggregation of Revenue [Line Items]
Revenue	0	0	0	0
Other Operating Segments and Business Activities | Net Sales
Disaggregation of Revenue [Line Items]
Revenue	0	0.2	0	19.1
Other Operating Segments and Business Activities | Other Revenue
Disaggregation of Revenue [Line Items]
Revenue	4.7	8.2	14.7	25
Other Operating Segments and Business Activities | Other - Representative Fees
Disaggregation of Revenue [Line Items]
Revenue		0.1		2
Other Operating Segments and Business Activities | Other - Other Product And Services
Disaggregation of Revenue [Line Items]
Revenue	4.7	8.1	14.7	23
Europe, Middle East & Africa | Operating Segments
Disaggregation of Revenue [Line Items]
Revenue	398.3	442.9	1,282.1	1,512
Europe, Middle East & Africa | Operating Segments | Beauty
Disaggregation of Revenue [Line Items]
Revenue	325.1	353.3	1,034.4	1,202.9
Europe, Middle East & Africa | Operating Segments | Beauty - Skincare
Disaggregation of Revenue [Line Items]
Revenue	125.2	133.7	400.9	457.4
Europe, Middle East & Africa | Operating Segments | Beauty - Fragrance
Disaggregation of Revenue [Line Items]
Revenue	129.2	139.5	386.9	446.5
Europe, Middle East & Africa | Operating Segments | Beauty - Color
Disaggregation of Revenue [Line Items]
Revenue	70.7	80.1	246.6	299
Europe, Middle East & Africa | Operating Segments | Fashion And Home
Disaggregation of Revenue [Line Items]
Revenue	52.8	67.6	183.4	237.1
Europe, Middle East & Africa | Operating Segments | Fashion & Home - Fashion
Disaggregation of Revenue [Line Items]
Revenue	46.4	58.9	162.1	211.5
Europe, Middle East & Africa | Operating Segments | Fashion & Home - Home
Disaggregation of Revenue [Line Items]
Revenue	6.4	8.7	21.3	25.6
Europe, Middle East & Africa | Operating Segments | Brazil IPI Tax Release
Disaggregation of Revenue [Line Items]
Revenue	0	0	0	0
Europe, Middle East & Africa | Operating Segments | Net Sales
Disaggregation of Revenue [Line Items]
Revenue	377.9	420.9	1,217.8	1,440
Europe, Middle East & Africa | Operating Segments | Other Revenue
Disaggregation of Revenue [Line Items]
Revenue	20.4	22	64.3	72
Europe, Middle East & Africa | Operating Segments | Other - Representative Fees
Disaggregation of Revenue [Line Items]
Revenue	20	21.8	63.5	71.5
Europe, Middle East & Africa | Operating Segments | Other - Other Product And Services
Disaggregation of Revenue [Line Items]
Revenue	0.4	0.2	0.8	0.5
South Latin America | Operating Segments
Disaggregation of Revenue [Line Items]
Revenue	494	645.4	1,351.7	1,658.6
South Latin America | Operating Segments | Beauty
Disaggregation of Revenue [Line Items]
Revenue	298.8	328.1	895.3	1,025.2
South Latin America | Operating Segments | Beauty - Skincare
Disaggregation of Revenue [Line Items]
Revenue	129.3	137.8	386.1	423.4
South Latin America | Operating Segments | Beauty - Fragrance
Disaggregation of Revenue [Line Items]
Revenue	100.2	113.8	313	363.9
South Latin America | Operating Segments | Beauty - Color
Disaggregation of Revenue [Line Items]
Revenue	69.3	76.5	196.2	237.9
South Latin America | Operating Segments | Fashion And Home
Disaggregation of Revenue [Line Items]
Revenue	93.7	114.6	296	355.5
South Latin America | Operating Segments | Fashion & Home - Fashion
Disaggregation of Revenue [Line Items]
Revenue	37.6	46	117.7	142.4
South Latin America | Operating Segments | Fashion & Home - Home
Disaggregation of Revenue [Line Items]
Revenue	56.1	68.6	178.3	213.1
South Latin America | Operating Segments | Brazil IPI Tax Release
Disaggregation of Revenue [Line Items]
Revenue	67.7	168.4	67.7	168.4
South Latin America | Operating Segments | Net Sales
Disaggregation of Revenue [Line Items]
Revenue	460.2	611.1	1,259	1,549.1
South Latin America | Operating Segments | Other Revenue
Disaggregation of Revenue [Line Items]
Revenue	33.8	34.3	92.7	109.5
South Latin America | Operating Segments | Other - Representative Fees
Disaggregation of Revenue [Line Items]
Revenue	28.7	33.7	87	105.1
South Latin America | Operating Segments | Other - Other Product And Services
Disaggregation of Revenue [Line Items]
Revenue	5.1	0.6	5.7	4.4
North Latin America | Operating Segments
Disaggregation of Revenue [Line Items]
Revenue	184.7	207	571.2	609.9
North Latin America | Operating Segments | Beauty
Disaggregation of Revenue [Line Items]
Revenue	111.4	114.3	348.3	352.5
North Latin America | Operating Segments | Beauty - Skincare
Disaggregation of Revenue [Line Items]
Revenue	44	38.2	144.2	128.8
North Latin America | Operating Segments | Beauty - Fragrance
Disaggregation of Revenue [Line Items]
Revenue	47.1	54.9	140.7	160.9
North Latin America | Operating Segments | Beauty - Color
Disaggregation of Revenue [Line Items]
Revenue	20.3	21.2	63.4	62.8
North Latin America | Operating Segments | Fashion And Home
Disaggregation of Revenue [Line Items]
Revenue	63.1	81.1	192.4	224
North Latin America | Operating Segments | Fashion & Home - Fashion
Disaggregation of Revenue [Line Items]
Revenue	19.4	25.1	61.4	70.1
North Latin America | Operating Segments | Fashion & Home - Home
Disaggregation of Revenue [Line Items]
Revenue	43.7	56	131	153.9
North Latin America | Operating Segments | Brazil IPI Tax Release
Disaggregation of Revenue [Line Items]
Revenue	0	0	0	0
North Latin America | Operating Segments | Net Sales
Disaggregation of Revenue [Line Items]
Revenue	174.5	195.4	540.7	576.5
North Latin America | Operating Segments | Other Revenue
Disaggregation of Revenue [Line Items]
Revenue	10.2	11.6	30.5	33.4
North Latin America | Operating Segments | Other - Representative Fees
Disaggregation of Revenue [Line Items]
Revenue	10.2	11.6	30.5	33.4
North Latin America | Operating Segments | Other - Other Product And Services
Disaggregation of Revenue [Line Items]
Revenue	0	0	0	0
Asia Pacific | Operating Segments
Disaggregation of Revenue [Line Items]
Revenue	106.3	120.5	330	345
Asia Pacific | Operating Segments | Beauty
Disaggregation of Revenue [Line Items]
Revenue	58.1	67.2	181.7	193.6
Asia Pacific | Operating Segments | Beauty - Skincare
Disaggregation of Revenue [Line Items]
Revenue	27.7	29.3	90.2	90.9
Asia Pacific | Operating Segments | Beauty - Fragrance
Disaggregation of Revenue [Line Items]
Revenue	19.1	23.7	56.1	62.4
Asia Pacific | Operating Segments | Beauty - Color
Disaggregation of Revenue [Line Items]
Revenue	11.3	14.2	35.4	40.3
Asia Pacific | Operating Segments | Fashion And Home
Disaggregation of Revenue [Line Items]
Revenue	46.5	51.5	143	146.4
Asia Pacific | Operating Segments | Fashion & Home - Fashion
Disaggregation of Revenue [Line Items]
Revenue	40.5	44.7	123.2	125.2
Asia Pacific | Operating Segments | Fashion & Home - Home
Disaggregation of Revenue [Line Items]
Revenue	6	6.8	19.8	21.2
Asia Pacific | Operating Segments | Brazil IPI Tax Release
Disaggregation of Revenue [Line Items]
Revenue	0	0	0	0
Asia Pacific | Operating Segments | Net Sales
Disaggregation of Revenue [Line Items]
Revenue	104.6	118.7	324.7	340
Asia Pacific | Operating Segments | Other Revenue
Disaggregation of Revenue [Line Items]
Revenue	1.7	1.8	5.3	5
Asia Pacific | Operating Segments | Other - Representative Fees
Disaggregation of Revenue [Line Items]
Revenue	1.7	1.8	5.2	4.9
Asia Pacific | Operating Segments | Other - Other Product And Services
Disaggregation of Revenue [Line Items]
Revenue	$ 0	$ 0	$ 0.1	$ 0.1

REVENUE Assets and Liabilities

REVENUE Assets and Liabilities (Details) - USD ($) $ in Millions	Sep. 30, 2019	Dec. 31, 2018
Revenue from Contract with Customer [Abstract]
Accounts receivable, net of allowances of $65 and $93	$ 303	$ 349.7
Account receivable allowances	65	93
Contract liabilities	$ 49.1	$ 84.4

REVENUE Narrative (Details)

REVENUE Narrative (Details) $ in Millions	9 Months Ended
	Sep. 30, 2019USD ($)
Revenue from Contract with Customer [Abstract]
Performance obligations satisfied	$ 67.2
Material rights	$ 32.9

INVENTORIES (Components of Inve

INVENTORIES (Components of Inventories) (Details) - USD ($) $ in Millions	Sep. 30, 2019	Dec. 31, 2018
Inventory Disclosure [Abstract]
Raw materials	$ 131.2	$ 157.8
Finished goods	368.2	384.2
Inventories	$ 499.4	$ 542

LEASES - Balance Sheet Implicat

LEASES - Balance Sheet Implication (Details) - USD ($) $ in Millions	Sep. 30, 2019	Jan. 01, 2019
Assets
Operating right-of-use assets	$ 172.3	$ 187.5
Finance right-of-use assets	2.5	3.2
Total right-of-use assets	174.8	190.7
Current
Operating lease liabilities	43.9	45.4
Finance lease liabilities	1	1.1
Total current lease liabilities	44.9	46.5
Noncurrent
Operating lease liabilities	141.7	155.9
Finance lease liabilities	1.5	1.9
Total noncurrent lease liabilities	143.2	157.8
Total lease liability	$ 188.1	$ 204.3

LEASES - Income and Expenses (D

LEASES - Income and Expenses (Details) - USD ($) $ in Millions	3 Months Ended	9 Months Ended
	Sep. 30, 2019	Sep. 30, 2019
Leases [Abstract]
Operating lease cost	$ 16.9	$ 49.9
Amortization of right-of-use assets	0.4	1.2
Interest on lease liabilities	0.1	0.2
Short-term leases costs	0.9	2.9
Sublease income	(2.5)	(8.3)
Net lease cost	$ 15.8	$ 45.9

LEASES - Maturity of Lease Liab

LEASES - Maturity of Lease Liability (Details) - USD ($) $ in Millions	Sep. 30, 2019	Jan. 01, 2019
Operating Leases
2019	$ 15.4
2020	55.3
2021	46.1
2022	38.3
2023	25.7
2024	18.4
Thereafter	29.1
Total lease payments	228.3
Less: Interest	42.7
Present value of lease liabilities	185.6
Finance Leases
2019	0.3
2020	1.1
2021	0.8
2022	0.5
2023	0.1
2024	0
Thereafter	0
Total lease payments	2.8
Less: Interest	0.3
Present value of lease liabilities	2.5
Total
2019	15.7
2020	56.4
2021	46.9
2022	38.8
2023	25.8
2024	18.4
Thereafter	29.1
Total lease payments	231.1
Less: Interest	43
Present value of lease liabilities	$ 188.1	$ 204.3

LEASES - Lease by Due Date (Det

LEASES - Lease by Due Date (Details) - USD ($) $ in Millions	Sep. 30, 2019	Jan. 01, 2019	Dec. 31, 2018
Operating Leases
2019			$ 56.4
2020			42
2021			35.3
2022			31.1
2023			22.4
Thereafter			46.9
Total lease payments			234.1
Finance Leases
2019			1.1
2020			0.6
2021			0.4
2022			0.2
2023			0.1
2024			0.1
Total lease payments			2.5
Total
2019			57.5
2020			42.6
2021			35.7
2022			31.3
2023			22.5
Thereafter			47
Total lease payments			$ 236.6
Total lease liability	$ 188.1	$ 204.3

LEASES - Lease Term and Discoun

LEASES - Lease Term and Discount Rate (Details)	Sep. 30, 2019
Leases [Abstract]
Weighted-average remaining lease term, operating leases	5 years
Weighted-average remaining lease term, finance leases	2 years 8 months 12 days
Weighted-average discount rate, operating leases	8.50%
Weighted-average discount rate, financing leases	10.70%

LEASES - Other Information (Det

LEASES - Other Information (Details) - USD ($) $ in Millions	3 Months Ended	9 Months Ended
	Sep. 30, 2019	Sep. 30, 2019
Leases [Abstract]
Operating Cash Flows From Operating Leases	$ 16.2	$ 47.9
Financing Cash Flows From Finance Leases	0.3	1
Cash Paid For Amounts Included In Measurement of Liabilities	16.5	48.9
Right-of-Use Assets Obtained in Exchange for New Finance Liabilities	0	0.9
Right-of-Use Assets Obtained in Exchange For New Operating Liabilities	$ 8.5	$ 33.9

EMPLOYEE BENEFIT PLANS (Compone

EMPLOYEE BENEFIT PLANS (Components of Net Periodic Benefit Cost) (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Sep. 30, 2019	Sep. 30, 2018	Sep. 30, 2019	Sep. 30, 2018
Postretirement Benefits
Defined Benefit Plan Disclosure [Line Items]
Service cost	$ 0	$ 0	$ 0	$ 0.1
Interest cost	0.3	0.2	0.9	0.8
Expected return on plan assets	0	0	0	0
Amortization of prior service credit	0	(0.1)	0	(0.3)
Amortization of net actuarial losses	0	0.1	0	0.1
Settlements/curtailments			0	0
Net periodic benefit costs	0.3	0.2	0.9	0.7
United States | Pension Plan
Defined Benefit Plan Disclosure [Line Items]
Service cost	0.3	0.6	1.3	2.4
Interest cost	0.6	0.6	1.8	1.8
Expected return on plan assets	(0.8)	(1)	(2.4)	(2.6)
Amortization of prior service credit	0	0	0	0
Amortization of net actuarial losses	0.6	0.7	2	3.3
Settlements/curtailments			0	0
Net periodic benefit costs	0.7	0.9	2.7	4.9
Non-U.S. Plans | Pension Plan
Defined Benefit Plan Disclosure [Line Items]
Service cost	0.9	1.1	2.9	3.5
Interest cost	3.5	3.4	11.2	11.6
Expected return on plan assets	(7.2)	(7.3)	(22.8)	(23.9)
Amortization of prior service credit	0	(0.1)	0	(0.1)
Amortization of net actuarial losses	1.1	1.5	3.7	5.1
Settlements/curtailments			0.1	0
Net periodic benefit costs	$ (1.7)	$ (1.4)	$ (4.9)	$ (3.8)

EMPLOYEE BENEFIT PLANS (Narrati

EMPLOYEE BENEFIT PLANS (Narrative) (Details) $ in Millions	9 Months Ended
	Sep. 30, 2019USD ($)
United States
Defined Benefit Plan Disclosure [Line Items]
Employer contribution, approximately	$ 1
United States | Minimum
Defined Benefit Plan Disclosure [Line Items]
Estimated contributions for the remainder of fiscal year	0
United States | Maximum
Defined Benefit Plan Disclosure [Line Items]
Estimated contributions for the remainder of fiscal year	5
Non-U.S. Plans
Defined Benefit Plan Disclosure [Line Items]
Employer contribution, approximately	3
Non-U.S. Plans | Minimum
Defined Benefit Plan Disclosure [Line Items]
Estimated contributions for the remainder of fiscal year	0
Non-U.S. Plans | Maximum
Defined Benefit Plan Disclosure [Line Items]
Estimated contributions for the remainder of fiscal year	$ 5

CONTINGENCIES (Details)

CONTINGENCIES (Details) $ in Millions	3 Months Ended			9 Months Ended
	Sep. 30, 2019USD ($)	Dec. 31, 2018USD ($)	Sep. 30, 2018USD ($)	Sep. 30, 2019USD ($)lawsuit	Sep. 30, 2018USD ($)	Apr. 18, 2018USD ($)	Oct. 03, 2017USD ($)	Jul. 31, 2013USD ($)
Loss Contingencies [Line Items]
Revenue	$ 1,188		$ 1,424.2	$ 3,549.7	$ 4,169.6
Other expense, net	57.9		22.2	$ 87.3	0.3
Number of litigation suits | lawsuit				106
Number of litigation suits, new | lawsuit				16
Number of litigation suits, dismissed | lawsuit				28
Assessment for 2012
Loss Contingencies [Line Items]
Assessment of contingencies, including penalties and accruing interest						$ 231		$ 293
Assessment of contingencies, including penalties and accruing interest, adjustment						$ 62
Assessment for 2017
Loss Contingencies [Line Items]
Assessment of contingencies, including penalties and accruing interest							$ 228
IPI Tax on Cosmetics
Loss Contingencies [Line Items]
Estimated litigation liability			$ 195		$ 195
Revenue		$ 168
Other expense, net		$ 27
Possible loss	249			$ 249
Tax reserve	77			77
Brazil labor-related
Loss Contingencies [Line Items]
Estimated litigation liability	$ 12			$ 12

ACCUMULATED OTHER COMPREHENSI_3

ACCUMULATED OTHER COMPREHENSIVE INCOME (LOSS) (Components of Accumulated Other Comprehensive Income (Loss)) (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Sep. 30, 2019	Sep. 30, 2018	Sep. 30, 2019	Sep. 30, 2018
AOCI Attributable to Parent, Net of Tax [Roll Forward]
Accumulated other comprehensive income, beginning balance			$ (904.5)
Other comprehensive loss other than reclassifications	$ (19.2)	$ (3.6)	(21.7)	$ (97.5)
Reclassifications into earnings:
Derivative losses on cash flow hedges, net of tax	0.2		1.1
Amortization of net actuarial loss and prior service cost, net of tax	1.6	2.1	4.7	7.8
Sale of New Avon	(3.4)		(3.4)
Total reclassifications into earnings	(1.6)	2.1	2.4	7.8
Accumulated other comprehensive income, ending balance	(882.1)		(882.1)
Derivative losses on cash flow hedges, tax	0		0
Amortization of net actuarial loss and prior service cost, tax	0.2	0.1	0.5	0.4
Foreign Currency Translation Adjustments
AOCI Attributable to Parent, Net of Tax [Roll Forward]
Accumulated other comprehensive income, beginning balance	(935.2)	(923.5)	(936.2)	(829.6)
Other comprehensive loss other than reclassifications	(19.1)	(3.6)	(18.1)	(97.5)
Reclassifications into earnings:
Amortization of net actuarial loss and prior service cost, net of tax	0	0	0	0
Total reclassifications into earnings	0	0	0	0
Accumulated other comprehensive income, ending balance	(954.3)	(927.1)	(954.3)	(927.1)
Cash Flow Hedges
AOCI Attributable to Parent, Net of Tax [Roll Forward]
Accumulated other comprehensive income, beginning balance	(2.1)		0.5
Other comprehensive loss other than reclassifications	(0.1)		(3.6)
Reclassifications into earnings:
Derivative losses on cash flow hedges, net of tax	0.2		1.1
Amortization of net actuarial loss and prior service cost, net of tax	0		0
Total reclassifications into earnings	0.2		1.1
Accumulated other comprehensive income, ending balance	(2)		(2)
Net Investment Hedges
AOCI Attributable to Parent, Net of Tax [Roll Forward]
Accumulated other comprehensive income, beginning balance	(4.3)	(4.3)	(4.3)	(4.3)
Other comprehensive loss other than reclassifications	0	0	0	0
Reclassifications into earnings:
Amortization of net actuarial loss and prior service cost, net of tax	0	0	0	0
Total reclassifications into earnings	0	0	0	0
Accumulated other comprehensive income, ending balance	(4.3)	(4.3)	(4.3)	(4.3)
Pension and Postretirement Benefits
AOCI Attributable to Parent, Net of Tax [Roll Forward]
Accumulated other comprehensive income, beginning balance	(90.7)	(90)	(93.8)	(95.7)
Other comprehensive loss other than reclassifications	0	0	0	0
Reclassifications into earnings:
Amortization of net actuarial loss and prior service cost, net of tax	1.6	2.1	4.7	7.8
Total reclassifications into earnings	1.6	2.1	4.7	7.8
Accumulated other comprehensive income, ending balance	(89.1)	(87.9)	(89.1)	(87.9)
Investment in New Avon
AOCI Attributable to Parent, Net of Tax [Roll Forward]
Accumulated other comprehensive income, beginning balance	3.4	3.4	3.4	3.4
Other comprehensive loss other than reclassifications	0	0	0	0
Reclassifications into earnings:
Amortization of net actuarial loss and prior service cost, net of tax	0	0	0	0
Sale of New Avon	(3.4)		(3.4)
Total reclassifications into earnings	(3.4)	0	(3.4)	0
Accumulated other comprehensive income, ending balance	0	3.4	0	3.4
AOCI Attributable to Parent
AOCI Attributable to Parent, Net of Tax [Roll Forward]
Accumulated other comprehensive income, beginning balance	(1,028.9)	(1,014.4)	(1,030.4)	(926.2)
Reclassifications into earnings:
Accumulated other comprehensive income, ending balance	$ (1,049.7)	$ (1,015.9)	$ (1,049.7)	$ (1,015.9)

ACCUMULATED OTHER COMPREHENSI_4

ACCUMULATED OTHER COMPREHENSIVE INCOME (LOSS) (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Sep. 30, 2019	Sep. 30, 2018	Sep. 30, 2019	Sep. 30, 2018
Equity [Abstract]
Foreign exchange gain (loss)	$ (5.1)	$ 1.2	$ (5.8)	$ (2.5)

SEGMENT INFORMATION (Total Reve

SEGMENT INFORMATION (Total Revenue and Operating Profit by Reporting Segment) (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Sep. 30, 2019	Sep. 30, 2018	Sep. 30, 2019	Sep. 30, 2018
Segment Reporting Information [Line Items]
Total revenue	$ 1,188	$ 1,424.2	$ 3,549.7	$ 4,169.6
Operating profit	97.7	186.9	124.3	284.8
CTI restructuring initiatives	(17.5)	(19.8)	(93.2)	(54.4)
Other expense, net	57.9	22.2	87.3	0.3
Brazil IPI Tax Release
Segment Reporting Information [Line Items]
Total revenue			68	168
Other expense, net	50
Reportable segments
Segment Reporting Information [Line Items]
Total revenue	1,183.3	1,415.8	3,535	4,125.5
Operating profit	192.4	264.1	462.7	552.8
Other Operating Segments and Business Activities
Segment Reporting Information [Line Items]
Total revenue	4.7	8.4	14.7	44.1
Operating profit	0.9	1.1	2	2.7
All other
Segment Reporting Information [Line Items]
Unallocated global expenses	(58.9)	(58.5)	(187.3)	(216.3)
CTI restructuring initiatives	(17.5)	(19.8)	(116.7)	(54.4)
Other expense, net	(19.2)	0	(36.4)	0
Europe, Middle East & Africa | Reportable segments
Segment Reporting Information [Line Items]
Total revenue	398.3	442.9	1,282.1	1,512
Operating profit	47.6	46.1	165.8	194.9
South Latin America | Reportable segments
Segment Reporting Information [Line Items]
Total revenue	494	645.4	1,351.7	1,658.6
Operating profit	118.4	194.1	207.4	276.5
North Latin America | Reportable segments
Segment Reporting Information [Line Items]
Total revenue	184.7	207	571.2	609.9
Operating profit	17	14.3	52.6	54.1
Asia Pacific | Reportable segments
Segment Reporting Information [Line Items]
Total revenue	106.3	120.5	330	345
Operating profit	$ 9.4	$ 9.6	$ 36.9	$ 27.3

SUPPLEMENTAL BALANCE SHEET IN_3

SUPPLEMENTAL BALANCE SHEET INFORMATION (Components of Prepaid Expenses and Other) (Details) - USD ($) $ in Millions	Sep. 30, 2019	Dec. 31, 2018
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Prepaid taxes and tax refunds receivable	$ 155.1	$ 145
Receivables other than trade	47.7	69.2
Prepaid brochure costs, paper and other literature	12	14.9
Other	50.6	42.9
Prepaid expenses and other	$ 265.4	$ 272

SUPPLEMENTAL BALANCE SHEET IN_4

SUPPLEMENTAL BALANCE SHEET INFORMATION (Components of Other Assets) (Details) - USD ($) $ in Millions	Sep. 30, 2019	Dec. 31, 2018
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Net overfunded pension plans	$ 95.2	$ 88.1
Capitalized software	81	89.3
Judicial deposits	67.9	74.1
Long-term receivables	186.4	73.2
Trust assets associated with supplemental benefit plans	39.4	37
Tooling (plates and molds associated with our beauty products)	12.6	12.6
Other	31.4	16.1
Other assets	$ 513.9	$ 390.4

SUPPLEMENTAL BALANCE SHEET IN_5

SUPPLEMENTAL BALANCE SHEET INFORMATION - Narrative (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Sep. 30, 2019	Sep. 30, 2018	Sep. 30, 2019	Sep. 30, 2018
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Brazil indirect taxes	$ 118		$ 118
Revenue	1,188	$ 1,424.2	3,549.7	$ 4,169.6
Other expense, net	57.9	22.2	87.3	0.3
Income taxes provision	31.5	68.3	78.2	136.5
Agreement to sale tax credits	80		$ 80
Repurchase term			3 years
Proceeds from monetization of COFINS tax credits	19.4	0	$ 19.4	0
Financing liability, indirect taxes	19		19
Brazil IPI Tax Release
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Revenue	67.7	$ 168.4	$ 67.7	$ 168.4
Other expense, net	50
Income taxes provision	$ 23

RESTRUCTURING INITIATIVES (Deta

RESTRUCTURING INITIATIVES (Details) $ in Millions	Dec. 31, 2018USD ($)	Sep. 30, 2018USD ($)	Jan. 31, 2016USD ($)	Sep. 30, 2019USD ($)	Sep. 30, 2018USD ($)	Sep. 30, 2019USD ($)	Sep. 30, 2018USD ($)	Dec. 31, 2018
Restructuring Cost and Reserve [Line Items]
Restructuring charges and other costs				$ 17.5	$ 19.8	$ 93.2	$ 54.4
Open Up Avon
Restructuring Cost and Reserve [Line Items]
Expected annualized savings before taxes		$ 400
Restructuring charges and other costs				10.8	19.1	$ 84.1	19.1
Reduction in workforce						0.10		0.08
Recorded total costs to implement restructuring initiatives				227.4		$ 227.4
Open Up Avon | Inventory/ Asset Write-offs
Restructuring Cost and Reserve [Line Items]
Restructuring charges and other costs	$ 88
Transformation Plan
Restructuring Cost and Reserve [Line Items]
Expected annualized savings before taxes			$ 350
Restructuring charges and other costs				6.7	0.7	9	36
Recorded total costs to implement restructuring initiatives				214.4		214.4
Other Restructuring Initiatives
Restructuring Cost and Reserve [Line Items]
Restructuring charges and other costs				$ 0	$ 0	$ 0.1	$ (0.7)

RESTRUCTURING INITIATIVES - Sum

RESTRUCTURING INITIATIVES - Summary (Details) - USD ($) $ in Millions	Dec. 31, 2018	Sep. 30, 2019	Sep. 30, 2018	Sep. 30, 2019	Sep. 30, 2018
Restructuring Cost and Reserve [Line Items]
CTI restructuring initiatives		$ 17.5	$ 19.8	$ 93.2	$ 54.4
Open Up Avon
Restructuring Cost and Reserve [Line Items]
CTI restructuring initiatives		10.8	19.1	84.1	19.1
Transformation Plan
Restructuring Cost and Reserve [Line Items]
CTI restructuring initiatives		6.7	0.7	9	36
Other Restructuring Initiatives
Restructuring Cost and Reserve [Line Items]
CTI restructuring initiatives		0	0	0.1	(0.7)
Inventory write-off | Open Up Avon
Restructuring Cost and Reserve [Line Items]
CTI restructuring initiatives	$ 88
Cost of Goods Sold
Restructuring Cost and Reserve [Line Items]
CTI restructuring initiatives		(1)	(0.1)	11.9	1
Cost of Goods Sold | Manufacturing asset write-offs
Restructuring Cost and Reserve [Line Items]
CTI restructuring initiatives		1.1	0	10.9	0
Cost of Goods Sold | Inventory write-off
Restructuring Cost and Reserve [Line Items]
CTI restructuring initiatives		(2.1)	(0.1)	1	1
Selling, General and Administrative Expense
Restructuring Cost and Reserve [Line Items]
CTI restructuring initiatives		18.5	19.9	104.8	53.4
Selling, General and Administrative Expense | Net charges for employee-related costs, including severance benefits
Restructuring Cost and Reserve [Line Items]
CTI restructuring initiatives		3.2	6.4	51.9	31.9
Selling, General and Administrative Expense | Implementation costs, primarily related to professional service fees
Restructuring Cost and Reserve [Line Items]
CTI restructuring initiatives		7.8	11.8	33.7	17.5
Selling, General and Administrative Expense | Dual running costs
Restructuring Cost and Reserve [Line Items]
CTI restructuring initiatives		3.7	0	8.2	0
Selling, General and Administrative Expense | Contract termination and other net benefits
Restructuring Cost and Reserve [Line Items]
CTI restructuring initiatives		(0.1)	(1.7)	4.5	(1)
Selling, General and Administrative Expense | Impairment of other assets
Restructuring Cost and Reserve [Line Items]
CTI restructuring initiatives		0.1	2.5	2.4	2.5
Selling, General and Administrative Expense | Accelerated depreciation
Restructuring Cost and Reserve [Line Items]
CTI restructuring initiatives		2.3	0.9	2.6	2.5
Selling, General and Administrative Expense | Variable lease charges
Restructuring Cost and Reserve [Line Items]
CTI restructuring initiatives		1.5	0	1.5	0
Operating Profit
Restructuring Cost and Reserve [Line Items]
CTI restructuring initiatives		17.5	19.8	116.7	54.4
Other Expenses | Gain on sale of Rye Office
Restructuring Cost and Reserve [Line Items]
CTI restructuring initiatives		0	0	(9.9)	0
Other Expenses | Gain on sale of Malaysia Maximin
Restructuring Cost and Reserve [Line Items]
CTI restructuring initiatives		0	0	(3.3)	0
Other Expenses | Gain on sale of China business (relating mainly to foreign currency translation adjustment gain)
Restructuring Cost and Reserve [Line Items]
CTI restructuring initiatives		$ 0	$ 0	$ (10.3)	$ 0

RESTRUCTURING INITIATIVES - OPE

RESTRUCTURING INITIATIVES - OPEN UP AVON (Details) - Open Up Avon $ in Millions	9 Months Ended
	Sep. 30, 2019USD ($)
Restructuring Reserve [Roll Forward]
Beginning balance	$ 20.7
2019 charges	63.9
Adjustments	(3.7)
Cash payments	(48.7)
Non-cash write-offs	(3.4)
Foreign exchange	(3)
Ending balance	25.8
Employee-Related Costs
Restructuring Reserve [Roll Forward]
Beginning balance	19.6
2019 charges	56.1
Adjustments	(3.6)
Cash payments	(46.2)
Non-cash write-offs	0
Foreign exchange	(3)
Ending balance	22.9
Inventory/ Asset Write-offs
Restructuring Reserve [Roll Forward]
Beginning balance	0
2019 charges	14.3
Adjustments	0
Cash payments	0
Non-cash write-offs	(14.3)
Foreign exchange	0
Ending balance	0
Foreign Currency Translation Adjustment Write-offs
Restructuring Reserve [Roll Forward]
Beginning balance	0
2019 charges	(10.9)
Adjustments	0
Cash payments	0
Non-cash write-offs	10.9
Foreign exchange	0
Ending balance	0
Contract Terminations/Other
Restructuring Reserve [Roll Forward]
Beginning balance	1.1
2019 charges	4.4
Adjustments	(0.1)
Cash payments	(2.5)
Non-cash write-offs	0
Foreign exchange	0
Ending balance	$ 2.9

RESTRUCTURING INITIATIVES - TRA

RESTRUCTURING INITIATIVES - TRANSFORMATION PLAN (Liability Balances) (Details) - Transformation Plan $ in Millions	9 Months Ended
	Sep. 30, 2019USD ($)
Restructuring Reserve [Roll Forward]
Beginning balance	$ 38
2019 charges	(0.5)
Cash payments	(28.6)
Foreign exchange	0.1
Ending balance	9
Employee-Related Costs
Restructuring Reserve [Roll Forward]
Beginning balance	34.4
2019 charges	(0.7)
Cash payments	(26.3)
Foreign exchange	0.1
Ending balance	7.5
Contract Terminations/Other
Restructuring Reserve [Roll Forward]
Beginning balance	3.6
2019 charges	0.2
Cash payments	(2.3)
Foreign exchange	0
Ending balance	$ 1.5

RESTRUCTURING INITIATIVES (Rest

RESTRUCTURING INITIATIVES (Restructuring Initiatives by Charge Type) (Details) $ in Millions	Sep. 30, 2019USD ($)
Open Up Avon
Restructuring Cost and Reserve [Line Items]
Charges incurred to-date	$ 177.2
Estimated charges to be incurred on approved initiatives	1.7
Total expected charges on approved initiatives	178.9
Open Up Avon | Employee-Related Costs
Restructuring Cost and Reserve [Line Items]
Charges incurred to-date	78.9
Estimated charges to be incurred on approved initiatives	0
Total expected charges on approved initiatives	78.9
Open Up Avon | Inventory/ Asset Write-offs
Restructuring Cost and Reserve [Line Items]
Charges incurred to-date	104.1
Estimated charges to be incurred on approved initiatives	0
Total expected charges on approved initiatives	104.1
Open Up Avon | Contract Terminations/Other
Restructuring Cost and Reserve [Line Items]
Charges incurred to-date	5.1
Estimated charges to be incurred on approved initiatives	1.7
Total expected charges on approved initiatives	6.8
Open Up Avon | Foreign Currency Translation Adjustment Write-offs
Restructuring Cost and Reserve [Line Items]
Charges incurred to-date	(10.9)
Estimated charges to be incurred on approved initiatives	0
Total expected charges on approved initiatives	(10.9)
Transformation Plan
Restructuring Cost and Reserve [Line Items]
Charges incurred to-date	174
Estimated charges to be incurred on approved initiatives	0
Total expected charges on approved initiatives	174
Transformation Plan | Employee-Related Costs
Restructuring Cost and Reserve [Line Items]
Charges incurred to-date	127.3
Estimated charges to be incurred on approved initiatives	0
Total expected charges on approved initiatives	127.3
Transformation Plan | Inventory/ Asset Write-offs
Restructuring Cost and Reserve [Line Items]
Charges incurred to-date	2.4
Estimated charges to be incurred on approved initiatives	0
Total expected charges on approved initiatives	2.4
Transformation Plan | Contract Terminations/Other
Restructuring Cost and Reserve [Line Items]
Charges incurred to-date	40.9
Estimated charges to be incurred on approved initiatives	0
Total expected charges on approved initiatives	40.9
Transformation Plan | Foreign Currency Translation Adjustment Write-offs
Restructuring Cost and Reserve [Line Items]
Charges incurred to-date	3.4
Estimated charges to be incurred on approved initiatives	0
Total expected charges on approved initiatives	$ 3.4

RESTRUCTURING INITIATIVES (Char

RESTRUCTURING INITIATIVES (Charges Reportable by Business Segment) (Details) - USD ($) $ in Millions	3 Months Ended			12 Months Ended
	Sep. 30, 2019	Jun. 30, 2019	Mar. 31, 2019	Dec. 31, 2018	Dec. 31, 2017	Dec. 31, 2016	Dec. 31, 2015
Open Up Avon
Restructuring Cost and Reserve [Line Items]
Charges incurred	$ 1.7	$ 25.2	$ 33.2	$ 117.1
Charges incurred to-date	177.2
Estimated charges to be incurred on approved initiatives	1.7
Total expected charges on approved initiatives	178.9
Open Up Avon | Europe, Middle East & Africa
Restructuring Cost and Reserve [Line Items]
Charges incurred	(0.8)	4.5	13.5	32.2
Charges incurred to-date	49.4
Estimated charges to be incurred on approved initiatives	1.7
Total expected charges on approved initiatives	51.1
Open Up Avon | South Latin America
Restructuring Cost and Reserve [Line Items]
Charges incurred	1.6	13.7	12.7	36.4
Charges incurred to-date	64.4
Estimated charges to be incurred on approved initiatives
Total expected charges on approved initiatives	64.4
Open Up Avon | North Latin America
Restructuring Cost and Reserve [Line Items]
Charges incurred	0.4	4.3	2.9	27.9
Charges incurred to-date	35.5
Estimated charges to be incurred on approved initiatives
Total expected charges on approved initiatives	35.5
Open Up Avon | Asia Pacific
Restructuring Cost and Reserve [Line Items]
Charges incurred	0.4	(1.2)	(3.2)	14.4
Charges incurred to-date	10.4
Estimated charges to be incurred on approved initiatives
Total expected charges on approved initiatives	10.4
Open Up Avon | Global & Other Operating Segments
Restructuring Cost and Reserve [Line Items]
Charges incurred	0.1	3.9	7.3	6.2
Charges incurred to-date	17.5
Estimated charges to be incurred on approved initiatives
Total expected charges on approved initiatives	17.5
Transformation Plan
Restructuring Cost and Reserve [Line Items]
Charges incurred	0.5	0	(0.8)	23.7	$ 54.8	$ 74.4	$ 21.4
Charges incurred to-date	174
Estimated charges to be incurred on approved initiatives	0
Total expected charges on approved initiatives	174
Transformation Plan | Europe, Middle East & Africa
Restructuring Cost and Reserve [Line Items]
Charges incurred	(0.1)	0	(1.1)	5	0.9	30.9	0
Charges incurred to-date	35.6
Estimated charges to be incurred on approved initiatives	0
Total expected charges on approved initiatives	35.6
Transformation Plan | South Latin America
Restructuring Cost and Reserve [Line Items]
Charges incurred	0.5	0	0	4.1	5.6	13.2	0
Charges incurred to-date	23.4
Estimated charges to be incurred on approved initiatives	0
Total expected charges on approved initiatives	23.4
Transformation Plan | North Latin America
Restructuring Cost and Reserve [Line Items]
Charges incurred	0	0	0	0.6	(0.6)	4.4	0
Charges incurred to-date	4.4
Estimated charges to be incurred on approved initiatives	0
Total expected charges on approved initiatives	4.4
Transformation Plan | Asia Pacific
Restructuring Cost and Reserve [Line Items]
Charges incurred	0	0	0	0.6	(0.5)	9.1	0
Charges incurred to-date	9.2
Estimated charges to be incurred on approved initiatives	0
Total expected charges on approved initiatives	9.2
Transformation Plan | Global & Other Operating Segments
Restructuring Cost and Reserve [Line Items]
Charges incurred	0.1	$ 0	$ 0.3	$ 13.4	$ 49.4	$ 16.8	$ 21.4
Charges incurred to-date	101.4
Estimated charges to be incurred on approved initiatives	0
Total expected charges on approved initiatives	$ 101.4

AGREEMENT AND PLAN OF MERGERS_2

AGREEMENT AND PLAN OF MERGERS WITH NATURA COSMETICOS S.A. (Details) - USD ($) $ in Millions	May 22, 2019	Sep. 30, 2019
Business Combination, Separately Recognized Transactions [Line Items]
Expected transaction costs remaining		$ 31
Merger Agreement
Business Combination, Separately Recognized Transactions [Line Items]
Share conversion ratio	60.00%
Transaction costs		$ 27
American Depositary Shares | Merger Agreement
Business Combination, Separately Recognized Transactions [Line Items]
Share conversion ratio	30.00%

GOODWILL (Schedule of Goodwill)

GOODWILL (Schedule of Goodwill) (Details) $ in Millions	9 Months Ended
	Sep. 30, 2019USD ($)
Goodwill [Roll Forward]
Net balance at beginning	$ 87.4
Foreign exchange	(4.9)
Net balance at ending	82.5
Europe, Middle East & Africa
Goodwill [Roll Forward]
Net balance at beginning	18
Foreign exchange	(1)
Net balance at ending	17
South Latin America
Goodwill [Roll Forward]
Net balance at beginning	66.8
Foreign exchange	(3.9)
Net balance at ending	62.9
Asia Pacific
Goodwill [Roll Forward]
Net balance at beginning	2.6
Foreign exchange	0
Net balance at ending	$ 2.6

FAIR VALUE FAIR VALUE ASSETS AN

FAIR VALUE FAIR VALUE ASSETS AND LIABILITIES (Details) - Fair Value, Measurements, Recurring $ in Millions	Sep. 30, 2019USD ($)
Assets:
Available-for-sale securities	$ 4
Foreign exchange forward contracts	17
Total Assets	21
Liabilities:
Foreign exchange forward contracts	2
Total Liabilities	2
Level 1
Assets:
Available-for-sale securities	4
Foreign exchange forward contracts	0
Total Assets	4
Liabilities:
Foreign exchange forward contracts	0
Total Liabilities	0
Level 2
Assets:
Available-for-sale securities	0
Foreign exchange forward contracts	17
Total Assets	17
Liabilities:
Foreign exchange forward contracts	2
Total Liabilities	$ 2

FAIR VALUE (Fair Value of Finan

FAIR VALUE (Fair Value of Financial Instruments) (Details) - USD ($) $ in Millions	Sep. 30, 2019	Dec. 31, 2018
Carrying Amount
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Available-for-sale securities	$ 4	$ 3.8
Debt maturing within one year	(116.2)	(12)
Long-term debt	(1,589.1)	(1,581.6)
Fair Value
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Available-for-sale securities	4	3.8
Debt maturing within one year	(117.4)	(12)
Long-term debt	(1,696.7)	(1,460.2)
Foreign exchange forward contracts | Carrying Amount
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Foreign exchange forward contracts	15	(5.1)
Foreign exchange forward contracts | Fair Value
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Foreign exchange forward contracts	$ 15	$ (5.1)

DERIVATIVE INSTRUMENTS FAIR VAL

DERIVATIVE INSTRUMENTS FAIR VALUE (Details) - Fair Value, Measurements, Recurring $ in Millions	Sep. 30, 2019USD ($)
Derivative [Line Items]
Foreign exchange forward contracts, asset	$ 17
Foreign exchange forward contracts, liability	2
Prepaid expenses and other | Designated as Hedging Instrument
Derivative [Line Items]
Foreign exchange forward contracts, asset	0
Prepaid expenses and other | Not Designated as Hedging Instrument
Derivative [Line Items]
Foreign exchange forward contracts, asset	17
Accounts payable | Designated as Hedging Instrument
Derivative [Line Items]
Foreign exchange forward contracts, liability	1.9
Accounts payable | Not Designated as Hedging Instrument
Derivative [Line Items]
Foreign exchange forward contracts, liability	$ 0.1

DERIVATIVE INSTRUMENTS AND HE_3

DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES (Details)	3 Months Ended		9 Months Ended
	Sep. 30, 2019USD ($)	Sep. 30, 2018USD ($)	Sep. 30, 2019USD ($)	Sep. 30, 2018USD ($)	Dec. 31, 2018	Mar. 31, 2012USD ($)derivative_instrument
Derivative [Line Items]
Total exposure to floating rate interest rates	7.00%		7.00%		1.00%
Foreign Exchange Contract
Derivative [Line Items]
Notional amount	$ 893,300,000		$ 893,300,000
Gain (loss) on foreign currency derivative instruments not designated as hedging instruments	35,100,000	$ 2,000,000	57,000,000	$ (1,100,000)
March 2012 Interest-Rate Swap Termination
Derivative [Line Items]
Number of interest-rate swap agreements terminated | derivative_instrument						2
Notional amount						$ 350,000,000
Deferred gain (loss) on discontinuation of interest rate fair value hedge						$ 46,100,000
Amortization of interest rate swap gains	0	$ 0	0	$ 6,000,000
Designated as Hedging Instrument | Foreign Exchange Contract
Derivative [Line Items]
Notional amount	$ 13,100,000		$ 13,100,000

DEBT (Details)

DEBT (Details)	1 Months Ended		3 Months Ended	9 Months Ended
	Feb. 28, 2019EUR (€)	Jun. 30, 2015USD ($)	Mar. 31, 2019USD ($)	Sep. 30, 2019USD ($)	Sep. 30, 2019EUR (€)	Jul. 31, 2019USD ($)	Aug. 31, 2016USD ($)	Jun. 30, 2013	Mar. 31, 2013USD ($)
Debt Instrument [Line Items]
Capitalized issue costs				$ 9,000,000
2015 Facility
Debt Instrument [Line Items]
Debt term		5 years
Line of credit facility		$ 400,000,000
Write off debt issuance costs			$ 2,000,000
2013 Notes
Debt Instrument [Line Items]
Increase in interest rate for every one-notch downgrade of long-term credit ratings below investment grade				0.25%
Maximum aggregate increase in interest rate related to downgrade of long-term credit ratings below investment grade				2.00%
4.6% Notes due February 2022 | 2019 Facility
Debt Instrument [Line Items]
Debt term	3 years
Line of credit facility	€ 200,000,000			$ 218,000,000
Interest rate	4.60%
Debt issuance costs			$ 11,000,000
Remaining borrowing capacity | €					€ 179,000,000
4.6% Notes due March 2023
Debt Instrument [Line Items]
Interest rate								4.60%	4.60%
Principal amount				112,300,000		$ 274,800,000			$ 500,000,000
5.0% Notes due March 2023
Debt Instrument [Line Items]
Interest rate									5.00%
Principal amount						$ 400,000,000			$ 500,000,000
6.95% Notes due March 2043
Debt Instrument [Line Items]
Interest rate									6.95%
Principal amount									$ 250,000,000
7.875% Notes due August 2023
Debt Instrument [Line Items]
Interest rate							7.875%
Principal amount							$ 500,000,000
6.5% Notes due in August 2022 | 2019 Notes
Debt Instrument [Line Items]
Interest rate						6.50%
Principal amount						$ 400
AIO
Debt Instrument [Line Items]
Standby letters of credit, recorded liability				$ 23,000,000

INCOME TAXES (Details)

INCOME TAXES (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Sep. 30, 2019	Sep. 30, 2018	Sep. 30, 2019	Sep. 30, 2018
Income Tax Disclosure [Abstract]
Effective income tax rate, excluding discrete items			25.20%	23.60%
Income taxes provision	$ 31.5	$ 68.3	$ 78.2	$ 136.5
Effective income tax rate	21.80%	37.50%	48.50%	71.00%
Discreet tax expense (benefit)			$ (5.2)
Miscellaneous income tax expense (benefit)	$ (2.3)	$ (1.9)	(2.2)	$ (1)
Change in income tax reserve (release)		(3.1)	$ (3)
Income tax accrual		14		14
Deferred tax asset		$ 4.1		4.1
Tax expense, uncertain tax positions				$ 10.9

Uncategorized Items - avp-20190

Label	Element	Value
Cumulative Effect of New Accounting Principle in Period of Adoption	us-gaap_CumulativeEffectOfNewAccountingPrincipleInPeriodOfAdoption	$ (41,100,000)
Retained Earnings, Appropriated [Member]
Cumulative Effect of New Accounting Principle in Period of Adoption	us-gaap_CumulativeEffectOfNewAccountingPrincipleInPeriodOfAdoption	$ (41,100,000)